estrone has been researched along with Menopause in 578 studies
Hydroxyestrones: Estrone derivatives substituted with one or more hydroxyl groups in any position. They are important metabolites of estrone and other estrogens.
Menopause: The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age.
Excerpt | Relevance | Reference |
---|---|---|
"One hundred and one postmenopausal patients with advanced breast cancer were enrolled in a randomized phase II clinical trial to investigate the clinical and hormonal response to aminoglutethimide administered at daily doses of 2 x 125 mg, 3 x 125 mg or 2 x 250 mg, with no addition of hydrocortisone." | 9.06 | Low dose aminoglutethimide without hydrocortisone for the treatment of advanced postmenopausal breast cancer. ( Bonfrer, JM; Bruning, PF; de Jong-Bakker, M; Hart, AA; Moolenaar, AJ; Nooijen, WJ; van der Linden, E, 1989) |
"4-Hydroxyandrostenedione (CGP32349; 4-OHA) is a clinically effective treatment for advanced postmenopausal breast cancer by both the parenteral and p." | 9.06 | Dose-related endocrine effects and pharmacokinetics of oral and intramuscular 4-hydroxyandrostenedione in postmenopausal breast cancer patients. ( Coombes, RC; Cunningham, DC; Dehennin, L; Dowsett, M; Evans, S; Hedley, A; Stein, RC, 1989) |
"A group of 122 postmenopausal patients with histologically proven node-positive primary breast cancer have been randomized to receive aminoglutethimide-hydrocortisone or placebo aminoglutethimide-placebo hydrocortisone for 2 years." | 9.05 | Adjuvant aminoglutethimide therapy for postmenopausal patients with primary breast cancer: progress report. ( Bettelheim, R; Chilvers, C; Coombes, RC; Dowsett, M; Ford, HT; Gazet, JC; Gordon, C; Powles, TJ; Smith, IE; Zava, D, 1982) |
"The effect of the dose of aminoglutethimide on the suppression of oestrone, oestradiol and dehydroepiandrosterone sulphate (DHAS) levels was studied in 36 women with advanced postmenopausal breast cancer, all of whom received 20 mg hydrocortisone twice daily as replacement glucocorticoid." | 9.05 | Aminoglutethimide dose and hormone suppression in advanced breast cancer. ( Dowsett, M; Harris, AL; Jeffcoate, SL; Smith, IE, 1983) |
"The endocrine effects of replacement doses of hydrocortisone in postmenopausal women with advanced breast cancer were compared with the same doses of hydrocortisone plus aminoglutethimide." | 9.05 | Hydrocortisone alone vs hydrocortisone plus aminoglutethimide: a comparison of the endocrine effects in postmenopausal breast cancer. ( Dowsett, M; Harris, AL; Jeffcoate, S; Smith, IE, 1984) |
"Aminoglutethimide is effective in the treatment of breast cancer in postmenopausal patients as a result of its inhibition of aromatase." | 7.68 | Low-dose aminoglutethimide in postmenopausal breast cancer: effects on adrenal and thyroid hormone secretion. ( Cantwell, BM; Dowsett, M; Harris, AL; Mehta, A, 1991) |
"Values were determined by means of a ligand binding assay using 17-FE (17-fluoresceinated estrone) in 53 breast cancer patients." | 7.68 | [Fixation of fluorescent estrone derivative on human breast cancer cells. Correlation with age, menopause status and histopathology]. ( Alamy, H; Baltali, E; Bouih, A; el Gueddari, B; el Hafed, A; Kettani, F; Morchid, M; Souadka, A; Souadka, F; Wydadi, M, 1990) |
"The activities of aromatase and estrone sulfatase which are important enzymes involved in the local production of estrogen in breast cancer tissue were measured to examine their availability in endocrine therapy and their clinical significance." | 7.67 | [Local production of estrogen via aromatase and estrone sulfatase in breast cancer tissue]. ( Utsumi, T, 1989) |
"The possibility that medroxyprogesterone acetate (MPA) is clinically effective at least in part by its suppression of adrenal steroidogenesis and a resultant reduction of circulating oestrogen levels was investigated in 49 postmenopausal patients with advanced breast cancer." | 7.67 | The effects of low and high dose medroxyprogesterone acetate on sex steroids and sex hormone binding globulin in postmenopausal breast cancer patients. ( Dowsett, M; Jeffcoate, SL; Lal, A; Smith, IE, 1987) |
"5 mg, twice a day) aminoglutethimide (AG), without hydrocortisone (HC), escalating at monthly intervals to a conventional dose of AG (500 mg twice a day) combined with HC, were studied in 33 postmenopausal breast cancer patients." | 7.67 | Endocrine effects of low dose aminoglutethimide as an aromatase inhibitor in the treatment of breast cancer. ( D'Souza, A; Donaldson, A; Dowsett, M; Harris, AL; Jeffcoate, SL; Smith, IE; Stuart-Harris, R, 1985) |
"The effects of aging as well as body weight on conversion of circulating Androstendione (A) to Estrone (E1) in 21 postmenopausal women of different ages and body weights have been studied." | 7.67 | [Effects of age and obesity on the conversion of androstenedione to estrone in postmenopausal women]. ( Ortega, E; Osorio, C; Ruiz, E, 1988) |
"Estrone and estradiol-17 beta concentration in breast cancer tissue are reported to be an order of magnitude higher than those of circulating plasma in breast cancer patients." | 7.67 | [Serum estrone sulfate levels in patients with breast cancer]. ( Honjyo, H; Oka, T; Okada, H; Yasumura, T, 1988) |
"The conversion of 1 beta [3H] androstenedione to estrone in the presence of NADPH by breast cancer homogenates was assessed in tumors from 35 subjects together with estrogen and progesterone receptor concentration." | 7.67 | Aromatisation of androstenedione by human breast cancer tissue: correlation with hormone receptor activity and possible biologic significance. ( Bezwoda, WR; Dansey, R; Esser, JD; Mansoor, N, 1987) |
"Oestrone sulphate, the oestrogen in highest concentration in the plasma, may play a role in the induction and growth of breast cancers." | 7.67 | Oestrone sulphate, adipose tissue, and breast cancer. ( Hawkins, RA; Killen, E; Thomson, ML, 1985) |
"Postmenopausal women with metastatic breast cancer were treated with trilostane, initially 240 mg daily increasing after 3 days to 480 mg daily and after a further three days to 960 mg daily." | 7.67 | Hormonal changes in postmenopausal women with breast cancer treated with trilostane and dexamethasone. ( Beardwell, CG; Bu'lock, D; Hindley, AC; St John, J; Wilkinson, PM, 1985) |
"Peripheral serum levels of cortisol, dehydroepiandrosterone (DHA), dehydroepiandrosterone sulphate (DHA-S), oestradiol-17 beta and total oestrone were measured in 17 postmenopausal breast cancer patients and on age-matched healthy controls." | 7.66 | Effects of tamoxifen on the serum levels of oestrogens and adrenocortical steroids in postmenopausal breast cancer patients. ( Carlström, K; Sköldefors, H; Theve, NO; Wallgren, A; Wilking, N, 1982) |
"Plasma androstenedione (A) levels and plasma oestrone (E1) levels were measured by radioimmunoassay in a total of 135 healthy women (the control group), around the menopause." | 7.66 | Plasma androstenedione and oestrone levels before and after the menopause. I. Glandular hyperplasia and adenocarcinoma of the endometrium. ( Battaglia, F; Mango, D; Montemurro, A; Scirpa, P; Scirpa, S, 1982) |
"To study the relation between body weight and height and the plasma sex-hormone levels wer measured the plasma levels of oestrone (E1), oestradiol (E2) and androstenedione (A) in a group of healthy post-menopausal women with a wide range of body weight." | 7.66 | Plasma oestrone, oestradiol and androstenedione levels in post-menopausal women: relation to body weight and height. ( de Waard, F; Poortman, J; Thijssen, JH, 1981) |
"The daily excretion of estrone, estradiol, and estriol was determined for 22 normal women and 35 women with primary breast cancer." | 7.66 | Urinary excretion of estrone, estradiol, and estriol in postmenopausal women with primary breast cancer. ( Dao, TL; Lonergan, PA; Morreal, CE; Nemoto, T, 1979) |
"To determine if delta 1-testololactone can inhibit the peripheral aromatization of androstenedione (delta), nine postmenopausal women with metastatic breast cancer were studied before and after 2 weeks of therapy with 250 mg of the drug, given every 6 h by mouth." | 7.66 | Inhibition of peripheral aromatization of androstenedione to estrone in postmenopausal women with breast cancer using delta 1-testololactone. ( Barone, RM; Judd, HL; Shamonki, IM; Siiteri, PK, 1979) |
"The concentrations of estrone (E1), androstenedione (A), testosterone (T) and sex-hormone-binding globulin (SHBG) in the serum were determined in 122 postmenopausal women, unselected with respect to age and stage of disease and with a newly diagnosed breast cancer." | 7.66 | Serum concentrations of estrone, androstenedione, testosterone and sex-hormone-binding globulin in postmenopausal women with breast cancer and in age-matched controls. ( Adami, HO; Johansson, ED; Vegelius, J; Victor, A, 1979) |
"The purpose of this study was to ascertain if a relationship exists between the transfer constant of conversion of plasma androstenedione to estrone ([rho]AE1BU) and total body weight or excessive body weight in 50 postmenopausal women, of whom 25 had adenocarcinoma of the endometrium and 25 had no endometrial disease." | 7.66 | Effect of obesity on conversion of plasma androstenedione to estrone in postmenopausal women with and without endometrial cancer. ( Edman, CD; Hemsell, DL; MacDonald, PC; Porter, JC; Siiteri, PK, 1978) |
"We have infused [6,7-3H]estrone or [6,7-3H]estradiol and [4-14C]estriol into seven women who had had breast cancer and into five normal postmenopausal women." | 7.66 | Estriol production rates and breast cancer. ( Longcope, C; Pratt, JH, 1978) |
"Fifty-nine postmenopausal women with advanced breast cancer were treated with tamoxifen (antiestrogen), 20 mg orally twice a day for at least 2 months." | 7.65 | Tamoxifen (antiestrogen) therapy in advanced breast cancer. ( Kennedy, BJ; Kiang, DT, 1977) |
" There was a significant monotonic dose-response relationship of estrone sulfate in raising HDL levels, lowering LDL levels, and raising the HDL/LDL ratio at all intervals measured." | 6.67 | Effect of cyclic estrone sulfate treatment on lipid profiles of postmenopausal women with elevated cholesterol levels. ( Green, EM; Jennings, D; Katz-Karp, S; Lancaster, J; Notelovitz, M; Stoll, RW, 1990) |
" While this regimen effectively blocked adrenal function, it was complicated by a drug interaction in which aminoglutethimide accelerated the metabolism and reduced the bioavailability of dexamethasone." | 6.36 | Kinetic, hormonal and clinical studies with aminoglutethimide in breast cancer. ( Harvey, H; Kendall, J; Lipton, A; Ruby, EB; Samojlik, E; Santen, RJ; Wells, SA, 1977) |
"Serum and urine were collected from 65 breast cancer patients and 36 controls after an overnight fast." | 5.30 | Urinary 2/16 alpha-hydroxyestrone ratio: correlation with serum insulin-like growth factor binding protein-3 and a potential biomarker of breast cancer risk. ( Foo, SC; Ho, GH; Ji, CY; Luo, XW; Ng, EH, 1998) |
"There was no change in the size of the uterine leiomyomata." | 5.28 | Tamoxifen prolongs luteal phase in premenopausal women but has no effect on the size of uterine fibroids. ( Baird, DT; Lumsden, MA; West, CP, 1989) |
"Ketoconazole was poorly tolerated due to gastrointestinal toxicity." | 5.27 | High dose ketoconazole: endocrine and therapeutic effects in postmenopausal breast cancer. ( Cantwell, BM; Dowsett, M; Harris, AL, 1988) |
" Ten patients with histologically proven endometrial hyperplasia were treated with Danazol at a dosage of 600 mg/day for 30 days." | 5.27 | Preliminary report on postmenopausal endometrial hyperplasia treatment with Danazol: histological and endocrinological aspects. ( Bulletti, C; Ciotti, P; Flamigni, C; Jasonni, VM; La Marca, L; Naldi, S; Vignudelli, A, 1986) |
" The dosages of E3 employed appear to vary considerably, and the need was felt to establish the dosage on a scientific basis." | 5.26 | The significance of oestriol in the management of the post-menopause. ( Aksu, MF; Greenblatt, RB; Tzingounis, VA, 1980) |
"Estriol was administered for a six-month period as estrogen replacement therapy to 52 symptomatic postmenopausal women." | 5.26 | Estriol in the management of the menopause. ( Aksu, MF; Greenblatt, RB; Tzingounis, VA, 1978) |
"One hundred and one postmenopausal patients with advanced breast cancer were enrolled in a randomized phase II clinical trial to investigate the clinical and hormonal response to aminoglutethimide administered at daily doses of 2 x 125 mg, 3 x 125 mg or 2 x 250 mg, with no addition of hydrocortisone." | 5.06 | Low dose aminoglutethimide without hydrocortisone for the treatment of advanced postmenopausal breast cancer. ( Bonfrer, JM; Bruning, PF; de Jong-Bakker, M; Hart, AA; Moolenaar, AJ; Nooijen, WJ; van der Linden, E, 1989) |
"4-Hydroxyandrostenedione (CGP32349; 4-OHA) is a clinically effective treatment for advanced postmenopausal breast cancer by both the parenteral and p." | 5.06 | Dose-related endocrine effects and pharmacokinetics of oral and intramuscular 4-hydroxyandrostenedione in postmenopausal breast cancer patients. ( Coombes, RC; Cunningham, DC; Dehennin, L; Dowsett, M; Evans, S; Hedley, A; Stein, RC, 1989) |
"A group of 122 postmenopausal patients with histologically proven node-positive primary breast cancer have been randomized to receive aminoglutethimide-hydrocortisone or placebo aminoglutethimide-placebo hydrocortisone for 2 years." | 5.05 | Adjuvant aminoglutethimide therapy for postmenopausal patients with primary breast cancer: progress report. ( Bettelheim, R; Chilvers, C; Coombes, RC; Dowsett, M; Ford, HT; Gazet, JC; Gordon, C; Powles, TJ; Smith, IE; Zava, D, 1982) |
"The effect of the dose of aminoglutethimide on the suppression of oestrone, oestradiol and dehydroepiandrosterone sulphate (DHAS) levels was studied in 36 women with advanced postmenopausal breast cancer, all of whom received 20 mg hydrocortisone twice daily as replacement glucocorticoid." | 5.05 | Aminoglutethimide dose and hormone suppression in advanced breast cancer. ( Dowsett, M; Harris, AL; Jeffcoate, SL; Smith, IE, 1983) |
"The endocrine effects of replacement doses of hydrocortisone in postmenopausal women with advanced breast cancer were compared with the same doses of hydrocortisone plus aminoglutethimide." | 5.05 | Hydrocortisone alone vs hydrocortisone plus aminoglutethimide: a comparison of the endocrine effects in postmenopausal breast cancer. ( Dowsett, M; Harris, AL; Jeffcoate, S; Smith, IE, 1984) |
"Aminoglutethimide (AG) has antitumor activity in disseminated breast cancer similar to that of surgical adrenalectomy." | 5.05 | The role of aromatase inhibitors in breast cancer. ( Powles, TJ, 1983) |
" Occult hypothyroidism reduces the rate of oestrogen inactivation by C2 hydroxylation, and 15-20% of women have low rates of C16 hydroxylation to oestriol." | 4.76 | Pathophysiologic considerations in the treatment of menopausal patients with oestrogens; the role of oestriol in the prevention of mammary carcinoma. ( Lemon, HM, 1980) |
"Androstenedione, the main circulating ovarian hormone present after menopause, has been shown to positively correlate with poor spatial memory in an ovary-intact rodent model of follicular depletion, and to impair spatial memory when administered exogenously to surgically menopausal ovariectomized rats." | 3.81 | Pharmacological blockade of the aromatase enzyme, but not the androgen receptor, reverses androstenedione-induced cognitive impairments in young surgically menopausal rats. ( Acosta, JI; Alderete, TJ; Bimonte-Nelson, HA; Camp, BW; Demers, LM; Koebele, SV; Mennenga, SE; Mousa, AA; Tsang, CW, 2015) |
"To describe changes in levels of cognitive symptoms (forgetting and difficulty concentrating) during the menopausal transition (MT) stages and early postmenopause, including effects of age, MT-related factors(MT stages, estrone, follicle stimulating hormone (FSH), testosterone), symptoms (hot flush, sleep, mood), health-related factors (alcohol use, smoking, exercise, perceived health), stress-related factors (perceived stress, history of sexual abuse, cortisol, catecholamines) and social factors (partner and parenting status, education, employment)." | 3.77 | Cognitive symptoms during the menopausal transition and early postmenopause. ( Mitchell, ES; Woods, NF, 2011) |
"A subset of Seattle Midlife Women's Health Study (SMWHS) participants who provided data during the early reproductive, early and late menopausal transition stages, or postmenopause (n = 286), including menstrual calendars for staging the MT, annual health reports between 1990 and 2005, and morning urine samples assayed for estrone glucuronide (E(1)G), testosterone (T), and follicle-stimulating hormone (FSH) was included." | 3.76 | Sexual desire during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women's Health Study. ( Mitchell, ES; Smith-Di Julio, K; Woods, NF, 2010) |
" Daily oral MPG (1000 mg/kg body weight) for 2 weeks significantly recovered uterine and adrenal gland atrophy and restored serum estradiol, estrone and progesterone levels that were decreased in rats by bilateral ovariectomy." | 3.76 | Estrogenic effects of the herbal formula, menoprogen, in ovariectomized rats. ( Chung, MH; Hattori, M; Lu, Y; Ma, H; Nishihara, T, 2010) |
"The aims of this study were to examine the association of smoking with the occurrence, frequency, and severity of hot flashes and to determine whether the mechanism by which active cigarette smoking increases the risk of hot flashes is by lowering estradiol and estrone levels." | 3.73 | Cigarette smoking, estrogen levels, and hot flashes in midlife women. ( Babus, J; Flaws, JA; Gallicchio, L; Lewis, LM; Miller, SR; Visvanathan, K; Zacur, H, 2006) |
" Although angiotensin converting enzyme inhibition has been shown to prevent progression of the disease in postmenopausal women, the interaction of angiotensin II and estrogen in this process before and after the menopause is poorly understood." | 3.70 | Angiotensin converting enzyme inhibition modulates cardiac fibroblast growth. ( Grohé, C; Kahlert, S; Löbbert, K; Neyses, L; Stimpel, M; van Eickels, M; Vetter, H, 1998) |
"This study examines the cross-sectional association of hysterectomy and oophorectomy status, chronological age, and years since menopause with plasma levels of total and bioavailable testosterone and estradiol, androstenedione, estrone, and sex hormone-binding globulin (SHBG) in community-dwelling postmenopausal women who were not using estrogen replacement therapy." | 3.70 | Hysterectomy, oophorectomy, and endogenous sex hormone levels in older women: the Rancho Bernardo Study. ( Barrett-Connor, E; Kritz-Silverstein, D; Laughlin, GA; von Mühlen, D, 2000) |
"A major obstacle to the understanding of the mechanisms of action of aromatase inhibitors in breast cancer is the observation that plasma estrogens are sustained at about 30-50% of their control levels despite 85-95% inhibition of the conversion of tracer androstenedione (A) to estrone (E1)." | 3.69 | A sensitive assay for measurement of plasma estrone sulphate in patients on treatment with aromatase inhibitors. ( Ekse, D; Lønning, PE, 1995) |
"Serum dehydroepiandrosterone (DHEA), estrone (E1), and estradiol (E2) levels were prospectively measured in 47 breast cancer patients before and during tamoxifen therapy for 2 years." | 3.69 | Changes in serum estrogen levels in women during tamoxifen therapy. ( Fletcher, WS; Lum, SS; Pommier, RF; Woltering, EA, 1997) |
"The aim of this study was to investigate the possible role of epidermal growth factor (EGF) and of insulin-like growth factor-I (IGF-I) in physiological and pathological changes of the endometrial tissue during aging." | 3.68 | Role of growth factors in the human endometrium during aging. ( Costantini, C; de Cecco, L; Gallo, G; Leone, M; Massajoli, M; Messeni Leone, M; Voci, A, 1993) |
"Aminoglutethimide is effective in the treatment of breast cancer in postmenopausal patients as a result of its inhibition of aromatase." | 3.68 | Low-dose aminoglutethimide in postmenopausal breast cancer: effects on adrenal and thyroid hormone secretion. ( Cantwell, BM; Dowsett, M; Harris, AL; Mehta, A, 1991) |
"The effect of tamoxifen on the vaginal mucosa and on serum oestrone, oestradiol and gonadotrophin concentrations was investigated in a group of nine postmenopausal women with non-metastatic breast cancer." | 3.68 | Tamoxifen and partial oestrogen agonism in postmenopausal women. ( Burton, R; Castleden, CM; Ekelund, P; Miodrag, A, 1991) |
"Values were determined by means of a ligand binding assay using 17-FE (17-fluoresceinated estrone) in 53 breast cancer patients." | 3.68 | [Fixation of fluorescent estrone derivative on human breast cancer cells. Correlation with age, menopause status and histopathology]. ( Alamy, H; Baltali, E; Bouih, A; el Gueddari, B; el Hafed, A; Kettani, F; Morchid, M; Souadka, A; Souadka, F; Wydadi, M, 1990) |
"Plasma estrone sulphate ( E1S ) and estrone (E1) concentrations were determined in healthy postmenopausal women and in postmenopausal women with endometrial cancer, matched for body weight, age, and years since menopause." | 3.67 | Estrone sulphate plasma levels in postmenopausal women with and without endometrial cancer. ( Bolelli, G; Bonavia, M; Bulletti, C; Ciotti, P; Flamigni, C; Franceschetti, F; Jasonni, VM, 1984) |
"Plasma androstenedione (A) and oestrone (E1) levels were measured by radioimmunoassay in a group of 78 healthy women who had undergone a natural menopause." | 3.67 | Plasma androstenedione and oestrone levels in the climacteric syndrome. ( Battaglia, F; Bini, E; Mango, D; Scirpa, P, 1984) |
"Plasma 4-en-androstenedione, testosterone, estradiol and estrone were measured during the day in six healthy postmenopausal women and in six breast cancer patients, three of whom received treatment with glucocorticoids." | 3.67 | Lack of diurnal variation in plasma levels of androstenedione, testosterone, estrone and estradiol in postmenopausal women. ( Dowsett, M; Hardy, J; Jacobs, S; Lønning, PE; Powles, TJ; Schem, B, 1989) |
"The activities of aromatase and estrone sulfatase which are important enzymes involved in the local production of estrogen in breast cancer tissue were measured to examine their availability in endocrine therapy and their clinical significance." | 3.67 | [Local production of estrogen via aromatase and estrone sulfatase in breast cancer tissue]. ( Utsumi, T, 1989) |
"The endocrine effects of aminoglutethimide 125 mg twice daily and hydrocortisone 20 mg twice daily were assessed in 45 postmenopausal women with advanced breast cancer." | 3.67 | Endocrine effects of low dose aminoglutethimide with hydrocortisone--an optimal hormone suppressive regimen. ( Cantwell, BM; Dowsett, M; Farndon, J; Harris, AL; Needham, G; Sainsbury, JR; Wilson, R, 1986) |
"The possibility that medroxyprogesterone acetate (MPA) is clinically effective at least in part by its suppression of adrenal steroidogenesis and a resultant reduction of circulating oestrogen levels was investigated in 49 postmenopausal patients with advanced breast cancer." | 3.67 | The effects of low and high dose medroxyprogesterone acetate on sex steroids and sex hormone binding globulin in postmenopausal breast cancer patients. ( Dowsett, M; Jeffcoate, SL; Lal, A; Smith, IE, 1987) |
" This loss, combined with the low plasma concentrations of androstenedione, dehydroepiandrosterone, and testosterone (and low concentrations of oestrone of adrenal origin), indicates that adrenal androgens may be essential for the maintenance of bone mass in postmenopausal women with Addison's disease." | 3.67 | Bone mineral density in Addison's disease: evidence for an effect of adrenal androgens on bone mass. ( Crabbé, J; Devogelaer, JP; Nagant de Deuxchaisnes, C, 1987) |
"5 mg, twice a day) aminoglutethimide (AG), without hydrocortisone (HC), escalating at monthly intervals to a conventional dose of AG (500 mg twice a day) combined with HC, were studied in 33 postmenopausal breast cancer patients." | 3.67 | Endocrine effects of low dose aminoglutethimide as an aromatase inhibitor in the treatment of breast cancer. ( D'Souza, A; Donaldson, A; Dowsett, M; Harris, AL; Jeffcoate, SL; Smith, IE; Stuart-Harris, R, 1985) |
"The effects of aging as well as body weight on conversion of circulating Androstendione (A) to Estrone (E1) in 21 postmenopausal women of different ages and body weights have been studied." | 3.67 | [Effects of age and obesity on the conversion of androstenedione to estrone in postmenopausal women]. ( Ortega, E; Osorio, C; Ruiz, E, 1988) |
"Estrone and estradiol-17 beta concentration in breast cancer tissue are reported to be an order of magnitude higher than those of circulating plasma in breast cancer patients." | 3.67 | [Serum estrone sulfate levels in patients with breast cancer]. ( Honjyo, H; Oka, T; Okada, H; Yasumura, T, 1988) |
"The results of hCG stimulation on peripheral levels of androstenedione (A), testosterone (T) and estrone (E1) were examined in 14 patients with ovarian tumors and in 9 tumor-free subjects, after the menopause." | 3.67 | Response to human chorionic gonadotropin in patients with ovarian tumors. ( Iacona, T; Liberati, M; Mancuso, S; Mango, D; Manna, P; Ricci, S; Scirpa, P; Tartaglia, E, 1988) |
"The conversion of 1 beta [3H] androstenedione to estrone in the presence of NADPH by breast cancer homogenates was assessed in tumors from 35 subjects together with estrogen and progesterone receptor concentration." | 3.67 | Aromatisation of androstenedione by human breast cancer tissue: correlation with hormone receptor activity and possible biologic significance. ( Bezwoda, WR; Dansey, R; Esser, JD; Mansoor, N, 1987) |
"After infusion of 3H-oestradiol or 3H-oestrone into post-menopausal women with breast cancer, there was a significant uptake of both steroids by breast tumour and normal tissue." | 3.67 | A comparison of the in vivo uptake and metabolism of 3H-oestrone and 3H-oestradiol by normal breast and breast tumour tissues in post-menopausal women. ( Beranek, PA; Bonney, RC; Ghilchik, MW; James, VH; McNeill, JM; Reed, MJ; Robinson, DJ, 1986) |
"Levels of circulating estrone (E1), estradiol (E2), androst-4-ene-3,17-dione (Adione), 3,5,3'-triiodothyronine (T3), thyroxine (T4), and sex hormone-binding globulin (SHBG) were measured in 10 obese postmenopausal patients with breast cancer and in 10 obese postmenopausal control subjects matched for age, body size, and menopausal status." | 3.67 | Decrease of circulating level of SHBG in postmenopausal obese women as a risk factor in breast cancer: reversible effect of weight loss. ( Cardillo, LR; del Carmen Cremona, M; Enriori, CL; Etkin, AE; Orsini, W; Reforzo-Membrives, J, 1986) |
"Oestrone sulphate, the oestrogen in highest concentration in the plasma, may play a role in the induction and growth of breast cancers." | 3.67 | Oestrone sulphate, adipose tissue, and breast cancer. ( Hawkins, RA; Killen, E; Thomson, ML, 1985) |
"Postmenopausal women with metastatic breast cancer were treated with trilostane, initially 240 mg daily increasing after 3 days to 480 mg daily and after a further three days to 960 mg daily." | 3.67 | Hormonal changes in postmenopausal women with breast cancer treated with trilostane and dexamethasone. ( Beardwell, CG; Bu'lock, D; Hindley, AC; St John, J; Wilkinson, PM, 1985) |
"Peripheral serum levels of cortisol, dehydroepiandrosterone (DHA), dehydroepiandrosterone sulphate (DHA-S), oestradiol-17 beta and total oestrone were measured in 17 postmenopausal breast cancer patients and on age-matched healthy controls." | 3.66 | Effects of tamoxifen on the serum levels of oestrogens and adrenocortical steroids in postmenopausal breast cancer patients. ( Carlström, K; Sköldefors, H; Theve, NO; Wallgren, A; Wilking, N, 1982) |
"An analysis of vasomotor, psychological, and physical symptoms of 136 women who were receiving piperazine oestrone sulphate (Ogen) and conjugated equine oestrogens (Premarin) after menopause has shown differences in responses which can be explained only if it is accepted that the two oestrogenic compounds have differing effects on various parts of the body." | 3.66 | Differential clinical response to oestrogens after menopause. ( Brown, LB; Routledge, DA; Wren, BG, 1982) |
"To investigate the influence of obesity on hormonal parameters in 186 apparently healthy women and in 176 women suffering from severe obesity the serum concentrations of FSH, LH, estrone (E1), estradiol (E2), androstenedione (A) and testosterone (T) were determined radioimmunologically." | 3.66 | Influence of severe obesity on peripheral hormone concentrations in pre- and postmenopausal women. ( Klinga, K; Runnebaum, B; von Holst, T, 1983) |
"Medroxyprogesterone acetate (MPA) was administered orally for at least 6 months to 25 patients with endometrial adenocarcinoma starting 1 week after hysterectomy and bilateral ovariectomy." | 3.66 | Effect of medroxyprogesterone acetate on serum levels of LH, FSH, cortisol, and estrone in patients with endometrial carcinoma. ( Backas, NE; Laatikainen, T; Pesonen, K; Stenman, UH; Vesterinen, E, 1981) |
"Estradiol receptor (ER) and progesterone receptor (PR) content along with the cytosol and plasma estrone and estradiol levels in 15 premenopausal and 26 postmenopausal women with breast cancer in different clinical stages (T123, N01, M0) were measured." | 3.66 | Estradiol and progesterone receptor levels in human breast cancer in relation to cytosol and plasma estrogen level. ( Anghel, C; Drafta, D; Gangură, M; Neacşu, E; Panaitescu, G; Prişcu, A; Schindler, AE; Stroe, E, 1983) |
"To evaluate the in vivo effect of delta 1-testololactone on peripheral aromatization, studies were performed on seven postmenopausal women with metastatic breast cancer." | 3.66 | In vivo effects of delta 1-testololactone on peripheral aromatization. ( Barone, RM; Gambone, JC; Judd, HL; Lasley, BL; Laufer, LR; Monfort, SL, 1982) |
"Plasma androstenedione (A) levels and plasma oestrone (E1) levels were measured by radioimmunoassay in a total of 135 healthy women (the control group), around the menopause." | 3.66 | Plasma androstenedione and oestrone levels before and after the menopause. I. Glandular hyperplasia and adenocarcinoma of the endometrium. ( Battaglia, F; Mango, D; Montemurro, A; Scirpa, P; Scirpa, S, 1982) |
" The levels of serum estrone, estradiol and estriol had a tendency of gradual decline after the age of 40, and decreased rapidly 3 years after menopause, but still remained in a certain level thereafter throughout the senile period." | 3.66 | [Serum sex steroid hormones in women with aging, and in the patients of climacteric syndrome and squamous cell carcinoma of the uterus]. ( Nishimura, T, 1982) |
"Twenty women in the perimenopause were studied for 12 months during which sodium-piperazine-estrone-sulphate 2." | 3.66 | Treatment with oral estrone sulphate in the female climacteric. I. Influence on lipids. ( Johnson, P; Lagrelius, A; Lunell, NO; Samsioe, G, 1981) |
"To study the relation between body weight and height and the plasma sex-hormone levels wer measured the plasma levels of oestrone (E1), oestradiol (E2) and androstenedione (A) in a group of healthy post-menopausal women with a wide range of body weight." | 3.66 | Plasma oestrone, oestradiol and androstenedione levels in post-menopausal women: relation to body weight and height. ( de Waard, F; Poortman, J; Thijssen, JH, 1981) |
"Circulating estradiol (E2), estrone (E1), adrostenedione, and testosterone levels were measured in 40 normal postmenopausal women of widely varying body weights." | 3.66 | Relationship of fasting urinary calcium to circulating estrogen and body weight in postmenopausal women. ( Deftos, LJ; Frumar, AM; Geola, F; Judd, HL; Meldrum, DR; Shamonki, IM; Tataryn, IV, 1980) |
"Plasma levels of oestrone and oestradiol-17beta were determined at 20 or 30 minute intervals for up to 24 hours in 26 postmenopausal or ovariectomised women of similar age, weight, and number of years since menopause or operation." | 3.66 | Relation between plasma oestrone and oestradiol and climacteric symptoms. ( Hutton, JD; Jacobs, HS; James, VH; Murray, MA, 1978) |
"To study the contribution of adrenal glands to circulating estrogens in woman, the concentrations of estrone (E1), estradiol-17 beta (E2), and estriol (E3) in adrenal and peripheral venous blood were measured by radioimmunoassay and the grandular secretion of estrogens after ACTH stimulation was investigated by analyzing the adrenal vein levels of these steroids in patients with breast cancer who were undergoing a therapeutic adrenal operation." | 3.66 | Adrenal contribution to circulating estrogens in woman. ( Akamine, Y; Ibayashi, H; Kato, K; Nomura, Y; Wasada, T, 1978) |
"In 55 patients after oophorectomy and 20 women after natural menopause an oral estrogen replacement therapy was performed with estrone-sulfate, estradiol 17-valerate, estriol-succinate, a combination of micronized estradiol and estriol (Estrifam, Trisequens), and natural conjugated estrogens." | 3.66 | Plasma concentrations of unconjugated and conjugated estrogens and gonadotrophins following application of various estrogen preparations after oophorectomy and in the menopause. ( Goessens, L; Lauritzen, C; Strecker, JR, 1979) |
"The daily excretion of estrone, estradiol, and estriol was determined for 22 normal women and 35 women with primary breast cancer." | 3.66 | Urinary excretion of estrone, estradiol, and estriol in postmenopausal women with primary breast cancer. ( Dao, TL; Lonergan, PA; Morreal, CE; Nemoto, T, 1979) |
"To determine if delta 1-testololactone can inhibit the peripheral aromatization of androstenedione (delta), nine postmenopausal women with metastatic breast cancer were studied before and after 2 weeks of therapy with 250 mg of the drug, given every 6 h by mouth." | 3.66 | Inhibition of peripheral aromatization of androstenedione to estrone in postmenopausal women with breast cancer using delta 1-testololactone. ( Barone, RM; Judd, HL; Shamonki, IM; Siiteri, PK, 1979) |
"The concentrations of estrone (E1), androstenedione (A), testosterone (T) and sex-hormone-binding globulin (SHBG) in the serum were determined in 122 postmenopausal women, unselected with respect to age and stage of disease and with a newly diagnosed breast cancer." | 3.66 | Serum concentrations of estrone, androstenedione, testosterone and sex-hormone-binding globulin in postmenopausal women with breast cancer and in age-matched controls. ( Adami, HO; Johansson, ED; Vegelius, J; Victor, A, 1979) |
"The purpose of this study was to ascertain if a relationship exists between the transfer constant of conversion of plasma androstenedione to estrone ([rho]AE1BU) and total body weight or excessive body weight in 50 postmenopausal women, of whom 25 had adenocarcinoma of the endometrium and 25 had no endometrial disease." | 3.66 | Effect of obesity on conversion of plasma androstenedione to estrone in postmenopausal women with and without endometrial cancer. ( Edman, CD; Hemsell, DL; MacDonald, PC; Porter, JC; Siiteri, PK, 1978) |
"Plasma sex hormone concentrations (testosterone, (T), androstenedione (A), oestrone (E1) and oestradiol (E2) were measured in forty post-menopausal women more than 4 years post-normal menopause." | 3.66 | Sex hormone concentrations in post-menopausal women. ( Verdonck, L; Vermeulen, A, 1978) |
"We have infused [6,7-3H]estrone or [6,7-3H]estradiol and [4-14C]estriol into seven women who had had breast cancer and into five normal postmenopausal women." | 3.66 | Estriol production rates and breast cancer. ( Longcope, C; Pratt, JH, 1978) |
"Fifty-nine postmenopausal women with advanced breast cancer were treated with tamoxifen (antiestrogen), 20 mg orally twice a day for at least 2 months." | 3.65 | Tamoxifen (antiestrogen) therapy in advanced breast cancer. ( Kennedy, BJ; Kiang, DT, 1977) |
" Firstly, by measuring the excretion of 12 estrogens in pooled human late pregnancy feces before and during the administration of ampicillin (2 g/day)." | 3.65 | Intestinal metabolism of estrogens. ( Adlercreutz, H; Dencker, H; Martin, F; Pulkkinen, M; Rimér, U; Sjöberg, NO; Tikkanen, MJ, 1976) |
" The estrogens (estriol, estrone, 2-methoxyestrone, estradiol-17beta, estradiol-17alpha, 16-epiestriol, 17-epiestriol, 16-alpha-hydroxyestrone, 16beta-hydroxyestrone, 16oxoestradiol-17beta, and 15alpha-hydroxyestrone) were quantitatively determined in bile from 1 male and 3 postmenopausal women, in the urine of a nonpregnant woman, and in a 20 ml pool of late pregnancy plasma obtained from 10 women." | 3.65 | Mass fragmentographic determination of eleven estrogens in the body fluids of pregnant and nonpregnant subjects. ( Adlercreutz, H; Hunneman, DH; Tikkanen, MJ, 1974) |
"Glycogen was measured fluorometrically in swab eluate." | 2.84 | Vaginal microbiota and genitourinary menopausal symptoms: a cross-sectional analysis. ( Blair, IA; Cohen, L; Fiedler, T; Fredricks, DN; Freeman, EW; Guthrie, KA; Hoffman, NG; Joffe, H; LaCroix, AZ; Liu, C; Mitchell, CM; Munch, M; Newton, K; Reed, SD; Srinivasan, S; Wu, MC; Zhan, X, 2017) |
" The primary pharmacokinetic endpoints were Cmax, AUC(0-t), and AUC(0-inf) for the test and reference products, assessed for bioequivalence using the scaled average bioequivalence or unscaled average bioequivalence method." | 2.80 | Pharmacokinetics of the first combination 17β-estradiol/progesterone capsule in clinical development for menopausal hormone therapy. ( Amadio, JM; Bernick, B; Bon, C; Mirkin, S; Pickar, JH, 2015) |
"Letrozole treatment reduced serum estrone (E1) and estradiol (E2) to near undetectable levels (p < 0." | 2.70 | Role of low levels of endogenous estrogen in regulation of bone resorption in late postmenopausal women. ( Heshmati, HM; Khosla, S; Melton, LJ; O'Fallon, WM; Riggs, BL; Robins, SP, 2002) |
"1)." | 2.68 | [The effect of carbon disulphide on menopause, concentration of monoamines, gonadotropins, estrogens and androgens in women]. ( Pieleszek, A, 1997) |
"The pharmacokinetic properties and biotransformation of two orally active oestrogens, piperazine oestrone sulphate (PE1S, 2." | 2.67 | Pharmacokinetics and biotransformation of orally administered oestrone sulphate and oestradiol valerate in post-menopausal women. ( Aedo, AR; Diczfalusy, E; Landgren, BM, 1990) |
" There was a significant monotonic dose-response relationship of estrone sulfate in raising HDL levels, lowering LDL levels, and raising the HDL/LDL ratio at all intervals measured." | 2.67 | Effect of cyclic estrone sulfate treatment on lipid profiles of postmenopausal women with elevated cholesterol levels. ( Green, EM; Jennings, D; Katz-Karp, S; Lancaster, J; Notelovitz, M; Stoll, RW, 1990) |
" The results showed reduced levels of both estrogens in smokers as compared with nonsmokers in all three dosage groups." | 2.66 | Cigarette smoking, serum estrogens, and bone loss during hormone-replacement therapy early after menopause. ( Christiansen, C; Jensen, J; Rødbro, P, 1985) |
"Menopause is associated with a significant decline in levels of estrogen, which reportedly leads to several distressing symptoms and adverse health effects on various target tissues including those on bones, heart, and brain." | 2.43 | Clinical pharmacology and differential cognitive efficacy of estrogen preparations. ( Asthana, S; Atwood, C; Carlsson, CM; Gleason, CE; Johnson, S, 2005) |
" The oestrogen preparations available, the dosage schemes, and the modes of administration are the main aspects of therapy which will be discussed in this paper." | 2.36 | Oestrogen therapy in the peri-menopause: A practical approach. ( Haspels, AA, 1980) |
" While this regimen effectively blocked adrenal function, it was complicated by a drug interaction in which aminoglutethimide accelerated the metabolism and reduced the bioavailability of dexamethasone." | 2.36 | Kinetic, hormonal and clinical studies with aminoglutethimide in breast cancer. ( Harvey, H; Kendall, J; Lipton, A; Ruby, EB; Samojlik, E; Santen, RJ; Wells, SA, 1977) |
"Obesity is associated with metabolic dysfunction with sex differences and chronic, low-grade inflammation." | 1.40 | Complement receptors C5aR and C5L2 are associated with metabolic profile, sex hormones, and liver enzymes in obese women pre- and postbariatric surgery. ( Cianflone, K; Lapointe, M; Marceau, P; Rezvani, R; Smith, J; Tchernof, A, 2014) |
"Menopause is associated with changes in bone, muscle and fat mass." | 1.38 | Increased 2-hydroxylation of estrogen is associated with lower body fat and increased lean body mass in postmenopausal women. ( Armamento-Villareal, RC; Giri, TK; Napoli, N; Nekkalapu, S; Qualls, C; Vattikuti, S; Yarramaneni, J, 2012) |
"Serum and urine were collected from 65 breast cancer patients and 36 controls after an overnight fast." | 1.30 | Urinary 2/16 alpha-hydroxyestrone ratio: correlation with serum insulin-like growth factor binding protein-3 and a potential biomarker of breast cancer risk. ( Foo, SC; Ho, GH; Ji, CY; Luo, XW; Ng, EH, 1998) |
"Two-hundred and six breast cancer cases were histologically confirmed breast cancer diagnoses at the Cancer Institute in Chennai (Madras), India." | 1.30 | A study on serum carotenoid levels in breast cancer patients of Indian women in Chennai (Madras), India. ( Gajalakshmi, KC; Ito, Y; Sasaki, R; Shanta, V; Suzuki, K, 1999) |
"We have previously shown that human breast cancer is autonomous in the regulation of its intra-tissue oestradiol concentration." | 1.28 | On the significance of in situ production of oestrogens in human breast cancer tissue. ( Blankenstein, MA; Daroszewski, J; Donker, GH; Maitimu-Smeele, I; Milewicz, A; Thijssen, JH, 1992) |
"Treatment with Danazol had no significant effect on tissue levels of 3H E1S or on the CRE1S E1 or MCR-E1S." | 1.28 | The origin of oestrone sulphate in normal and malignant breast tissues in postmenopausal women. ( Ghilchik, MW; Purohit, A; Reed, MJ; Riaz, AA, 1992) |
"Estrone levels were not measurable with a sensitive RIA technique." | 1.28 | Endogenous estrogen levels in postmenopausal women with severe urogenital atrophy. ( Heimer, G; Nilsson, K, 1992) |
"Estrone was also positively related to androstenedione concentrations (r = 0." | 1.28 | Reliability and interrelations among serum sex hormones in postmenopausal women. ( Cauley, JA; Gutai, JP; Kuller, LH; Powell, JG, 1991) |
"E1/E2 ratio in cervical cancer patients was higher than that in normal postmenopausal women (P less than 0." | 1.28 | [Plasma estrogen level in patients with cervical cancer]. ( Zheng, Y, 1990) |
"There was no change in the size of the uterine leiomyomata." | 1.28 | Tamoxifen prolongs luteal phase in premenopausal women but has no effect on the size of uterine fibroids. ( Baird, DT; Lumsden, MA; West, CP, 1989) |
" This study demonstrates that smoking exerts a powerful inducing effect on the 2-hydroxylation pathway of estradiol metabolism, which is likely to lead to decreased bioavailability at estrogen target tissues." | 1.27 | Increased 2-hydroxylation of estradiol as a possible mechanism for the anti-estrogenic effect of cigarette smoking. ( Bradlow, HL; Fishman, J; Hershcopf, RJ; Michnovicz, JJ; Naganuma, H, 1986) |
" Forty-two climacteric women were studied before and after treatment with various drugs at different doses (patients receiving identical compounds served as their own controls for the evaluation of dosage effects; duration of medication: 14 days at each dose)." | 1.27 | Effects of various replacement oestrogens on hepatic transcortin synthesis in climacteric women. ( Hammerstein, J; Moltz, L; Schneller, E; Schwartz, U; Volger, H, 1983) |
"5-mg dosage of VCE raised estrone levels to values similar to those in premenopausal women in the late follicular phase, and estradiol concentrations were similar to early follicular phase concentrations." | 1.27 | Biological effects of various doses of vaginally administered conjugated equine estrogens in postmenopausal women. ( Eggena, P; Geola, FL; Hershman, JM; Judd, HL; Lu, JH; Mandel, FP; Meldrum, DR; Sambhi, MP, 1983) |
" The most sensitive marker was vaginal cytology, with the E2 dosage reverting the maturation index to premenopausal values." | 1.27 | Estrogen replacement therapy by transdermal estradiol administration. ( DeFazio, JL; Eggena, P; Hershman, JM; Judd, HL; Laufer, LR; Lu, JK; Meldrum, DR; Sambhi, MP, 1983) |
"Oestrone levels were found to be significantly higher in patients with endometrial carcinoma." | 1.27 | Hormonal profile of endometrial cancer. ( Eibschitz, I; Levitan, Z; Oettinger, M; Samberg, I; Sharf, M, 1984) |
" A dose-response relation was apparent for these hormones; mean plasma levels increased concomitantly with cigarette consumption." | 1.27 | Cigarette smoking and levels of adrenal androgens in postmenopausal women. ( Barrett-Connor, E; Khaw, KT; Tazuke, S, 1988) |
"We report two cases of metastatic breast cancer occurring in two postmenopausal women." | 1.27 | Two partial remissions induced by an LHRH analogue in two postmenopausal women with metastatic breast cancer. ( Guiochet, N; Keiling, R; Schwartz, L, 1988) |
"Ketoconazole was poorly tolerated due to gastrointestinal toxicity." | 1.27 | High dose ketoconazole: endocrine and therapeutic effects in postmenopausal breast cancer. ( Cantwell, BM; Dowsett, M; Harris, AL, 1988) |
"Naloxone infusion was performed in basal conditions and after chronic oral treatment with conjugated estrogens (CE) (1." | 1.27 | Sex steroids modulate prolactin response to naloxone in postmenopausal women. ( Cagnacci, A; Fioretti, P; Gambacciani, M; Mais, V; Melis, GB; Paoletti, AM; Petacchi, FD, 1985) |
"We conducted a dose-response study in 23 postmenopausal women to compare the physiologic effects of transdermal estradiol and oral conjugated equine estrogens." | 1.27 | Biologic effects of transdermal estradiol. ( Alkjaersig, NK; Chetkowski, RJ; Eggena, P; Fletcher, AP; Hershman, JM; Judd, HL; Lu, JK; Meldrum, DR; Randle, D; Steingold, KA, 1986) |
" It was concluded that transdermal administration of E2 at the dosage employed produces a physiological plasma protein distribution of E2 and E1 and does not affect liver protein production." | 1.27 | Biological and endocrine aspects of transdermal 17 beta-oestradiol administration in post-menopausal women. ( Bulletti, C; Ciotti, P; Di Cosmo, D; Flamigni, C; Jasonni, VM; Lazzaretto, R; Naldi, S, 1988) |
"Estrone levels were independently related to radial bone density." | 1.27 | Endogenous estrogen levels and calcium intakes in postmenopausal women. Relationships with cortical bone measures. ( Cauley, JA; Gutai, JP; Kuller, LH; LeDonne, D; Powell, JG; Sandler, RB; Sashin, D, 1988) |
" Ten patients with histologically proven endometrial hyperplasia were treated with Danazol at a dosage of 600 mg/day for 30 days." | 1.27 | Preliminary report on postmenopausal endometrial hyperplasia treatment with Danazol: histological and endocrinological aspects. ( Bulletti, C; Ciotti, P; Flamigni, C; Jasonni, VM; La Marca, L; Naldi, S; Vignudelli, A, 1986) |
"When levonorgestrel was used in doses as low as 30 micrograms daily, there was no change in cholesterol levels over a period of 6 mth, suggesting that the adverse effect of the androgenic type progestogens is dose-related and is probably only significant when extremely high dosages are administered." | 1.27 | The effect of low-dose piperazine oestrone sulphate and low-dose levonorgestrel on blood lipid levels in post-menopausal women. ( Garrett, D; Wren, B, 1985) |
"94 patients with endometrial cancer and double that number of matched controls were examined." | 1.26 | Doubts about oestrogen therapy in postmenopausal women. ( , 1976) |
"Urinary incontinence was treated conservatively in 100 patients." | 1.26 | Conservative treatment of urinary incontinence in women with special reference to the use of oestrogens. ( Kilkku, P; Kiukko, P; Punnonen, R; Rauramo, L, 1981) |
" Each dosage of each formulation was ingested by three women." | 1.26 | Comparison of pharmacodynamic properties of various estrogen formulations. ( Brenner, PF; Dozono-Takano, R; Eggena, P; Lobo, RA; Mashchak, CA; Mishell, DR; Nakamura, RM, 1982) |
" It is concluded that the effects of estrogens on the endocrine system in peri- and postmenopausal women are influenced by chemical structure, dosage and mode of administration of the estrogen as well as by the endogenous hormone profile." | 1.26 | Treatment with oral estrone sulphate in the female climacteric. II. Hormonal aspects. ( Carlström, K; Lagrelius, A; Lunell, NO, 1981) |
" The dosages of E3 employed appear to vary considerably, and the need was felt to establish the dosage on a scientific basis." | 1.26 | The significance of oestriol in the management of the post-menopause. ( Aksu, MF; Greenblatt, RB; Tzingounis, VA, 1980) |
"Since unopposed estrogen therapy, as well as overly high doses, has been implicated in increasing the risk for endometrial cancer, this study tried to determine the effect of reducing the daily amount of estrogen and dividing that reduced dosage into 3 daily doses." | 1.26 | Pharmacokinetic studies on low dose estradiol 17 beta administered orally to postmenopausal women. ( Lähteenmäki, P; Luukkainen, T; Sipinen, S, 1980) |
"Obesity is a physiological state associated with alterations in hormone production and metabolism." | 1.26 | Obesity, hormones, and cancer. ( Ertel, N; Kirschner, MA; Schneider, G, 1981) |
"To study the effects of exogenous estrogens on the postmenopausal endometrium, and to determine the time course and minimum dosage of added progestins necessary to oppose estrogen stimulation, we obtained endometrial specimens from symptomatic postmenopausal women being treated with various preparations of estrogens and progestins." | 1.26 | Effects of estrogens and progestins on the biochemistry and morphology of the postmenopausal endometrium. ( King, RJ; Pryse-Davies, J; Ryder, TA; Townsend, PT; Whitehead, MI, 1981) |
"Crystalline oestradiol-17 beta is poorly absorbed from the gastrointestinal tract." | 1.26 | Oral versus vaginal absorption in oestradiol in postmenopausal women. Effects of different particles sizes. ( Englund, DE; Johansson, ED, 1981) |
"Estrone sulfate levels were measured in the plasma of 63 postmenopausal women." | 1.26 | Plasma estrone sulfate levels in postmenopausal women. ( Bleau, G; Chapdelaine, A; Roberts, KD; Rochefort, JG, 1980) |
" Requisites of such therapy are a through history to establish a real need, a complete gynecologic examination with a Pap smear before therapy begins and annually afterward, use of the smallest daily dose of estrogen that gives the desired effect, and periodic attempts to reduce the dosage or stop the hormone." | 1.26 | Estrogens for the menopause. Maximizing benefits, minimizing risks. ( Seller, JC, 1977) |
"Estriol was administered for a six-month period as estrogen replacement therapy to 52 symptomatic postmenopausal women." | 1.26 | Estriol in the management of the menopause. ( Aksu, MF; Greenblatt, RB; Tzingounis, VA, 1978) |
"Women who had had breast cancer were compared to a group of normal controls and were also found to have similar blood production rates for estriol, estrone, and estradiol." | 1.26 | Relationship between urine and plasma estrogen ratios. ( Longcope, C; Pratt, JH, 1978) |
"Estrone production was 68 microng/day, most of which could be accounted fo by the extraglandular formation from androstenedione." | 1.26 | The origin of androgen and estrogen in a virilized postmenopausal woman with bilateral benign cystic teratomas. ( Aiman, J; Edman, CD; Jacobs, A; MacDonald, PC; Nalick, RH; Porter, JC; Vellios, F, 1977) |
"Androstenedione metabolism was studied at the New York Medical College-Metropolitan Hospital Center in 14 patients with endometrial cancer." | 1.26 | Androstenedione metabolism in patients with endometrial cancer. ( Calanog, A; Gordon, GG; Sall, S; Southren, AL, 1977) |
"When estrone-(3)H was infused, constancy of estrone-(3)H levels was not attained in either the 2-hr infusions or in the two 12-hr infusions." | 1.25 | A study of estrogen metabolic clearance rates and transfer factors. ( Bardin, CW; Hembree, WC; Lipsett, MB, 1969) |
"In patients with breast and prostate cancer hormone excretion patterns differ in a similar way from patterns in persons without cancer." | 1.24 | HORMONE EXCRETION PATTERNS IN BREAST AND PROSTATE CANCER ARE ABNORMAL. ( HOPKINS, CE; MARMORSTON, J; STERN, E; WEINER, JM, 1964) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 462 (79.93) | 18.7374 |
1990's | 71 (12.28) | 18.2507 |
2000's | 25 (4.33) | 29.6817 |
2010's | 16 (2.77) | 24.3611 |
2020's | 4 (0.69) | 2.80 |
Authors | Studies |
---|---|
Napoli, N | 1 |
Vattikuti, S | 1 |
Yarramaneni, J | 1 |
Giri, TK | 1 |
Nekkalapu, S | 1 |
Qualls, C | 1 |
Armamento-Villareal, RC | 1 |
Berg, D | 1 |
Sonsalla, R | 1 |
Kuss, E | 1 |
Schinfeld, JS | 1 |
Tulchinsky, D | 2 |
Schiff, I | 2 |
Fishman, J | 4 |
Ursin, G | 1 |
London, S | 1 |
Stanczyk, FZ | 4 |
Gentzschein, E | 1 |
Paganini-Hill, A | 2 |
Ross, RK | 4 |
Pike, MC | 2 |
Ziegler, RG | 2 |
Rossi, SC | 1 |
Fears, TR | 2 |
Bradlow, HL | 3 |
Adlercreutz, H | 7 |
Sepkovic, D | 1 |
Kiuru, P | 1 |
Wahala, K | 1 |
Vaught, JB | 2 |
Donaldson, JL | 2 |
Falk, RT | 1 |
Fillmore, CM | 1 |
Siiteri, PK | 12 |
Hoover, RN | 2 |
Gail, MH | 2 |
Ho, GH | 1 |
Luo, XW | 1 |
Ji, CY | 1 |
Foo, SC | 1 |
Ng, EH | 1 |
Westerlind, KC | 1 |
Gibson, KJ | 1 |
Wolfe, P | 1 |
Michnovicz, JJ | 1 |
Hershcopf, RJ | 1 |
Naganuma, H | 1 |
Kling, JM | 3 |
Dowling, NM | 3 |
Bimonte-Nelson, H | 3 |
Gleason, CE | 4 |
Kantarci, K | 3 |
Stonnington, CM | 3 |
Harman, SM | 5 |
Naftolin, F | 3 |
Pal, L | 3 |
Cedars, M | 3 |
Manson, JE | 3 |
James, TT | 3 |
Brinton, EA | 3 |
Miller, VM | 3 |
Kawakita, T | 1 |
Yasui, T | 3 |
Yoshida, K | 1 |
Matsui, S | 1 |
Iwasa, T | 1 |
Grummisch, JA | 1 |
Sykes Tottenham, L | 1 |
Gordon, JL | 1 |
Ideno, Y | 1 |
Onizuka, Y | 1 |
Nakajima-Shimada, J | 1 |
Shinozaki, H | 1 |
Hayashi, K | 1 |
van Winden, LJ | 1 |
Kok, M | 1 |
Acda, M | 1 |
Dezentje, V | 1 |
Linn, S | 1 |
Shi, RZ | 1 |
van Rossum, HH | 1 |
Mitchell, CM | 1 |
Srinivasan, S | 1 |
Zhan, X | 1 |
Wu, MC | 1 |
Reed, SD | 1 |
Guthrie, KA | 1 |
LaCroix, AZ | 1 |
Fiedler, T | 1 |
Munch, M | 1 |
Liu, C | 1 |
Hoffman, NG | 1 |
Blair, IA | 1 |
Newton, K | 1 |
Freeman, EW | 1 |
Joffe, H | 1 |
Cohen, L | 1 |
Fredricks, DN | 1 |
Thurston, RC | 1 |
Bhasin, S | 1 |
Chang, Y | 2 |
Barinas-Mitchell, E | 1 |
Matthews, KA | 3 |
Jasuja, R | 1 |
Santoro, N | 4 |
Veldhuis, JD | 2 |
Dyer, RB | 1 |
Trushin, SA | 1 |
Bondar, OP | 1 |
Singh, RJ | 1 |
Klee, GG | 1 |
Woods, NF | 4 |
Cray, L | 1 |
Mitchell, ES | 4 |
Herting, JR | 1 |
Rezvani, R | 1 |
Smith, J | 1 |
Lapointe, M | 1 |
Marceau, P | 1 |
Tchernof, A | 1 |
Cianflone, K | 1 |
Mennenga, SE | 1 |
Koebele, SV | 1 |
Mousa, AA | 1 |
Alderete, TJ | 1 |
Tsang, CW | 2 |
Acosta, JI | 1 |
Camp, BW | 1 |
Demers, LM | 3 |
Bimonte-Nelson, HA | 2 |
Pickar, JH | 1 |
Bon, C | 1 |
Amadio, JM | 1 |
Mirkin, S | 1 |
Bernick, B | 1 |
Swanepoel, AC | 1 |
Naidoo, P | 1 |
Nielsen, VG | 1 |
Pretorius, E | 1 |
Crandall, CJ | 1 |
Guan, M | 1 |
Laughlin, GA | 2 |
Ursin, GA | 1 |
Ingles, SA | 1 |
Barrett-Connor, E | 3 |
Greendale, GA | 3 |
COULTON, D | 1 |
SEWALL, CW | 1 |
Finni, T | 1 |
Kovanen, V | 1 |
Ronkainen, PH | 1 |
Pöllänen, E | 1 |
Bashford, GR | 1 |
Kaprio, J | 1 |
Alén, M | 1 |
Kujala, UM | 1 |
Sipilä, S | 1 |
O'Connor, KA | 1 |
Ferrell, RJ | 1 |
Brindle, E | 1 |
Shofer, J | 1 |
Holman, DJ | 1 |
Miller, RC | 1 |
Schechter, DE | 1 |
Singer, B | 1 |
Weinstein, M | 1 |
Lønning, PE | 4 |
Helle, H | 1 |
Duong, NK | 1 |
Ekse, D | 3 |
Aas, T | 1 |
Geisler, J | 1 |
Smith-Di Julio, K | 1 |
Ma, H | 1 |
Chung, MH | 1 |
Lu, Y | 1 |
Nishihara, T | 1 |
Hattori, M | 1 |
Shimizu, Y | 2 |
Franklin, SL | 1 |
Engler-Chiurazzi, EB | 1 |
Talboom, JS | 1 |
Braden, BB | 1 |
Mennenga, S | 1 |
Andrews, M | 1 |
Wilborn, WH | 1 |
Hyde, BM | 1 |
Vardy, MD | 1 |
Lindsay, R | 1 |
Scotti, RJ | 1 |
Mikhail, M | 1 |
Richart, RM | 1 |
Nieves, J | 1 |
Zion, M | 1 |
Cosman, F | 1 |
BERGER, J | 1 |
KELLER, M | 1 |
CALDERON DE LAGUNA, J | 1 |
AGUILAR, OR | 1 |
SCIARRA, F | 1 |
LUCHETTI, L | 1 |
DE FELICE, M | 1 |
RAURAMO, L | 4 |
GROENROOS, M | 1 |
NISSEN-MEYER, R | 3 |
SANNER, T | 1 |
LEMON, HM | 4 |
PARSONS, L | 2 |
MOZDEN, PH | 1 |
KECSKES, L | 1 |
KOBOR, J | 1 |
MUTSEHLER, F | 1 |
LAURITZEN, C | 4 |
STERN, E | 2 |
HOPKINS, CE | 2 |
WEINER, JM | 1 |
MARMORSTON, J | 2 |
BARANOV, VG | 1 |
BLAGOSKLONNAIA, IaV | 1 |
NIKOLAENKO, NF | 1 |
PODOLSKAIA, IIu | 1 |
RAFALSKII, IaD | 1 |
ROZOVSKAIA, IT | 1 |
SAVCHENKO, ON | 1 |
STEPANOV, GS | 1 |
SKOLOV, EG | 1 |
MOZDEN, PJ | 1 |
PERSSON, BH | 1 |
RISHOLM, L | 1 |
ROSNER, F | 1 |
LEE, SL | 1 |
OLINA, A | 1 |
CROWLEY, LG | 1 |
MYERS, SM | 1 |
BIRNBERG, CH | 1 |
SHERBER, DA | 1 |
BRANDMAN, LJ | 1 |
Lasley, B | 2 |
McConnell, D | 2 |
Allsworth, J | 1 |
Crawford, S | 3 |
Gold, EB | 2 |
Finkelstein, JS | 1 |
Kelsey, J | 1 |
Korenman, S | 1 |
Luborsky, JL | 3 |
Matthews, K | 1 |
Midgley, R | 1 |
Powell, L | 2 |
Sabatine, J | 1 |
Schocken, M | 1 |
Sowers, MF | 2 |
Weiss, G | 3 |
HAHN, H | 1 |
Sharp, L | 1 |
Cardy, AH | 1 |
Cotton, SC | 1 |
Little, J | 1 |
Noh, JJ | 1 |
Maskarinec, G | 1 |
Pagano, I | 1 |
Cheung, LW | 1 |
Carlsson, CM | 1 |
Johnson, S | 1 |
Atwood, C | 1 |
Asthana, S | 1 |
Kavanagh, K | 1 |
Koudy Williams, J | 1 |
Wagner, JD | 1 |
Gallicchio, L | 1 |
Miller, SR | 1 |
Visvanathan, K | 1 |
Lewis, LM | 1 |
Babus, J | 1 |
Zacur, H | 1 |
Flaws, JA | 1 |
Wright, JV | 1 |
Pasternak, RC | 1 |
Sutton-Tyrrell, K | 1 |
Sowers, M | 2 |
Lebrun, CE | 1 |
van der Schouw, YT | 1 |
de Jong, FH | 1 |
Pols, HA | 1 |
Grobbee, DE | 1 |
Lamberts, SW | 1 |
Curcio, JJ | 1 |
Wollner, DA | 1 |
Schmidt, JW | 1 |
Kim, LS | 1 |
Meyer, PM | 1 |
Zeger, SL | 1 |
Harlow, SD | 1 |
Janssen, I | 1 |
McConnell, DS | 1 |
Randolph, JF | 2 |
Bochkareva, NV | 1 |
Kondakova, IV | 1 |
Kolomiets, LA | 1 |
Muntyan, AB | 1 |
Shevchenko, VP | 1 |
Nagaev, IY | 1 |
Shevchenko, KV | 1 |
Myasoedov, NF | 1 |
Dorofeeva, NN | 1 |
Smith-DiJulio, K | 1 |
Percival, DB | 1 |
Tao, EY | 1 |
VOGEL, M | 1 |
McGAVACK, TH | 1 |
MELLOW, J | 1 |
Crawford, SL | 1 |
Lasley, WL | 1 |
Korenman, SG | 1 |
Whittaker, PG | 1 |
Morgan, MR | 1 |
Dean, PD | 1 |
Cameron, EH | 1 |
Lind, T | 1 |
Masarei, JR | 1 |
Armstrong, BK | 1 |
Skinner, MW | 1 |
Ratajczak, T | 1 |
Hähnel, R | 1 |
Crooke, D | 1 |
Clarke, HT | 1 |
Grönroos, M | 4 |
Kauppila, O | 1 |
Pulkkinen, M | 2 |
Turunen, S | 1 |
Salmi, T | 1 |
Raekallio, J | 1 |
Varma, TR | 4 |
Morsman, J | 1 |
Kapetanakis, E | 1 |
Dmowski, WP | 1 |
Auletta, F | 1 |
Scommegna, A | 1 |
Coombes, RC | 4 |
Chilvers, C | 1 |
Dowsett, M | 17 |
Gazet, JC | 2 |
Ford, HT | 1 |
Bettelheim, R | 1 |
Gordon, C | 1 |
Smith, IE | 9 |
Zava, D | 1 |
Powles, TJ | 4 |
Wilking, N | 2 |
Carlström, K | 19 |
Sköldefors, H | 1 |
Theve, NO | 1 |
Wallgren, A | 1 |
Adami, HO | 4 |
Axelsson, O | 1 |
Vegelius, J | 2 |
Akerström, G | 1 |
Harris, AL | 10 |
Jeffcoate, SL | 5 |
Pelusi, G | 3 |
Moretti, B | 2 |
Martinelli, G | 2 |
Camerini, T | 1 |
Busacchi, P | 2 |
Cavallina, R | 2 |
Brody, S | 3 |
von Uexküll, AK | 2 |
Lagrelius, A | 6 |
Lunell, NO | 7 |
Rosenborg, L | 3 |
Bonney, RC | 4 |
Scanlon, MJ | 2 |
Reed, MJ | 16 |
Jones, DL | 2 |
Beranek, PA | 7 |
James, VH | 18 |
Jeffcoate, S | 1 |
Stuart-Harris, RC | 1 |
Paterson, ME | 1 |
Sturdee, DW | 1 |
Moore, B | 1 |
Whitehead, TP | 1 |
Bhavnani, BR | 2 |
Sarda, IR | 1 |
Woolever, CA | 1 |
King, RJ | 4 |
Townsend, PT | 4 |
Whitehead, MI | 7 |
Towobola, OA | 1 |
Crilly, RC | 1 |
Oakey, RE | 1 |
Luisi, M | 2 |
Franchi, F | 2 |
Kicovic, PM | 1 |
Hintz, BL | 1 |
Kagan, AR | 1 |
Gilbert, HA | 1 |
Rao, AR | 1 |
Chan, P | 1 |
Nussbaum, H | 1 |
Coope, J | 1 |
Helgason, S | 4 |
Damber, MG | 7 |
Damber, JE | 2 |
Selstam, G | 2 |
von Schoultz, B | 12 |
Punnonen, R | 4 |
Kilkku, P | 1 |
Kiukko, P | 1 |
Stigbrand, T | 2 |
Mashchak, CA | 1 |
Lobo, RA | 3 |
Dozono-Takano, R | 1 |
Eggena, P | 4 |
Nakamura, RM | 2 |
Brenner, PF | 2 |
Mishell, DR | 2 |
Wren, BG | 2 |
Brown, LB | 1 |
Routledge, DA | 1 |
Samojlik, E | 8 |
Santen, RJ | 8 |
Worgul, TJ | 2 |
Schwartz, U | 1 |
Volger, H | 1 |
Schneller, E | 1 |
Moltz, L | 1 |
Hammerstein, J | 1 |
Mandel, FP | 1 |
Geola, FL | 1 |
Meldrum, DR | 5 |
Lu, JH | 1 |
Sambhi, MP | 2 |
Hershman, JM | 3 |
Judd, HL | 16 |
Routledge, AD | 1 |
Davidson, K | 1 |
McCormick, W | 1 |
Singer, F | 1 |
Roy, S | 2 |
Jasonni, VM | 8 |
Bulletti, C | 9 |
Bolelli, GF | 3 |
Franceschetti, F | 6 |
Bonavia, M | 6 |
Ciotti, P | 8 |
Flamigni, C | 9 |
Laufer, LR | 3 |
DeFazio, JL | 1 |
Lu, JK | 2 |
Falsetti, L | 1 |
Omodei, U | 1 |
Dordoni, D | 1 |
Scagliola, P | 1 |
Turla, R | 1 |
Zotti, L | 1 |
Archetti, L | 1 |
Klinga, K | 3 |
von Holst, T | 3 |
Runnebaum, B | 3 |
Yoshimoto, S | 1 |
Fujita, T | 1 |
Tataryn, IV | 2 |
Frumar, AM | 3 |
Erlik, Y | 1 |
Lu, KH | 1 |
Crilly, RG | 4 |
Francis, RM | 1 |
Nordin, BE | 8 |
Marshall, DH | 7 |
Barkworth, SA | 1 |
Wells, SA | 4 |
Lucisano, A | 2 |
Acampora, MG | 2 |
Russo, N | 2 |
Maniccia, E | 2 |
Montemurro, A | 3 |
Dell'Acqua, S | 2 |
Vermeulen-Meiners, C | 2 |
Jaszmann, LJ | 1 |
Haspels, AA | 3 |
Poortman, J | 9 |
Thijssen, JH | 16 |
Longcope, C | 16 |
Baker, RS | 2 |
Hui, SL | 4 |
Johnston, CC | 7 |
Friedrich, EG | 1 |
Kalra, PS | 2 |
Prost, O | 2 |
Turrel, MO | 1 |
Dahan, N | 1 |
Craveur, C | 1 |
Adessi, GL | 2 |
Holst, J | 3 |
Einhorn, N | 1 |
Fredricsson, B | 1 |
Sundelin, P | 1 |
Davidson, BJ | 3 |
Lagasse, LD | 2 |
Cheng, RW | 1 |
Noel, CT | 3 |
Dudley, HA | 1 |
Mattsson, LA | 1 |
Abrahamsson, L | 1 |
Cullberg, G | 1 |
Samsioe, G | 2 |
Bolelli, G | 2 |
Guerami, A | 1 |
MacDonald, PC | 6 |
Casey, ML | 1 |
Wiegerninck, MA | 1 |
Donker, GH | 3 |
Oettinger, M | 1 |
Samberg, I | 1 |
Levitan, Z | 1 |
Eibschitz, I | 1 |
Sharf, M | 1 |
Mango, D | 6 |
Scirpa, P | 6 |
Battaglia, F | 4 |
Bini, E | 1 |
Jasonni, M | 1 |
Armani, A | 1 |
Shoupe, D | 1 |
Paul, W | 1 |
Kasai, T | 1 |
Takeda, B | 1 |
Takamizawa, H | 1 |
Tzingounis, VA | 2 |
Aksu, MF | 2 |
Greenblatt, RB | 3 |
Sipinen, S | 4 |
Lähteenmäki, P | 3 |
Luukkainen, T | 2 |
Drafta, D | 2 |
Schindler, AE | 3 |
Milcu, SM | 1 |
Keller, E | 1 |
Stroe, E | 2 |
Horodniceanu, E | 1 |
Bălănescu, I | 1 |
Sitruk-Ware, R | 1 |
de Lignieres, B | 2 |
Basdevant, A | 2 |
Mauvais-Jarvis, P | 1 |
Keller, PJ | 3 |
Riedmann, R | 2 |
Fischer, M | 2 |
Thom, MH | 2 |
Collins, WP | 6 |
Studd, JW | 4 |
Vesterinen, E | 1 |
Backas, NE | 1 |
Pesonen, K | 1 |
Stenman, UH | 1 |
Laatikainen, T | 1 |
Gerber, C | 1 |
Dyer, GI | 1 |
Young, O | 1 |
Englund, DE | 4 |
Victor, A | 2 |
Johansson, ED | 6 |
Argenio, GF | 1 |
Barletta, D | 1 |
Romano, MR | 1 |
Bernini, GP | 1 |
Gasperi, M | 1 |
Sgrilli, R | 1 |
Fiet, J | 1 |
Hermano, M | 1 |
Witte, J | 1 |
Villette, JM | 1 |
Haimart, M | 1 |
Gourmel, B | 1 |
Tabuteau, F | 1 |
Rouffy, J | 1 |
Dreux, C | 1 |
Wollesen, F | 1 |
Knigge, U | 1 |
Larsen, K | 1 |
Fåhraeus, L | 1 |
Larsson-Cohn, U | 2 |
Prişcu, A | 1 |
Neacşu, E | 1 |
Gangură, M | 1 |
Anghel, C | 1 |
Panaitescu, G | 1 |
Trichopoulos, D | 2 |
Polychronopoulou, A | 1 |
Brown, J | 2 |
MacMahon, B | 2 |
Rémy-Martin, A | 1 |
Nicollier, M | 1 |
Burnod, J | 1 |
Cajander, S | 1 |
Schneider, J | 1 |
Anderson, KE | 1 |
Kappas, A | 1 |
Aiman, J | 3 |
Heinonen, PK | 1 |
Tuimala, R | 1 |
Pyykkö, K | 2 |
Pystynen, P | 2 |
Shamonki, IM | 3 |
Kirschner, MA | 7 |
Ertel, NH | 1 |
Barone, RM | 3 |
Gambone, JC | 1 |
Monfort, SL | 1 |
Lasley, BL | 4 |
Scirpa, S | 2 |
Södergård, R | 1 |
de Waard, F | 5 |
de Pedro-Alvarez Ferrero, M | 1 |
Baanders-van Halewijn, EA | 1 |
Cole, P | 1 |
Nishimura, T | 1 |
Rezaković, D | 1 |
Jovanović, V | 1 |
Ferraretti, AP | 1 |
Fuschini, G | 1 |
De March, A | 1 |
La Marca, L | 2 |
Jacobs, HS | 7 |
Hammond, GD | 1 |
Johnson, P | 1 |
Jaffee, W | 2 |
Griffing, G | 2 |
Vilska, S | 1 |
Ertel, N | 1 |
Schneider, G | 1 |
Lane, G | 1 |
Dyer, G | 2 |
Zumoff, B | 1 |
Strain, GW | 1 |
Kream, J | 1 |
O'Connor, J | 2 |
Levin, J | 1 |
Fukushima, DK | 2 |
Braunsberg, H | 1 |
Short, F | 1 |
Dias, VO | 1 |
Baxendale, PM | 2 |
Pryse-Davies, J | 1 |
Ryder, TA | 1 |
Folkerd, EJ | 1 |
Lodi, S | 1 |
Preti, S | 1 |
Geola, F | 1 |
Deftos, LJ | 1 |
Riggs, BL | 3 |
Coulam, CB | 1 |
Toft, DO | 1 |
Klemi, PJ | 1 |
Roberts, KD | 1 |
Rochefort, JG | 1 |
Bleau, G | 1 |
Chapdelaine, A | 2 |
Dzieciuchowicz, L | 2 |
Lyrenäs, S | 1 |
Bäckström, T | 1 |
Uemura, H | 1 |
Yoneda, N | 1 |
Irahara, M | 1 |
Aono, T | 1 |
Sunahara, S | 1 |
Hata, K | 1 |
Leone, M | 1 |
Costantini, C | 1 |
Gallo, G | 1 |
Voci, A | 1 |
Massajoli, M | 1 |
Messeni Leone, M | 1 |
de Cecco, L | 1 |
Rannevik, G | 2 |
Jeppsson, S | 3 |
Johnell, O | 1 |
Bjerre, B | 2 |
Laurell-Borulf, Y | 1 |
Svanberg, L | 2 |
Wysowski, DK | 1 |
Golden, L | 1 |
Burke, L | 1 |
Pansini, F | 1 |
Albertazzi, P | 1 |
Bonaccorsi, G | 1 |
Calisesi, M | 1 |
Campobasso, C | 1 |
Zanotti, L | 1 |
Bagni, B | 1 |
Mollica, G | 1 |
Massobrio, M | 1 |
Migliardi, M | 1 |
Cassoni, P | 1 |
Menzaghi, C | 1 |
Revelli, A | 1 |
Cenderelli, G | 1 |
Svensson, LO | 1 |
Johnson, SH | 1 |
Olsson, SE | 1 |
Söderqvist, G | 1 |
Olsson, H | 1 |
Iveson, TJ | 1 |
Ahern, J | 1 |
Smithers, DA | 1 |
Trunet, PF | 1 |
Casper, RF | 2 |
Noguchi, T | 1 |
Kitawaki, J | 1 |
Tamura, T | 1 |
Kim, T | 1 |
Kanno, H | 1 |
Yamamoto, T | 1 |
Okada, H | 2 |
Chandler, DW | 1 |
Hyer, MB | 1 |
Pee, D | 1 |
Ricker, WV | 1 |
Bancroft, J | 1 |
Cawood, EH | 1 |
Lum, SS | 1 |
Woltering, EA | 1 |
Fletcher, WS | 1 |
Pommier, RF | 1 |
Gilardi, KV | 1 |
Shideler, SE | 3 |
Valverde, CR | 1 |
Roberts, JA | 1 |
Blaakaer, J | 1 |
Pieleszek, A | 1 |
Grohé, C | 1 |
Kahlert, S | 1 |
Löbbert, K | 1 |
Neyses, L | 1 |
van Eickels, M | 1 |
Stimpel, M | 1 |
Vetter, H | 1 |
Abplanalp, W | 1 |
Rymaszewski, M | 1 |
Adamski, J | 1 |
Subbiah, MT | 1 |
Ito, Y | 1 |
Gajalakshmi, KC | 1 |
Sasaki, R | 1 |
Suzuki, K | 1 |
Shanta, V | 1 |
Kritz-Silverstein, D | 1 |
von Mühlen, D | 1 |
Yanaihara, T | 2 |
Haiman, CA | 1 |
Hankinson, SE | 2 |
Spiegelman, D | 1 |
De Vivo, I | 2 |
Colditz, GA | 2 |
Willett, WC | 1 |
Speizer, FE | 1 |
Hunter, DJ | 2 |
Brennan, JJ | 1 |
Lu, Z | 1 |
Whitman, M | 1 |
Stafiniak, P | 1 |
van der Hoop, RG | 1 |
Gee, NA | 1 |
Chen, J | 1 |
Heshmati, HM | 1 |
Khosla, S | 1 |
Robins, SP | 1 |
O'Fallon, WM | 1 |
Melton, LJ | 2 |
Nand, SL | 1 |
Webster, MA | 1 |
Baber, R | 1 |
Heller, GZ | 1 |
Li, L | 1 |
Pollow, K | 1 |
Boquoi, E | 1 |
Baumann, J | 1 |
Schmidt-Gollwitzer, M | 2 |
Pollow, B | 1 |
Rose, DP | 3 |
Davis, TE | 1 |
Miller, WR | 2 |
Hawkins, RA | 3 |
Creel, RJ | 1 |
Forrest, AP | 1 |
Hutton, JD | 5 |
Murray, MA | 3 |
Daniell, HW | 1 |
Rimsten, A | 2 |
Wide, L | 1 |
Veldhuis, J | 2 |
Lipton, A | 3 |
Harvey, H | 3 |
Hill, P | 1 |
Wynder, EL | 1 |
Helman, P | 1 |
Hickman, R | 1 |
Rona, G | 1 |
Kuno, K | 1 |
Maroulis, GB | 2 |
Abraham, GE | 2 |
Sansone-Bazzano, G | 1 |
Seeler, AK | 1 |
Cummings, B | 1 |
Reisner, RM | 1 |
Furuhjelm, M | 4 |
Joelsson, I | 1 |
Kontula, K | 1 |
Jänne, O | 1 |
Vihko, R | 2 |
de Jager, E | 1 |
de Visser, J | 1 |
Zeelen, F | 1 |
Schwarz, F | 2 |
Vermeulen, A | 4 |
Sakai, F | 1 |
Saez, S | 2 |
Studd, J | 1 |
Fern, M | 1 |
Liskowski, L | 1 |
Milbrath, JR | 1 |
Ruby, EB | 1 |
Kendall, J | 1 |
Seller, JC | 1 |
Wasada, T | 1 |
Akamine, Y | 1 |
Kato, K | 1 |
Ibayashi, H | 1 |
Nomura, Y | 1 |
Kruyver, GP | 1 |
Beard, RW | 1 |
Dickerson, J | 1 |
Bressler, R | 1 |
Christian, CD | 1 |
Hermann, HW | 1 |
Strecker, JR | 1 |
Goessens, L | 1 |
Franz, C | 2 |
Watson, D | 1 |
Santner, S | 1 |
Davis, B | 1 |
Ruby, E | 1 |
Morreal, CE | 2 |
Dao, TL | 3 |
Nemoto, T | 1 |
Lonergan, PA | 1 |
Crilly, R | 3 |
Horsman, A | 1 |
Knab, DR | 1 |
Schneider, WH | 1 |
Spona, J | 1 |
Schneider, HP | 1 |
Pinkus, JL | 1 |
Charles, D | 1 |
Chattoraj, SC | 1 |
Lynch, HT | 1 |
Trolp, R | 1 |
Breckwoldt, M | 1 |
Hoff, A | 1 |
Verdonck, L | 3 |
Fisher, RP | 1 |
Lillienberg, L | 1 |
Svanborg, A | 1 |
de Thibault de Boesinghe, L | 1 |
Eechaute, W | 1 |
Lacroix, E | 1 |
Little, B | 1 |
Billiar, RB | 1 |
Jassani, M | 1 |
Papadaki, L | 1 |
Beilby, JO | 1 |
Chowaniec, J | 1 |
Coulson, WF | 1 |
Darby, AJ | 1 |
Newman, J | 1 |
O'Shea, A | 1 |
Wykes, JR | 1 |
Morse, AR | 1 |
Cohen, FB | 1 |
Ryan, C | 1 |
Lipsett, MB | 2 |
Isaacs, AJ | 1 |
Havard, CW | 1 |
Andriesse, R | 1 |
Thussen, JH | 1 |
Deutsch, S | 1 |
Benjamin, F | 1 |
Pelc, B | 1 |
Guha, P | 1 |
Khan, MY | 1 |
Edman, CD | 3 |
Hemsell, DL | 1 |
Porter, JC | 2 |
Kågedal, B | 1 |
Wallentin, L | 1 |
Goodall, A | 1 |
Baxendale, P | 1 |
Varela, RM | 1 |
Woytoń, J | 1 |
Sward, J | 1 |
Weiland, AJ | 1 |
Bookstein, JJ | 1 |
Cleary, RE | 1 |
Martin, PM | 1 |
Chouvet, CD | 1 |
Pratt, JH | 2 |
Cawood, M | 1 |
Bird, CE | 1 |
Finnis, W | 1 |
Boroomand, K | 1 |
Murphy, J | 1 |
Clark, AF | 1 |
Chakravarti, S | 2 |
Badawy, SZ | 1 |
Elliott, LJ | 1 |
Elbadawi, A | 1 |
Marshall, LD | 1 |
Aylward, M | 2 |
Maddock, J | 1 |
Rees, P | 1 |
Hackman, BW | 1 |
Galbraith, D | 1 |
Thomson, J | 1 |
Lee, SG | 1 |
Lundy, LE | 1 |
Kashef, M | 1 |
Dorn, J | 1 |
McEwan, HP | 1 |
Monroe, SE | 1 |
Menon, KM | 1 |
Wu, CH | 1 |
Gambrell, RD | 2 |
Asch, RH | 1 |
Nalick, RH | 1 |
Jacobs, A | 1 |
Vellios, F | 2 |
Gross, J | 1 |
Modan, B | 1 |
Bertini, B | 1 |
Spira, O | 1 |
Vestergaard, P | 1 |
Ryan, KJ | 1 |
Nagamani, M | 2 |
Lin, TJ | 1 |
McDonough, PG | 1 |
Watatani, H | 1 |
McPherson, JC | 1 |
Mahesh, VB | 1 |
Calanog, A | 1 |
Sall, S | 1 |
Gordon, GG | 1 |
Southren, AL | 1 |
Kiang, DT | 1 |
Kennedy, BJ | 1 |
Grodin, JM | 2 |
Lucas, WE | 2 |
Yen, SS | 3 |
Martin, F | 1 |
Dencker, H | 1 |
Rimér, U | 1 |
Sjöberg, NO | 1 |
Tikkanen, MJ | 2 |
Bulbrook, RD | 1 |
Swain, MC | 1 |
Wang, DY | 1 |
Hayward, JL | 1 |
Kumaoka, S | 1 |
Takatani, O | 1 |
Abe, O | 1 |
Utsunomiya, J | 1 |
Forecast, JD | 1 |
Newton, JR | 1 |
Oram, DH | 1 |
Mesnard, F | 1 |
Stone, SC | 1 |
Mickal, A | 1 |
Rye, PH | 1 |
Grattarola, R | 2 |
Secreto, G | 2 |
Recchione, C | 2 |
Daw, E | 2 |
Martin, PL | 1 |
Burnier, AM | 1 |
Czekala, NM | 2 |
Greaney, MO | 1 |
Callantine, MR | 1 |
Andrews, MC | 1 |
Wentz, AC | 1 |
Rizkallah, TH | 1 |
Tovell, HM | 1 |
Kelly, WG | 1 |
Leyendecker, G | 1 |
Geppert, G | 1 |
Nocke, W | 1 |
Ufer, J | 1 |
Tominaga, T | 1 |
Tei, N | 1 |
Kitamura, M | 1 |
Taguchi, T | 1 |
Azuma, Y | 1 |
Ziel, HK | 1 |
Finkle, WD | 1 |
Weiss, NS | 1 |
Szekely, DR | 1 |
Austin, DF | 1 |
Bohdanowicz-Pawlak, A | 1 |
Milewicz, A | 4 |
Amałowicz, B | 1 |
Tupikowska, G | 1 |
Bolanowski, M | 1 |
Blankenstein, MA | 4 |
Maitimu-Smeele, I | 1 |
Daroszewski, J | 3 |
Owen, EJ | 1 |
Siddle, NC | 1 |
McGarrigle, HT | 1 |
Pugh, MA | 1 |
Purohit, A | 1 |
Riaz, AA | 1 |
Ghilchik, MW | 5 |
van der Mooren, MJ | 1 |
Demacker, PN | 1 |
Thomas, CM | 1 |
Rolland, R | 1 |
Nilsson, K | 2 |
Heimer, G | 2 |
Phillips, SM | 1 |
Sherwin, BB | 4 |
Jurgens, RW | 1 |
Downey, LJ | 1 |
Abernethy, WD | 1 |
Cutler, NR | 1 |
Conrad, J | 1 |
Mancini, A | 2 |
di Pietro, C | 2 |
de Marinis, L | 2 |
Rossi, S | 2 |
Lombardi, CP | 2 |
Iacona, T | 2 |
Bellantone, R | 2 |
Liberale, I | 2 |
Menini, E | 2 |
Crucitti, F | 2 |
Szymczak, J | 1 |
Reginster, JY | 2 |
Deroisy, R | 2 |
Fontaine, MA | 1 |
Franchimont, P | 2 |
Lynch, J | 1 |
Mulagha, M | 1 |
Hanagan, J | 1 |
Garber, JE | 1 |
Henderson, IC | 1 |
Navari, RM | 1 |
Goldman, M | 1 |
Connolly, JM | 1 |
Strong, LE | 1 |
Regensteiner, JG | 1 |
Hiatt, WR | 1 |
Byyny, RL | 1 |
Pickett, CK | 1 |
Woodard, WD | 1 |
Moore, LG | 1 |
Mehta, A | 2 |
Cantwell, BM | 6 |
Eichner, JE | 1 |
Friedrich, CA | 1 |
Cauley, JA | 6 |
Kamboh, MI | 1 |
Gutai, JP | 7 |
Kuller, LH | 7 |
Ferrell, RE | 1 |
Cagnacci, A | 2 |
Melis, GB | 2 |
Soldani, R | 1 |
Paoletti, AM | 2 |
Gambacciani, M | 2 |
Spinetti, A | 1 |
Fioretti, P | 2 |
Rae, MH | 3 |
Mole, PA | 3 |
Paterson, CR | 3 |
Bellantoni, MF | 2 |
Cho, DE | 1 |
Blackman, MR | 2 |
Becker, U | 2 |
Almdal, T | 1 |
Christensen, E | 1 |
Gluud, C | 2 |
Farholt, S | 2 |
Bennett, P | 3 |
Svenstrup, B | 3 |
Hardt, F | 2 |
Micic, S | 2 |
Cullins, VE | 1 |
Engelhardt, SM | 1 |
Miodrag, A | 1 |
Ekelund, P | 1 |
Burton, R | 1 |
Castleden, CM | 1 |
Powell, JG | 4 |
Austin, H | 1 |
Austin, JM | 1 |
Partridge, EE | 1 |
Hatch, KD | 1 |
Shingleton, HM | 1 |
Bagdade, JD | 1 |
Subbaiah, PV | 1 |
Ohta, H | 1 |
Suda, Y | 1 |
Makita, K | 1 |
Nozawa, S | 1 |
Nemoto, K | 1 |
Zheng, Y | 1 |
Herbert, PN | 1 |
McKinlay, SM | 1 |
Goldfield, SR | 1 |
Schlemmer, A | 1 |
Jensen, J | 6 |
Riis, BJ | 4 |
Christiansen, C | 8 |
Nilas, L | 1 |
Aedo, AR | 3 |
Landgren, BM | 3 |
Diczfalusy, E | 3 |
Stein, RC | 2 |
Suranyi-Cadotte, BE | 1 |
Notelovitz, M | 2 |
Katz-Karp, S | 1 |
Jennings, D | 1 |
Lancaster, J | 1 |
Green, EM | 1 |
Stoll, RW | 1 |
Shimizu, H | 1 |
Bernstein, L | 1 |
Henderson, BE | 1 |
Colvin, PL | 1 |
Auerbach, BJ | 1 |
Koritnik, DR | 1 |
Hazzard, WR | 1 |
Applebaum-Bowden, D | 1 |
Baltali, E | 1 |
Souadka, A | 1 |
el Hafed, A | 1 |
Wydadi, M | 1 |
Kettani, F | 1 |
Alamy, H | 1 |
el Gueddari, B | 1 |
Morchid, M | 1 |
Bouih, A | 1 |
Souadka, F | 1 |
Liberati, M | 2 |
Manna, P | 3 |
Ricci, S | 2 |
Mancuso, S | 2 |
DeVane, GW | 1 |
Benirschke, K | 1 |
Carmichael, J | 2 |
Le Donne, M | 1 |
Sundén, M | 1 |
Pattison, NS | 1 |
Uptin, T | 1 |
Knox, B | 1 |
France, J | 1 |
Lumsden, MA | 1 |
West, CP | 1 |
Baird, DT | 2 |
Jacobs, S | 1 |
Schem, B | 1 |
Hardy, J | 1 |
Yamagata, S | 1 |
Yamamoto, K | 2 |
Tsuchida, S | 1 |
Kawamura, N | 1 |
Matsumoto, Y | 1 |
Ueki, S | 1 |
Sugawa, T | 1 |
Bruning, PF | 1 |
Bonfrer, JM | 1 |
Hart, AA | 1 |
van der Linden, E | 1 |
de Jong-Bakker, M | 1 |
Moolenaar, AJ | 1 |
Nooijen, WJ | 1 |
LeDonne, D | 2 |
Pschera, H | 1 |
Hjerpe, A | 1 |
Tait, GH | 1 |
Newton, CJ | 2 |
Donát, J | 1 |
Jirkalová, V | 1 |
Utsumi, T | 1 |
Cunningham, DC | 1 |
Evans, S | 1 |
Dehennin, L | 1 |
Hedley, A | 1 |
Albert, A | 2 |
Denis, D | 1 |
Lecart, MP | 1 |
Collette, J | 1 |
Stuart-Harris, R | 2 |
Hill, M | 1 |
van Landeghem, AA | 2 |
Goss, PE | 1 |
Hutchison, G | 1 |
Brodie, AM | 1 |
Sainsbury, JR | 1 |
Needham, G | 1 |
Farndon, J | 1 |
Wilson, R | 1 |
Friedman, AJ | 1 |
Ravnikar, VA | 1 |
Barbieri, RL | 1 |
Lal, A | 1 |
Devogelaer, JP | 1 |
Crabbé, J | 1 |
Nagant de Deuxchaisnes, C | 1 |
Khaw, KT | 1 |
Tazuke, S | 1 |
Pugeat, M | 1 |
Lejeune, H | 1 |
Mazenod, B | 1 |
Dechaud, H | 1 |
Fleury, MC | 1 |
Tourniaire, J | 1 |
Schwartz, L | 1 |
Guiochet, N | 1 |
Keiling, R | 1 |
Everard, D | 1 |
Hole, D | 1 |
D'Souza, A | 1 |
Donaldson, A | 1 |
Düsterberg, B | 1 |
Hümpel, M | 1 |
Powers, MS | 1 |
Schenkel, L | 1 |
Darley, PE | 1 |
Good, WR | 1 |
Balestra, JC | 1 |
Place, VA | 1 |
Mais, V | 1 |
Petacchi, FD | 1 |
Chetkowski, RJ | 1 |
Steingold, KA | 1 |
Randle, D | 1 |
Alkjaersig, NK | 1 |
Fletcher, AP | 1 |
Folan, J | 1 |
Gosling, JP | 1 |
Fottrell, PF | 1 |
Thomas, G | 1 |
Thalabard, JC | 1 |
Mercier-Bodard, C | 1 |
Conard, J | 1 |
Guyene, TT | 2 |
Mairon, N | 1 |
Corvol, P | 1 |
Guy-Grand, B | 1 |
Tan, YM | 1 |
Steele, PA | 1 |
Judd, SJ | 1 |
Rødbro, P | 3 |
Karlsson, S | 1 |
Kullander, S | 1 |
Morello, C | 1 |
Baker, R | 1 |
Dahl, KD | 1 |
Lim, P | 1 |
Hsueh, AJ | 1 |
Trévoux, R | 1 |
De Brux, J | 1 |
Castanier, M | 1 |
Nahoul, K | 1 |
Soule, JP | 1 |
Scholler, R | 1 |
Grün, R | 1 |
Günther, C | 1 |
Kaffarnik, H | 1 |
Tsai, CC | 1 |
Semmens, JP | 2 |
Semmens, EC | 1 |
Lam, CF | 1 |
Lee, FS | 1 |
Wilson, PD | 1 |
Faragher, B | 1 |
Butler, B | 1 |
Bu'Lock, D | 2 |
Robinson, EL | 1 |
Brown, AD | 1 |
Fink, B | 1 |
Moller, S | 1 |
Alapin-Rubillovitz, S | 1 |
Ortega, E | 1 |
Ruiz, E | 1 |
Osorio, C | 1 |
Karlgren, E | 1 |
Yasumura, T | 1 |
Oka, T | 1 |
Honjyo, H | 1 |
Helin, HJ | 1 |
Isola, JJ | 1 |
Helle, MJ | 1 |
Kuang, AK | 1 |
Naldi, S | 3 |
Di Cosmo, D | 1 |
Lazzaretto, R | 1 |
Sandler, RB | 2 |
Sashin, D | 2 |
Tartaglia, E | 2 |
Wu, FR | 1 |
Kauppila, A | 1 |
Kivinen, S | 1 |
Stenbäck, F | 1 |
Vuopala, S | 1 |
Nagasako, S | 1 |
Asanuma, N | 1 |
Nagata, Y | 1 |
Hassager, C | 1 |
Strøm, V | 1 |
Hagerty, MA | 1 |
Howie, BJ | 1 |
Tan, S | 1 |
Shultz, TD | 1 |
Fantl, JA | 1 |
Wyman, JF | 1 |
Anderson, RL | 1 |
Matt, DW | 1 |
Bump, RC | 1 |
Jokela, H | 1 |
Kudo, R | 1 |
Punnonen, K | 1 |
Simberg, N | 1 |
Murai, J | 2 |
Ernster, VL | 1 |
Wrensch, MR | 1 |
Petrakis, NL | 1 |
King, EB | 1 |
Miike, R | 1 |
Goodson, WH | 1 |
Slemenda, C | 1 |
Bezwoda, WR | 1 |
Mansoor, N | 1 |
Dansey, R | 1 |
Esser, JD | 1 |
Cobb, JO | 1 |
Wahner, HW | 1 |
Richelson, LS | 1 |
Offord, KP | 1 |
Fabiano, A | 1 |
Fattibene, M | 1 |
Parlati, E | 1 |
Samuel, DL | 1 |
Forney, JP | 1 |
Parker, CR | 1 |
McNeill, JM | 1 |
Robinson, DJ | 1 |
Matsumine, H | 1 |
Hirato, K | 1 |
Tamada, T | 1 |
Yoshida, M | 1 |
Evans, WS | 1 |
Rogol, AD | 1 |
Ridgeway, CE | 1 |
Crowley, WF | 1 |
Kolp, L | 1 |
Checinska, E | 1 |
Thorner, MO | 1 |
Kvinnsland, S | 1 |
Thorsen, T | 1 |
Vignudelli, A | 1 |
Puolakka, J | 1 |
Lahti, A | 1 |
Viinikka, L | 1 |
Ylikorkala, O | 1 |
LaPorte, RE | 1 |
Falch, JA | 1 |
Oftebro, H | 1 |
Haug, E | 1 |
Gelfand, MM | 1 |
Kano, T | 1 |
Nishikawa, K | 1 |
Mathur, RS | 1 |
Landgrebe, SC | 1 |
Moody, LO | 1 |
Williamson, HO | 1 |
Wren, B | 1 |
Garrett, D | 1 |
Witt, RM | 1 |
Appledorn, R | 1 |
Enriori, CL | 1 |
Orsini, W | 1 |
del Carmen Cremona, M | 1 |
Etkin, AE | 1 |
Cardillo, LR | 1 |
Reforzo-Membrives, J | 1 |
Hannigan, EV | 1 |
Dillard, EA | 1 |
Van Dinh, T | 1 |
Hummer, L | 1 |
Nabuurs, M | 1 |
Thomson, ML | 1 |
Killen, E | 1 |
Whitworth, NS | 1 |
Meeks, GR | 1 |
Mason, RC | 1 |
Beardwell, CG | 1 |
Hindley, AC | 1 |
Wilkinson, PM | 1 |
St John, J | 1 |
Argüelles, AE | 1 |
Poggi, UL | 1 |
Saborida, C | 1 |
Hoffman, C | 1 |
Chekherdemian, M | 1 |
Blanchard, O | 1 |
Oertel, GW | 1 |
Menzel, P | 1 |
Procopé, BJ | 4 |
Howard, RP | 1 |
Keaty, EC | 1 |
Lozman, H | 1 |
Barlow, AL | 1 |
Levitt, DG | 1 |
Stone, S | 1 |
Kharma, KM | 1 |
Thorneycroft, IH | 1 |
Fechner, RE | 1 |
Willcox, PA | 1 |
Thomas, GH | 1 |
Saez, JM | 1 |
Morera, AM | 1 |
Dazord, A | 1 |
Bertrand, J | 1 |
Coertz, GR | 1 |
Crepy, OC | 1 |
Judas, OE | 1 |
Longchampt, JE | 1 |
Jayle, MF | 1 |
Hunneman, DH | 1 |
Widholm, O | 1 |
Vartiainen, E | 1 |
Holly, F | 1 |
Parker, RJ | 1 |
Cooper, W | 1 |
Marnie, M | 1 |
Iakovleva, VV | 1 |
Judd, GE | 1 |
Göretzlehner, G | 1 |
Kyank, H | 1 |
Herre, HD | 1 |
Töwe, J | 1 |
Fahmy, N | 1 |
Frandsen, VA | 1 |
Nakayama, T | 1 |
Brown, JB | 1 |
Beischer, NA | 1 |
Warner, PO | 1 |
Delvoye, P | 1 |
Vekemans, M | 1 |
Calaf, J | 1 |
L'Hermite, M | 1 |
Robyn, C | 1 |
Hausknecht, RU | 2 |
Gusberg, SB | 2 |
Rader, MD | 1 |
Flickinger, GL | 1 |
DeVilla, GO | 1 |
Mikuta, JJ | 1 |
Mikhail, G | 1 |
Jiang, NS | 1 |
Ryan, RJ | 1 |
Abdel-Aziz, MT | 1 |
Abdel-Kader, MM | 1 |
Khattab, M | 1 |
Saleh, SA | 1 |
Gobba, S | 1 |
Taema, H | 1 |
Gläser, F | 1 |
Ebert, A | 1 |
Kurt, H | 1 |
Friedrich, E | 1 |
Castellini, W | 1 |
Pratt, JJ | 1 |
van der Linden, G | 1 |
Doorenbos, H | 1 |
Woldring, MG | 1 |
Cedard, L | 1 |
Heilbronner, N | 1 |
Schnirer, J | 1 |
Fontenay, M | 1 |
Varangot, J | 1 |
Taylor, JP | 2 |
Kaplan, HG | 1 |
Hreshchyshyn, MM | 1 |
Dapunt, O | 1 |
Gleispach, H | 1 |
Daxenbichler, G | 1 |
Knorr, DW | 1 |
Grudzień, M | 1 |
Lambillon, J | 1 |
Stern, MI | 1 |
Loraine, JA | 3 |
Adamopoulos, DA | 2 |
Seddon, RJ | 1 |
Dove, GA | 3 |
Morley, F | 1 |
Batchelor, A | 1 |
Lunn, SF | 1 |
Veeman, W | 1 |
Dilman, VM | 1 |
Berstein, LM | 1 |
Bobrov, YF | 1 |
Bohman, YV | 1 |
Kovaleva, IG | 1 |
Krylova, NV | 1 |
Konoplia, EF | 1 |
Aho, AJ | 1 |
Guevara, A | 1 |
Goldfarb, AF | 1 |
Papanicolaou, AD | 1 |
Hembree, WC | 1 |
Bardin, CW | 1 |
Ludwig, E | 1 |
Buzzoni, P | 1 |
Ingrassia, F | 1 |
Bonfirraro, G | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Effects of Estrogen Replacement on Atherosclerosis Progression in Recently Menopausal Women[NCT00154180] | Phase 4 | 728 participants (Anticipated) | Interventional | 2005-09-30 | Active, not recruiting | ||
Defining the Vaginal Microbiome and the Vaginal pH of Menopausal Women With and Without Genitourinary Syndrome and With and Without Hormone Replacement Therapy[NCT05122065] | 432 participants (Anticipated) | Observational | 2021-12-01 | Not yet recruiting | |||
A Multicenter, Open-label Randomized Study on the Efficacy, Cycle Control and Safety of a Contraceptive Vaginal Ring Delivering a Daily Dose of Nestorone® and Estradiol (NES-E2 CVR).[NCT03432416] | Phase 2 | 300 participants (Anticipated) | Interventional | 2018-02-12 | Recruiting | ||
A Mechanistic Examination of Continuous Cycle Oral Contractive Administration in Binge Eating[NCT04278755] | Phase 2 | 8 participants (Actual) | Interventional | 2020-09-24 | Terminated (stopped due to Halted prematurely due to COVID-19-related enrollment challenges.) | ||
Characterizing the Neural Substrates of Irritability in Women: an Experimental Neuroendocrine Model[NCT04051320] | Phase 2 | 23 participants (Actual) | Interventional | 2020-01-02 | Completed | ||
Pharmacokinetic Aspects of 25-mg Estradiol Pellet in Climacteric Women Comprehensive Longitudinal Assessment of Release With Estradiol Pellet Analysis (CLARA Study)[NCT06136208] | 25 participants (Anticipated) | Interventional | 2023-10-27 | Recruiting | |||
Follicle Stimulating Hormone (FSH) Glycosylation in Women: Effect of Estradiol[NCT03868202] | Phase 2 | 10 participants (Anticipated) | Interventional | 2019-07-03 | Recruiting | ||
The Effects of Estrogen Replacement Therapy in Postmenopausal Women With Hypercalciuria and Low Bone Mass[NCT01928082] | Phase 2 | 1 participants (Actual) | Interventional | 2013-08-01 | Terminated (stopped due to The fellow conducting the recruitment and screening left the institution) | ||
Aromatase Inhibitors: Skeletal Effects and the Role of CYP19 Gene Polymorphisms[NCT00603967] | 151 participants (Actual) | Interventional | 2006-03-31 | Completed | |||
The Effects of Testosterone and Nutritional Supplementation, Alone and Combined, on the Adverse Effects of Under-Nutrition in the Elderly[NCT00117000] | Phase 3 | 200 participants | Interventional | 2003-07-31 | Active, not recruiting | ||
Effectiveness of Physiotherapy Treatment to Improve the Flow on Vascular Area of the Endometrial / Subendometrial in Uterus of Infertile Women With Hypoestrogenemia Evaluated by Three-dimensional Ultrasound Angiography.[NCT02437435] | 54 participants (Actual) | Interventional | 2018-08-01 | Completed | |||
[NCT00005223] | 0 participants | Observational | 1988-04-30 | Completed | |||
Effect of DHEA on Skin Aging - Placebo-Controlled and Randomized Phase III Study in Postmenopausal Women.[NCT00248989] | Phase 3 | 150 participants (Actual) | Interventional | 2004-11-01 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
The Behavioral Inhibition/Behavioral Activation questionnaire will be used to assess behavioural inhibition (BI). The minimum score on the BI subscale is 7, maximum 28. Greater scores indicate greater BI. Change is defined as the average change in BI from pre-intervention to intervention. (NCT04278755)
Timeframe: Pre-intervention (week 1) to intervention endpoint (week 12)
Intervention | score on a scale (Mean) |
---|---|
Continuous OC | 1.43 |
"Binge eating will be measured using the 8-item binge eating subscale of the Eating Pathology Symptoms Inventory (EPSI), which measures features of binge eating (e.g., consumption of large quantities of food, mindless eating) on a 5-point Likert scale from never to very often. The EPSI scale is designed to assess behavior over the past 28 days. Items are summed for a scale score ranging from 0-32. Higher scores indicate more frequent experiences with binge eating behavior. Change is defined as the average change in the binge eating scale score from pre-intervention to intervention." (NCT04278755)
Timeframe: Pre-intervention (week 1) to intervention endpoint (week 12)
Intervention | score on a scale (Mean) |
---|---|
Continuous OC | -6.60 |
The Monetary Choice Questionnaire will be used to measure delay discounting. Participants will be asked to make a series of hypothetical choices between small, sooner (impulsive) vs. larger, later (self controlled) hypothetical monetary outcomes. k is a hyperbolic function with larger k values indicating more valuation of a larger delayed reward and smaller values indicating preference for more immediate, smaller rewards (more impulsivity). k can range from 0 to .25 with scores of .25 indicating complete valuation of the immediate reward and 0 indicating complete valuation of the larger, delayed reward. Change is defined as the average change in k from pre-intervention to intervention. (NCT04278755)
Timeframe: Pre-intervention (week 1) to intervention endpoint (week 12)
Intervention | k value (Mean) |
---|---|
Continuous OC | .01 |
"Nucleus Accumbens (NAcc) reactivity to reward during the Monetary Incentive Delay (MIDT) task compared pre and post treatment. During MIDT task, participants respond to win trials by pressing a button on a button box in the MRI as quickly as possible when they see a target. Reactivity is measured by examining participant's change in blood-oxygen-level dependent (BOLD) (i.e., measurement of oxygen level that is carried to neurons by red blood cells since areas of the brain that are thought to be more active or involved in certain tasks require more oxygen) in response to a stimulus of interest (win trials) versus non-stimulus (non-win trials). Percent signal change in BOLD activation between monetary reward versus non-reward is the outcome of interest. Percent signal change is then compared pre- and post-treatment." (NCT04278755)
Timeframe: Pre-intervention (week 1) to intervention endpoint (week 12)
Intervention | percentage signal change (Mean) |
---|---|
Continuous OC | .0423 |
"Prefrontal cortex reactivity to reward during the Monetary Incentive Delay (MIDT) task compared pre and post treatment. During MIDT task, participants respond to win trials by pressing a button on a button box in the MRI as quickly as possible when they see a target. Reactivity is measured by examining participant's change in blood-oxygen-level dependent (BOLD) (i.e., measurement of oxygen level that is carried to neurons by red blood cells since areas of the brain that are thought to be more active or involved in certain tasks require more oxygen) in response to a stimulus of interest (win trials) versus non-stimulus (non-win trials). Percent signal change in BOLD activation between monetary reward versus non-reward is the outcome of interest. Percent signal change is then compared pre- and post-treatment." (NCT04278755)
Timeframe: Pre-intervention (week 1) to intervention endpoint (week 12)
Intervention | percentage signal change (Mean) |
---|---|
Continuous OC | .01 |
Sensitivity to Punishment/Sensitivity to Reward Questionnaire will be used to measure reward sensitivity. The reward sensitivity subscale will be used, which is rated on a true/false scale with scores ranging 0-24. Higher scores indicate more sensitivity to reward. Change is defined as the average change in reward sensitivity from pre-intervention to intervention. (NCT04278755)
Timeframe: Pre-intervention (week 1) to intervention endpoint (week 12)
Intervention | score on a scale (Mean) |
---|---|
Continuous OC | 1.60 |
Binge eating frequency is based on a weekly diary of self-reported binge eating frequency. Participants were asked how many times during the past week they had a binge eating episode. Scores can range from 0 to infinity as frequency is self-reported as the number of binge eating episodes in the previous week. Higher scores indicate more episodes of binge eating. Change is defined as the average change in self-reported binge eating frequency from pre-intervention to intervention. (NCT04278755)
Timeframe: Pre-intervention (week 1) to intervention endpoint (week 12)
Intervention | episodes/week (Mean) |
---|---|
Continuous OC | -0.43 |
"Dorsal striatum reactivity (defined as caudate signal intensity and putamen signal intensity) to reward during the Monetary Incentive Delay (MIDT) task compared pre and post treatment. During MIDT task, participants respond to win trials by pressing a button on a button box in the MRI as quickly as possible when they see a target. Reactivity is measured by examining participant's change in blood-oxygen-level dependent (BOLD) (i.e., measurement of oxygen level that is carried to neurons by red blood cells since areas of the brain that are thought to be more active or involved in certain tasks require more oxygen) in response to a stimulus of interest (win trials) versus non-stimulus (non-win trials). Percent signal change in BOLD activation between monetary reward versus non-reward is the outcome of interest. Percent signal change is then compared pre- and post-treatment." (NCT04278755)
Timeframe: Pre-intervention (week 1) to intervention endpoint (week 12)
Intervention | percentage signal change (Mean) | |
---|---|---|
Caudate | Putamen | |
Continuous OC | -.012 | .02 |
"This outcome measure determines the degree of irritability and reactive aggression in HS+ during hormone addback and its relationship to the target population. Irritability will be defined as score on the IDAS Ill Temper Scale. Reactive aggression will be defined as the number of point subtractions the participant makes during the Point Subtraction Aggression Paradigm.~The Point Subtraction Aggression Paradigm measures relational aggression (approach behavior) in response to frustration. In the task, participants are asked to press a button to ac" (NCT04051320)
Timeframe: Endpoint (week 6)
Intervention | correlation coefficient (Number) |
---|---|
Hormone Sensitive Women (HS+) | 0.18 |
Hormone Insensitive Women (HS-) | 0.03 |
"This outcome measure determines the degree of subcortical (amygdala, caudate, putamen, and nucleus accumbens) activation in HS+ during hormone addback and it's relationship to the target population. The activation in amygdala and ventral striatum (caudate, putamen, nucleus accumbens) regions of interest (ROIs) will be assessed during the Affective Posner Task.~The Affective Posner Task tests whether HS+ is characterized by reduced subcortical activation in response to frustration. This task is divided into 3 runs: during Run 1 (practice run), participants receive accurate feedback about their performance on the task and do not win or lose money; during Run 2, participants receive accurate feedback about their performance and win or lose 50 cents per trial; and during Run 3 (frustration), participants are told they must respond accurately to win money, but participants are given feedback that they responded too slowly on 60% of accurate trials, regardless of their performance." (NCT04051320)
Timeframe: Endpoint (week 6)
Intervention | correlation coefficient (Number) |
---|---|
Hormone Sensitive Women (HS+) | 0.47 |
This outcome measure determines the extent to which irritability is characterized by dysfunctional reward processing during reproductive hormone challenge in HS+ and HS- by examining the correlation between the Inventory of Depressive and Anxiety Symptoms (IDAS) Ill Temper (i.e., irritability) Scale and threat attention bias. (NCT04051320)
Timeframe: Endpoint (week 6)
Intervention | correlation coefficient (Number) |
---|---|
Hormone Sensitive Women (HS+) | -0.35 |
Hormone Insensitive Women (HS-) | 0.11 |
This outcome measure determines the extent to which irritability is characterized by dysfunctional reward processing during reproductive hormone challenge in HS+ and HS- by examining the correlation between the IDAS Ill Temper (i.e., irritability) Scale and amygdala-medial PFC connectivity in HS+. (NCT04051320)
Timeframe: Endpoint (week 6)
Intervention | correlation coefficient (Mean) |
---|---|
Hormone Sensitive Women (HS+) | -0.13 |
Hormone Insensitive Women (HS-) | 0.49 |
This outcome measure determines the extent to which irritability is characterized by dysfunctional reward processing during reproductive hormone challenge in HS+ and HS- by examining the correlation between the IDAS Ill Temper (i.e., irritability) Scale and amygdala-medial PFC connectivity in HS+. (NCT04051320)
Timeframe: Endpoint (week 6)
Intervention | correlation coefficient (Number) |
---|---|
Hormone Sensitive Women (HS+) | -0.57 |
Hormone Insensitive Women (HS-) | -0.08 |
"This outcome measure determines the extent to which HS+ is characterized by BOLD activation of the left amygdala in response to frustrative non-reward (FNR) in the Affective Posner Task during hormone addback relative to baseline in the target population.~The Affective Posner Task tests whether HS+ is characterized by reduced subcortical activation in response to frustration. This task is divided into 3 runs: during Run 1 (practice run), participants receive accurate feedback about their performance on the task and do not win or lose money; during Run 2, participants receive accurate feedback about their performance and win or lose 50 cents per trial; and during Run 3 (frustration), participants are told they must respond accurately to win money, but participants are given feedback that they responded too slowly on 60% of accurate trials, regardless of their performance." (NCT04051320)
Timeframe: up to 6 weeks
Intervention | Arbitrary Units (Mean) | |
---|---|---|
Baseline (Visit 3) | Hormone Addback (Visit 6) | |
Hormone Insensitive Women (HS-) | -0.009866667 | -0.086876444 |
Hormone Sensitive Women (HS+) | 0.005316917 | -0.047401917 |
"This outcome measure determines the extent to which HS+ is characterized by BOLD activation of the left caudate in response to frustrative non-reward (FNR) in the Affective Posner Task during hormone addback relative to baseline in the target population.~The Affective Posner Task tests whether HS+ is characterized by reduced subcortical activation in response to frustration. This task is divided into 3 runs: during Run 1 (practice run), participants receive accurate feedback about their performance on the task and do not win or lose money; during Run 2, participants receive accurate feedback about their performance and win or lose 50 cents per trial; and during Run 3 (frustration), participants are told they must respond accurately to win money, but participants are given feedback that they responded too slowly on 60% of accurate trials, regardless of their performance." (NCT04051320)
Timeframe: up to 6 weeks
Intervention | Arbitrary Units (Mean) | |
---|---|---|
Baseline (Visit 3) | Hormone Addback (Visit 6) | |
Hormone Insensitive Women (HS-) | 0.0077258 | -0.049988 |
Hormone Sensitive Women (HS+) | -0.043943333 | 0.059099917 |
"This outcome measure determines the extent to which HS+ is characterized by BOLD activation of the left nucleus accumbens in response to frustrative non-reward (FNR) in the Affective Posner Task during hormone addback relative to baseline in the target population.~The Affective Posner Task tests whether HS+ is characterized by reduced subcortical activation in response to frustration. This task is divided into 3 runs: during Run 1 (practice run), participants receive accurate feedback about their performance on the task and do not win or lose money; during Run 2, participants receive accurate feedback about their performance and win or lose 50 cents per trial; and during Run 3 (frustration), participants are told they must respond accurately to win money, but participants are given feedback that they responded too slowly on 60% of accurate trials, regardless of their performance." (NCT04051320)
Timeframe: up to 6 weeks
Intervention | Arbitrary Units (Mean) | |
---|---|---|
Baseline (Visit 3) | Hormone Addback (Visit 6) | |
Hormone Insensitive Women (HS-) | 0.0691907 | -0.072512 |
Hormone Sensitive Women (HS+) | -0.028451818 | 0.031632727 |
"This outcome measure determines the extent to which HS+ is characterized by BOLD activation of the left putamen in response to frustrative non-reward (FNR) in the Affective Posner Task during hormone addback relative to baseline in the target population.~The Affective Posner Task tests whether HS+ is characterized by reduced subcortical activation in response to frustration. This task is divided into 3 runs: during Run 1 (practice run), participants receive accurate feedback about their performance on the task and do not win or lose money; during Run 2, participants receive accurate feedback about their performance and win or lose 50 cents per trial; and during Run 3 (frustration), participants are told they must respond accurately to win money, but participants are given feedback that they responded too slowly on 60% of accurate trials, regardless of their performance." (NCT04051320)
Timeframe: up to 6 weeks
Intervention | Arbitrary Units (Mean) | |
---|---|---|
Baseline (Visit 3) | Hormone Addback (Visit 6) | |
Hormone Insensitive Women (HS-) | 0.0383029 | -0.021029 |
Hormone Sensitive Women (HS+) | -0.001223462 | 0.048155385 |
"This outcome measure determines the extent to which HS+ is characterized by BOLD activation of the right amygdala in response to frustrative non-reward (FNR) in the Affective Posner Task during hormone addback relative to baseline in the target population.~The Affective Posner Task tests whether HS+ is characterized by reduced subcortical activation in response to frustration. This task is divided into 3 runs: during Run 1 (practice run), participants receive accurate feedback about their performance on the task and do not win or lose money; during Run 2, participants receive accurate feedback about their performance and win or lose 50 cents per trial; and during Run 3 (frustration), participants are told they must respond accurately to win money, but participants are given feedback that they responded too slowly on 60% of accurate trials, regardless of their performance." (NCT04051320)
Timeframe: up to 6 weeks
Intervention | Arbitrary Units (Mean) | |
---|---|---|
Baseline (Visit 3) | Hormone Addback (Visit 6) | |
Hormone Insensitive Women (HS-) | 0.037334 | -0.15643 |
Hormone Sensitive Women (HS+) | -0.04544 | 0.022654 |
"This outcome measure determines the extent to which HS+ is characterized by BOLD activation of the right caudate in response to frustrative non-reward (FNR) in the Affective Posner Task during hormone addback relative to baseline in the target population.~The Affective Posner Task tests whether HS+ is characterized by reduced subcortical activation in response to frustration. This task is divided into 3 runs: during Run 1 (practice run), participants receive accurate feedback about their performance on the task and do not win or lose money; during Run 2, participants receive accurate feedback about their performance and win or lose 50 cents per trial; and during Run 3 (frustration), participants are told they must respond accurately to win money, but participants are given feedback that they responded too slowly on 60% of accurate trials, regardless of their performance." (NCT04051320)
Timeframe: up to 6 weeks
Intervention | Arbitrary Units (Mean) | |
---|---|---|
Baseline (Visit 3) | Hormone Addback (Visit 6) | |
Hormone Insensitive Women (HS-) | 0.061407 | 0.0058011 |
Hormone Sensitive Women (HS+) | -0.069919077 | 0.045146154 |
"This outcome measure determines the extent to which HS+ is characterized by BOLD activation of the right nucleus accumbens in response to frustrative non-reward (FNR) in the Affective Posner Task during hormone addback relative to baseline in the target population.~The Affective Posner Task tests whether HS+ is characterized by reduced subcortical activation in response to frustration. This task is divided into 3 runs: during Run 1 (practice run), participants receive accurate feedback about their performance on the task and do not win or lose money; during Run 2, participants receive accurate feedback about their performance and win or lose 50 cents per trial; and during Run 3 (frustration), participants are told they must respond accurately to win money, but participants are given feedback that they responded too slowly on 60% of accurate trials, regardless of their performance." (NCT04051320)
Timeframe: up to 6 weeks
Intervention | Arbitrary Units (Mean) | |
---|---|---|
Baseline (Visit 3) | Hormone Addback (Visit 6) | |
Hormone Insensitive Women (HS-) | 0.052685333 | -0.006394444 |
Hormone Sensitive Women (HS+) | 0.044384167 | -0.005181667 |
"This outcome measure determines the extent to which HS+ is characterized by BOLD activation of the right putamen in response to frustrative non-reward (FNR) in the Affective Posner Task during hormone addback relative to baseline in the target population.~The Affective Posner Task tests whether HS+ is characterized by reduced subcortical activation in response to frustration. This task is divided into 3 runs: during Run 1 (practice run), participants receive accurate feedback about their performance on the task and do not win or lose money; during Run 2, participants receive accurate feedback about their performance and win or lose 50 cents per trial; and during Run 3 (frustration), participants are told they must respond accurately to win money, but participants are given feedback that they responded too slowly on 60% of accurate trials, regardless of their performance." (NCT04051320)
Timeframe: up to 6 weeks
Intervention | Arbitrary Units (Mean) | |
---|---|---|
Baseline (Visit 3) | Hormone Addback (Visit 6) | |
Hormone Insensitive Women (HS-) | 0.002542222 | -0.080736333 |
Hormone Sensitive Women (HS+) | -0.007560692 | 0.036225385 |
"This outcome measure determines the extent to which irritability is characterized by dysfunctional threat processing during reproductive hormone challenge relative to baseline in HS+ and HS-. By examining amygdala-medial prefrontal cortex (PFC) connectivity in response to threatening faces on the implicit emotion face processing fMRI task in HS+ (compared with HS-) during hormone challenge relative to baseline.~The implicit emotion face processing task asks participants to identify the gender of angry, happy, and fearful faces at 50%, 100% and 150% emotion intensity presented in random order for 2000 milliseconds followed by jittered fixation. Trials appear in 3 blocks, generating 30 trials of each emotion at each intensity and 90 neutral face emotion trials." (NCT04051320)
Timeframe: up to 6 weeks
Intervention | arbitrary units (Mean) | |
---|---|---|
Baseline (Visit 3) | Hormone Addback (Visit 6) | |
Hormone Insensitive Women (HS-) | 0.0213 | 0.00111 |
Hormone Sensitive Women (HS+) | 0.0247 | -0.0192 |
"This outcome measure determines the extent to which HS+ is characterized by reactive aggression during hormone addback relative to baseline in the target population. Reactive aggression will be defined as the number of point subtractions the participant makes during the Point Subtraction Aggression Paradigm.~Point Subtraction Aggression Paradigm measures relational aggression (approach behavior) in response to frustration. In the task, participants are asked to press a button to accrue money or press another button to subtract money from a (fictional) partner at no direct gain to themselves. Frustration is induced by periodic subtractions of their own money, which is attributed to the partner." (NCT04051320)
Timeframe: up to 6 weeks
Intervention | Number of subtraction responses (Mean) | |
---|---|---|
Baseline (Visit 3) | Hormone Addback (Visit 6) | |
Hormone Insensitive Women (HS-) | 129.20 | 54.90 |
Hormone Sensitive Women (HS+) | 103.08 | 34.62 |
"This outcome measure determines the extent to which irritability is characterized by dysfunctional threat processing during reproductive hormone challenge relative to baseline in HS+ and HS-. By examining amygdala-medial prefrontal cortex (PFC) Blood-oxygen-level-dependent (BOLD) connectivity in response to threatening faces on the implicit emotion face processing fMRI task in HS+ (compared with HS-) during hormone challenge relative to baseline.~The implicit emotion face processing task asks participants to identify the gender of angry, happy, and fearful faces at 50%, 100% and 150% emotion intensity presented in random order for 2000 milliseconds followed by jittered fixation. Trials appear in 3 blocks, generating 30 trials of each emotion at each intensity and 90 neutral face emotion trials." (NCT04051320)
Timeframe: up to 6 weeks
Intervention | arbitrary units (Mean) | |
---|---|---|
Baseline (Visit 3) | Hormone Addback (Visit 6) | |
Hormone Insensitive Women (HS-) | 0.0533 | 0.00804 |
Hormone Sensitive Women (HS+) | 0.0174 | -0.0114 |
"This outcome measure determines the extent to which irritability is characterized by dysfunctional threat processing during reproductive hormone challenge relative to baseline in HS+ and HS- by examining threat attention bias assessed during the visual dot-probe paradigm.~The Visual Dot-Probe Paradigm asks participants to detect a target stimulus that is embedded in a matrix of distracting stimuli (e.g., a target stimulus, an angry face, might be embedded in a matrix of neutral distractor faces). Attention biases are inferred from faster response times to detect a threatening stimulus in a matrix of neutral stimuli relative to response time to detect neutral stimuli in neutral matrices. Thus, positive times reflect attention bias toward threat, whereas negative times reflect attention bias away from threat." (NCT04051320)
Timeframe: up to 6 weeks
Intervention | attention bias in milliseconds (Mean) | |
---|---|---|
Baseline (Visit 3) | Hormone Addback (Visit 6) | |
Hormone Insensitive Women (HS-) | 36.92 | -42.35 |
Hormone Sensitive Women (HS+) | -0.57 | -9.04 |
21 reviews available for estrone and Menopause
Article | Year |
---|---|
CYP17 gene polymorphisms: prevalence and associations with hormone levels and related factors. a HuGE review.
Topics: 5' Untranslated Regions; Age Factors; Breast; Confounding Factors, Epidemiologic; Estradiol; Estroge | 2004 |
Clinical pharmacology and differential cognitive efficacy of estrogen preparations.
Topics: Administration, Cutaneous; Administration, Oral; Cognition; Estradiol; Estrogen Replacement Therapy; | 2005 |
Aminoglutethimide in the treatment of advanced breast cancer.
Topics: Adrenalectomy; Aged; Aminoglutethimide; Androstenedione; Breast Neoplasms; Clinical Trials as Topic; | 1984 |
Steroid hormones, ageing and bone.
Topics: Adult; Aged; Aging; Androstenedione; Bone and Bones; Calcium; Castration; Dehydroepiandrosterone; Es | 1981 |
Ovarian failure and ageing.
Topics: Administration, Oral; Aging; Androgens; Blood Coagulation Disorders; Castration; Climacteric; Drug I | 1981 |
Pathophysiologic considerations in the treatment of menopausal patients with oestrogens; the role of oestriol in the prevention of mammary carcinoma.
Topics: Adolescent; Adult; Aged; Animals; Breast Neoplasms; Estradiol; Estriol; Estrogens; Estrone; Female; | 1980 |
Oestrogen therapy in the peri-menopause: A practical approach.
Topics: Administration, Oral; Aged; Drug Therapy, Combination; Estradiol; Estradiol Congeners; Estriol; Estr | 1980 |
Age, estrogen, and the endometrium.
Topics: Androstenedione; Endometrium; Estradiol; Estrogens; Estrone; Female; Humans; Menopause; Progesterone | 1981 |
The pituitary-gonadal function in postmenopausal women with epithelial ovarian tumors.
Topics: Animals; Biomarkers, Tumor; Blood Proteins; CA-125 Antigen; Epithelium; Estradiol; Estrone; Female; | 1997 |
[Estrogen: estrone (E1), estradiol (E2), estriol (E3) and estetrol (4)].
Topics: Adolescent; Adult; Estetrol; Estradiol; Estriol; Estrone; Female; Humans; Menopause; Menstruation; O | 1999 |
Kinetic, hormonal and clinical studies with aminoglutethimide in breast cancer.
Topics: Adrenocorticotropic Hormone; Aldosterone; Aminoglutethimide; Androstenedione; Breast Neoplasms; Dehy | 1977 |
Estrogen and endometrial carcinoma.
Topics: Androstenedione; Animals; Diethylstilbestrol; Estrogens; Estrone; Female; Humans; Luteinizing Hormon | 1977 |
The role of hormones in the etiology of human breast cancer.
Topics: 17-Ketosteroids; Androgens; Androsterone; Breast Neoplasms; Contraceptives, Oral, Hormonal; Estradio | 1977 |
Estrogenic hormones -- general considerations.
Topics: Animals; Carcinogens; Chemical Phenomena; Chemistry; Estradiol; Estradiol Congeners; Estriol; Estrog | 1976 |
Hormonal dynamics associated with the menopause.
Topics: Androgens; Androstenedione; Estradiol; Estrogens; Estrone; Female; Gonadotropins, Pituitary; Humans; | 1976 |
Post-menopausal estrogen production, with special reference to patients with mammary carcinoma.
Topics: Age Factors; Aged; Androgens; Androstenedione; Binding, Competitive; Body Weight; Breast Neoplasms; | 1975 |
Estrone v estradiol: an examination of relative carcinogenic potential.
Topics: Aged; Estradiol; Estrone; Female; Humans; Menopause; Middle Aged; Risk Factors; Uterine Neoplasms | 1986 |
The saga of the ring B unsaturated equine estrogens.
Topics: Animals; Cholesterol; Equilin; Estradiol; Estrogens; Estrone; Female; Horses; Humans; Menopause; Pre | 1988 |
Endocrine influences on human mammary cancer formation. A critique.
Topics: Adrenocorticotropic Hormone; Androgens; Androsterone; Animals; Binding Sites; Breast Diseases; Breas | 1969 |
[Female gonadal gland].
Topics: Adult; Aged; Aging; Androgens; Estradiol; Estrogens; Estrone; Female; Follicle Stimulating Hormone; | 1973 |
Current status of estrogen assay in gynecology and obstetrics. I. Estrogen assays in gynecology and early pregnancy.
Topics: Abortion, Threatened; Chorionic Gonadotropin; Chromatography, Gas; Contraceptive Agents, Female; End | 1972 |
60 trials available for estrone and Menopause
Article | Year |
---|---|
Associations between pituitary-ovarian hormones and cognition in recently menopausal women independent of type of hormone therapy.
Topics: Animals; Cognition; Estradiol; Estrone; Female; Horses; Humans; Menopause; Pituitary Hormones | 2023 |
Associations between pituitary-ovarian hormones and cognition in recently menopausal women independent of type of hormone therapy.
Topics: Animals; Cognition; Estradiol; Estrone; Female; Horses; Humans; Menopause; Pituitary Hormones | 2023 |
Associations between pituitary-ovarian hormones and cognition in recently menopausal women independent of type of hormone therapy.
Topics: Animals; Cognition; Estradiol; Estrone; Female; Horses; Humans; Menopause; Pituitary Hormones | 2023 |
Associations between pituitary-ovarian hormones and cognition in recently menopausal women independent of type of hormone therapy.
Topics: Animals; Cognition; Estradiol; Estrone; Female; Horses; Humans; Menopause; Pituitary Hormones | 2023 |
Associations between pituitary-ovarian hormones and cognition in recently menopausal women independent of type of hormone therapy.
Topics: Animals; Cognition; Estradiol; Estrone; Female; Horses; Humans; Menopause; Pituitary Hormones | 2023 |
Associations between pituitary-ovarian hormones and cognition in recently menopausal women independent of type of hormone therapy.
Topics: Animals; Cognition; Estradiol; Estrone; Female; Horses; Humans; Menopause; Pituitary Hormones | 2023 |
Associations between pituitary-ovarian hormones and cognition in recently menopausal women independent of type of hormone therapy.
Topics: Animals; Cognition; Estradiol; Estrone; Female; Horses; Humans; Menopause; Pituitary Hormones | 2023 |
Associations between pituitary-ovarian hormones and cognition in recently menopausal women independent of type of hormone therapy.
Topics: Animals; Cognition; Estradiol; Estrone; Female; Horses; Humans; Menopause; Pituitary Hormones | 2023 |
Associations between pituitary-ovarian hormones and cognition in recently menopausal women independent of type of hormone therapy.
Topics: Animals; Cognition; Estradiol; Estrone; Female; Horses; Humans; Menopause; Pituitary Hormones | 2023 |
Vaginal microbiota and genitourinary menopausal symptoms: a cross-sectional analysis.
Topics: Adult; Biomarkers; Cross-Sectional Studies; Estradiol; Estrone; Female; Glycogen; Hot Flashes; Human | 2017 |
Pharmacokinetics of the first combination 17β-estradiol/progesterone capsule in clinical development for menopausal hormone therapy.
Topics: Administration, Oral; Adult; Aged; Biological Availability; Drug Combinations; Estradiol; Estrone; F | 2015 |
Increases in serum estrone sulfate level are associated with increased mammographic density during menopausal hormone therapy.
Topics: Biomarkers, Tumor; Breast Neoplasms; Contraceptives, Oral, Synthetic; Drug Therapy, Combination; Est | 2008 |
Short-term urogenital effects of raloxifene, tamoxifen, and estrogen.
Topics: Aged; Atrophy; Double-Blind Method; Estradiol; Estrogens; Estrogens, Conjugated (USP); Estrone; Fema | 2003 |
Serum equilin, oestrone, and oestradiol levels in postmenopausal women receiving conjugated equine oestrogens ('Premarin').
Topics: 17-Ketosteroids; Castration; Equilin; Estradiol; Estrogens, Conjugated (USP); Estrone; Female; Human | 1980 |
Adjuvant aminoglutethimide therapy for postmenopausal patients with primary breast cancer: progress report.
Topics: Adult; Aged; Aminoglutethimide; Breast Neoplasms; Clinical Trials as Topic; Dehydroepiandrosterone; | 1982 |
Aminoglutethimide dose and hormone suppression in advanced breast cancer.
Topics: Adult; Aged; Aminoglutethimide; Breast Neoplasms; Dehydroepiandrosterone; Dehydroepiandrosterone Sul | 1983 |
Hydrocortisone alone vs hydrocortisone plus aminoglutethimide: a comparison of the endocrine effects in postmenopausal breast cancer.
Topics: Aminoglutethimide; Androstenedione; Breast Neoplasms; Dehydroepiandrosterone; Dehydroepiandrosterone | 1984 |
Aminoglutethimide in the treatment of advanced breast cancer.
Topics: Adrenalectomy; Aged; Aminoglutethimide; Androstenedione; Breast Neoplasms; Clinical Trials as Topic; | 1984 |
Is oestrogen therapy effective in the treatment of menopausal depression?
Topics: Adult; Clinical Trials as Topic; Depression; Double-Blind Method; Estrogens, Conjugated (USP); Estro | 1981 |
The effect of type and dose of oestrogen on the blood pressure of post-menopausal women.
Topics: Antihypertensive Agents; Blood Pressure; Depression, Chemical; Dose-Response Relationship, Drug; Est | 1983 |
The role of aromatase inhibitors in breast cancer.
Topics: Aged; Aminoglutethimide; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as | 1983 |
[Percutaneous estrogen replacement therapy. An alternative for oral treatment].
Topics: Estradiol; Estrone; Female; Humans; Lynestrenol; Menopause; Middle Aged; Skin Absorption | 1983 |
Uptake and metabolism of oestriol in human target tissues.
Topics: Endometrium; Estradiol; Estriol; Estrone; Female; Humans; Menopause; Middle Aged; Myometrium; Subcel | 1984 |
Steroid and gonadotropin profiles in menopausal women on three different oral replacement regimens.
Topics: Adult; Clinical Trials as Topic; Drug Administration Schedule; Estradiol; Estrogens; Estrone; Female | 1980 |
Oestrogens, gonadotrophins and SHBG during oral and cutaneous administration of oestradiol-17 beta to menopausal women.
Topics: Administration, Oral; Administration, Topical; Adult; Estradiol; Estrone; Female; Follicle Stimulati | 1982 |
Intracellular estradiol, estrone and estrogen receptor levels in endometria from postmenopausal women receiving estrogens and progestins.
Topics: Cell Nucleus; Cytosol; Endometrium; Estradiol; Estradiol Congeners; Estrone; Female; Humans; Menopau | 1980 |
Plasma concentrations of medroxyprogesterone acetate, estradiol and estrone following oral administration of Klimaxil, Trisequence/Provera and Divina. A randomized, single-blind, triple cross-over bioavailability study in menopausal women.
Topics: Administration, Oral; Biological Availability; Drug Combinations; Estradiol; Estrogen Replacement Th | 1994 |
Phase I study of the oral nonsteroidal aromatase inhibitor CGS 20267 in healthy postmenopausal women.
Topics: 17-alpha-Hydroxyprogesterone; Administration, Oral; Aged; Aldosterone; Androstenedione; Aromatase In | 1993 |
[The effect of carbon disulphide on menopause, concentration of monoamines, gonadotropins, estrogens and androgens in women].
Topics: 17-alpha-Hydroxyprogesterone; Abortion, Spontaneous; Adult; Carbon Disulfide; Chemical Industry; Dop | 1997 |
Serum concentrations of 17beta-estradiol and estrone after multiple-dose administration of percutaneous estradiol gel in symptomatic menopausal women.
Topics: Administration, Topical; Adult; Aged; Double-Blind Method; Estradiol; Estrone; Female; Gels; Humans; | 2001 |
Role of low levels of endogenous estrogen in regulation of bone resorption in late postmenopausal women.
Topics: Aged; Aromatase Inhibitors; Bone Remodeling; Bone Resorption; Double-Blind Method; Enzyme Inhibitors | 2002 |
Menopausal symptom control and side-effects on continuous estrone sulfate and three doses of medroxyprogesterone acetate. Ogen/Provera Study Group.
Topics: Adult; Affect; Breast; Depression; Double-Blind Method; Estrogen Replacement Therapy; Estrone; Femal | 1998 |
Plasma oestrone, oestradiol and gonadotrophin concentrations in postmenopausal patients treated with oestradiol or with a combination of oestradiol and oestriol.
Topics: Climacteric; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Estradiol; Estriol; E | 1979 |
Efficacy of estradiol vaginal cream in postmenopausal women.
Topics: Administration, Topical; Aged; Dosage Forms; Double-Blind Method; Estradiol; Estrogens, Conjugated ( | 1979 |
Experimental and clinical data on Cyclabil.
Topics: Adult; Cervix Mucus; Cervix Uteri; Clinical Trials as Topic; Drug Combinations; Estradiol; Estrone; | 1977 |
Letter: Natural oestrogen replacement therapy and blood clotting.
Topics: Blood Coagulation; Clinical Trials as Topic; Estrone; Ethinyl Estradiol; Female; Humans; Menopause | 1976 |
Replacement therapy and piperazine oestrone sulphate ('Harmogen') and its effect on memory.
Topics: Adult; Aged; Clinical Trials as Topic; Estrone; Female; Humans; Memory; Menopause; Middle Aged; Pipe | 1976 |
Double blind study on the effect of estrogen on sleep, anxiety and depression in perimenopausal women: preliminary results.
Topics: Anxiety; Climacteric; Clinical Trials as Topic; Depression; Estrone; Female; Humans; Menopause; Midd | 1976 |
Postmenopausal symptomatology, maturation index, and plasma estrogen levels.
Topics: Adult; Aged; Castration; Clinical Trials as Topic; Estradiol; Estradiol Congeners; Estrogens; Estron | 1975 |
Low-dose oestradiol in the treatment of urogenital oestrogen deficiency--a pharmacokinetic and pharmacodynamic study.
Topics: Administration, Intravaginal; Aged; Atrophy; Double-Blind Method; Epithelium; Estradiol; Estrone; Fe | 1992 |
Effects of estrogen on memory function in surgically menopausal women.
Topics: Climacteric; Estradiol; Estrogen Replacement Therapy; Estrone; Female; Humans; Hysterectomy; Menopau | 1992 |
A comparison of circulating hormone levels in postmenopausal women receiving hormone replacement therapy.
Topics: Adult; Aged; Estradiol; Estrogen Replacement Therapy; Estrone; Female; Humans; Menopause; Middle Age | 1992 |
Short-term effects of estrogen and progestin on blood pressure of normotensive postmenopausal women.
Topics: Blood Pressure; Drug Therapy, Combination; Estradiol; Estrogens, Conjugated (USP); Estrone; Female; | 1991 |
Neuroendocrine and clinical effects of transdermal 17 beta-estradiol in postmenopausal women.
Topics: Administration, Cutaneous; Adult; Alkaline Phosphatase; Body Temperature; Bone Density; Calcium; Est | 1991 |
Effects of progestin-opposed transdermal estrogen administration on growth hormone and insulin-like growth factor-I in postmenopausal women of different ages.
Topics: Aged; Aging; Body Mass Index; Estradiol; Estrogen Replacement Therapy; Estrone; Female; Growth Hormo | 1991 |
Transdermal estradiol with oral progestin: biological and clinical effects in younger and older postmenopausal women.
Topics: Administration, Cutaneous; Administration, Oral; Aged; Aging; Analysis of Variance; Body Mass Index; | 1991 |
The impact of different doses of estrogen and progestin on mood and sexual behavior in postmenopausal women.
Topics: Affect; Estradiol; Estrogens, Conjugated (USP); Estrone; Female; Humans; Medroxyprogesterone; Medrox | 1991 |
Pharmacokinetics and biotransformation of orally administered oestrone sulphate and oestradiol valerate in post-menopausal women.
Topics: Administration, Oral; Biotransformation; Estradiol; Estrogens; Estrone; Female; Half-Life; Humans; L | 1990 |
Potency and selectivity of the non-steroidal aromatase inhibitor CGS 16949A in postmenopausal breast cancer patients.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Breast Neoplasms; Dose-Response Relationship, Drug; | 1990 |
Up-regulatory effect of estrogen on platelet 3H-imipramine binding sites in surgically menopausal women.
Topics: Affect; Blood Platelets; Carrier Proteins; Estradiol; Estrogen Replacement Therapy; Estrone; Female; | 1990 |
Effect of cyclic estrone sulfate treatment on lipid profiles of postmenopausal women with elevated cholesterol levels.
Topics: Cholesterol, HDL; Cholesterol, LDL; Double-Blind Method; Estrone; Female; Humans; Hypercholesterolem | 1990 |
The relation of endogenous sex steroid hormone concentrations to serum lipid and lipoprotein levels in postmenopausal women.
Topics: Androstenedione; Cholesterol; Cholesterol, HDL; Cross-Sectional Studies; Estradiol; Estrone; Female; | 1990 |
Effect of orally administered oestrogens on gonadotrophin levels in post-menopausal women.
Topics: Administration, Oral; Drug Combinations; Estradiol; Estriol; Estrogens, Conjugated (USP); Estrone; F | 1989 |
Effect of orally administered oestrogens on circulating oestrogen profiles in post-menopausal women.
Topics: Administration, Oral; Drug Combinations; Estradiol; Estriol; Estrogens; Estrogens, Conjugated (USP); | 1989 |
Transdermal oestrogen for postmenopausal women: a double blind crossover comparative study with ethinyl oestradiol.
Topics: Administration, Cutaneous; Administration, Oral; Double-Blind Method; Estradiol; Estrogen Replacemen | 1989 |
Low dose aminoglutethimide without hydrocortisone for the treatment of advanced postmenopausal breast cancer.
Topics: 17-alpha-Hydroxyprogesterone; Aminoglutethimide; Androstenedione; Breast Neoplasms; Drug Evaluation; | 1989 |
Dose-related endocrine effects and pharmacokinetics of oral and intramuscular 4-hydroxyandrostenedione in postmenopausal breast cancer patients.
Topics: Administration, Oral; Androstenedione; Breast Neoplasms; Dose-Response Relationship, Drug; Estradiol | 1989 |
Effects of smoking on serum lipoproteins and bone mineral content during postmenopausal hormone replacement therapy.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Bone and Bones; Cholesterol, HDL; Cholestero | 1988 |
Treatment with oral piperazine oestrone sulphate for genuine stress incontinence in postmenopausal women.
Topics: Aged; Clinical Trials as Topic; Double-Blind Method; Estradiol Congeners; Estrone; Female; Follicle | 1987 |
Tamoxifen and natural progesterone as supplements to low-dose postmenopausal estrogen therapy.
Topics: Alanine Transaminase; Aspartate Aminotransferases; Clinical Trials as Topic; Double-Blind Method; Dr | 1988 |
The long-term effect of oral and percutaneous estradiol on plasma renin substrate and blood pressure.
Topics: Administration, Cutaneous; Administration, Oral; Blood Pressure; Clinical Trials as Topic; Estradiol | 1987 |
Effect of low- and high-fat intakes on the hormonal milieu of premenopausal women.
Topics: Adult; Dietary Fats; Energy Intake; Estradiol; Estrogens; Estrone; Female; Hormones; Humans; Luteini | 1988 |
Oestrogen-progestogen replacement therapy changes body composition in early post-menopausal women.
Topics: Adult; Body Composition; Body Weight; Creatinine; Drug Therapy, Combination; Estradiol; Estrogens; E | 1986 |
Differential symptom response to parenteral estrogen and/or androgen administration in the surgical menopause.
Topics: Adult; Androgens; Appetite; Castration; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, | 1985 |
Cigarette smoking, serum estrogens, and bone loss during hormone-replacement therapy early after menopause.
Topics: Adult; Bone Resorption; Drug Combinations; Estradiol; Estriol; Estrogens; Estrone; Female; Humans; M | 1985 |
The absorption of conjugated oestrogen and sodium oestrone sulphate from the vagina.
Topics: Aged; Estradiol; Estriol; Estrogens; Estrogens, Conjugated (USP); Estrone; Female; Humans; Menopause | 1974 |
An evaluation of clinical response to piperazine oestrone sulphate ('Harmogen') in menopause patients.
Topics: Adult; Amenorrhea; Atrophy; Clinical Trials as Topic; Estradiol Congeners; Estrogens; Estrogens, Con | 1974 |
A clinical trial of piperazine oestrone sulphate ('Harmogen') in the treatment of menopausal symptoms.
Topics: Adult; Estradiol; Estrone; Female; Humans; Hysterectomy; Menopause; Middle Aged; Piperazines; Placeb | 1974 |
498 other studies available for estrone and Menopause
Article | Year |
---|---|
Increased 2-hydroxylation of estrogen is associated with lower body fat and increased lean body mass in postmenopausal women.
Topics: Adipose Tissue; Aged; Aged, 80 and over; Body Composition; Body Fluid Compartments; Calcium, Dietary | 2012 |
Concentrations of 2-methoxyoestrogens in human serum measured by a heterologous immunoassay with an 125I-labelled ligand.
Topics: Adult; Aged; Cross Reactions; Estrone; Female; Fetal Blood; Humans; Hydroxyestrones; Infant, Newborn | 1983 |
Suppression of prolactin and gonadotropin secretion in post-menopausal women by 2-hydroxyestrone.
Topics: Estrone; Female; Follicle Stimulating Hormone; Humans; Hydroxyestrones; Kinetics; Luteinizing Hormon | 1980 |
A pilot study of urinary estrogen metabolites (16alpha-OHE1 and 2-OHE1) in postmenopausal women with and without breast cancer.
Topics: Breast Neoplasms; Case-Control Studies; Estradiol; Estriol; Estrone; Female; Humans; Hydroxyestrones | 1997 |
Quantifying estrogen metabolism: an evaluation of the reproducibility and validity of enzyme immunoassays for 2-hydroxyestrone and 16alpha-hydroxyestrone in urine.
Topics: Adult; Biomarkers; Breast Neoplasms; Estrogens; Evaluation Studies as Topic; Female; Follicular Phas | 1997 |
Urinary 2/16 alpha-hydroxyestrone ratio: correlation with serum insulin-like growth factor binding protein-3 and a potential biomarker of breast cancer risk.
Topics: Age Factors; Anticarcinogenic Agents; Biomarkers, Tumor; Body Mass Index; Breast Neoplasms; Cell Tra | 1998 |
The effect of diurnal and menstrual cyclicity and menopausal status on estrogen metabolites: implications for disease-risk assessment.
Topics: Adult; Circadian Rhythm; Female; Humans; Hydroxyestrones; Menopause; Menstrual Cycle; Risk Assessmen | 1999 |
Increased 2-hydroxylation of estradiol as a possible mechanism for the anti-estrogenic effect of cigarette smoking.
Topics: Adult; Estradiol; Estrogens; Female; Humans; Hydroxyestrones; Hydroxylation; Menopause; Menstrual Cy | 1986 |
Associations of LH and FSH with reproductive hormones depending on each stage of the menopausal transition.
Topics: Androgens; Androstenedione; Cross-Sectional Studies; Estradiol; Estrone; Female; Follicle Stimulatin | 2023 |
Within-person changes in reproductive hormones and cognition in the menopause transition.
Topics: Cognition; Estradiol; Estrone; Executive Function; Female; Humans; Menopause | 2023 |
Variation of urinary follicle-stimulating hormone level after menopause : From the results of Japan Nurses' Health Study.
Topics: Body Mass Index; Cross-Sectional Studies; Estradiol; Estrone; Female; Follicle Stimulating Hormone; | 2019 |
Simultaneous analysis of E1 and E2 by LC-MS/MS in healthy volunteers: estimation of reference intervals and comparison with a conventional E2 immunoassay.
Topics: Adolescent; Adult; Chromatography, Liquid; Estradiol; Estrone; Female; Humans; Immunoassay; Limit of | 2021 |
Reproductive Hormones and Subclinical Cardiovascular Disease in Midlife Women.
Topics: Adult; Asymptomatic Diseases; Brachial Artery; Cardiovascular Diseases; Carotid Intima-Media Thickne | 2018 |
SULESTREX.
Topics: Climacteric; Estrogens; Estrone; Female; Menopause | 1952 |
EFFECTIVE estrogenic therapy with sulestrex. . . for menopause and suppression of lactation.
Topics: Climacteric; Estrogens; Estrone; Female; Humans; Lactation; Menopause | 1952 |
Immunologic and mass-spectrometric estimates of SHBG concentrations in healthy women.
Topics: Adult; Aged; Blood Glucose; Body Mass Index; Cholesterol, HDL; Estradiol; Estrone; Female; Humans; I | 2014 |
Endocrine biomarkers and symptom clusters during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women's Health Study.
Topics: Adult; Affective Symptoms; Autonomic Nervous System; Cognition Disorders; Estrone; Female; Follicle | 2014 |
Complement receptors C5aR and C5L2 are associated with metabolic profile, sex hormones, and liver enzymes in obese women pre- and postbariatric surgery.
Topics: Adult; Age Factors; Aged; Animals; Apolipoproteins; Bariatric Surgery; Cholesterol, LDL; Complement | 2014 |
Pharmacological blockade of the aromatase enzyme, but not the androgen receptor, reverses androstenedione-induced cognitive impairments in young surgically menopausal rats.
Topics: Anastrozole; Androgen Antagonists; Androstenedione; Animals; Aromatase Inhibitors; Brain; Cognition | 2015 |
Clinical relevance of hypercoagulability and possible hypofibrinolysis associated with estrone and estriol.
Topics: Adolescent; Adult; Estriol; Estrone; Female; Fibrin; Fibrinolysis; Humans; Male; Menopause; Pregnanc | 2017 |
THEELIN in menopause.
Topics: Estrone; Female; Humans; Menopause | 1948 |
Meprane in the treatment of the menopausal syndrome; an evaluation of estrogenic efficiency and toxicity.
Topics: Estrone; Female; Humans; Menopause; Syndrome | 1948 |
Combination of hormone replacement therapy and high physical activity is associated with differences in Achilles tendon size in monozygotic female twin pairs.
Topics: Achilles Tendon; Aged; Cholesterol; Estrogens; Estrone; Female; Hormone Replacement Therapy; Humans; | 2009 |
Total and unopposed estrogen exposure across stages of the transition to menopause.
Topics: Adult; Algorithms; Estrone; Female; Humans; Menopause; Middle Aged; Pregnanediol; Time Factors | 2009 |
Tissue estradiol is selectively elevated in receptor positive breast cancers while tumour estrone is reduced independent of receptor status.
Topics: Adult; Aged; Aged, 80 and over; Breast; Breast Neoplasms; Estradiol; Estrone; Female; Humans; Menopa | 2009 |
Sexual desire during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women's Health Study.
Topics: Aged; Estrone; Female; Follicle Stimulating Hormone; Health Services Research; Humans; Libido; Menop | 2010 |
Estrogenic effects of the herbal formula, menoprogen, in ovariectomized rats.
Topics: Adrenal Glands; Animals; Atrophy; Drugs, Chinese Herbal; Estradiol; Estrone; Female; Gonadal Steroid | 2010 |
THEELIN therapy of menopause.
Topics: Estrone; Female; Humans; Menopause | 1946 |
[Estrogen: estrone (E1), estradiol (E2), estriol (E3) and estetrol (E4)].
Topics: Adolescent; Adult; Estetrol; Estradiol; Estriol; Estrone; Female; Humans; Menopause; Menstruation; O | 2010 |
THEELIN therapy of menopause.
Topics: Estrone; Female; Humans; Menopause | 1945 |
Effects of unintentional exposure of children to compounded transdermal sex hormone therapy.
Topics: Administration, Cutaneous; Age Determination by Skeleton; Child, Preschool; Drug Compounding; Estrad | 2011 |
Cognitive symptoms during the menopausal transition and early postmenopause.
Topics: Adult; Attention; Cognition Disorders; Estrone; Female; Health Status; Humans; Hydrocortisone; Longi | 2011 |
Continuous estrone treatment impairs spatial memory and does not impact number of basal forebrain cholinergic neurons in the surgically menopausal middle-aged rat.
Topics: Animals; Cholinergic Neurons; Estradiol; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjuga | 2012 |
Doubts about oestrogen therapy in postmenopausal women.
Topics: Age Factors; Biology; Birth Rate; Contraception; Contraceptive Agents; Contraceptive Agents, Female; | 1976 |
Ultrastructure of endometrium of postmenopausal patients on two modes of hormonal therapy: estrone sulfate with or without MPA.
Topics: Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Endocrine System; Endome | 1983 |
[Estrogenic function in the menopause].
Topics: Climacteric; Estradiol Congeners; Estrogens; Estrone; Female; Humans; Menopause; Ovary | 1954 |
[The cytological picture of estrogenic action during the climacteric].
Topics: Climacteric; Estrone; Female; Humans; Menopause; Ovary; Vaginal Smears | 1961 |
[Estrogenic hormones in men: the chromatographic separation of urinary estriol, estrone and estradiol in normal adults and subjects in the climacteric].
Topics: Chromatography; Climacteric; Estradiol; Estriol; Estrone; Humans; Menopause; Urinary Tract | 1962 |
ESTROGEN METABOLISM IN POSTMENAPAUSAL WOMEN WITH GENITAL CANCER.
Topics: Body Fluids; Estradiol; Estriol; Estrogens; Estrone; Female; Genital Neoplasms, Female; Humans; Lipi | 1963 |
THE EXCRETION OF OESTRONE, PREGNANEDIOL AND PREGNANETRIOL IN BREAST CANCER PATIENTS. I. EXCRETION AFTER SPONTANEOUS MENOPAUSE.
Topics: Breast Neoplasms; Estrone; Geriatrics; Humans; Menopause; Pregnanediol; Pregnanetriol; Urine | 1963 |
ABDOMINOVAGINAL POTENTIAL DIFFERENCE IN POSTMENOPAUSAL PATIENTS WITH AND WITHOUT BREAST CANCER.
Topics: Abdominal Wall; Adolescent; Androgens; Breast Neoplasms; Castration; Climacteric; Electrophysiology; | 1964 |
[ISOLATION OF ESTRONE, 17-BETA ESTRADIOL AND AN UNUSUAL LARGE QUANTITY OF ESTRIOL FROM THE URINE OF A PATIENT WITH OVARIAN CANCER].
Topics: Body Fluids; Chromatography; Estradiol; Estriol; Estrone; Female; Granulosa Cell Tumor; Humans; Meno | 1964 |
[STUDY ON THE BIOLOGICAL ACTIVITY OF THE ESTRIOL EPIMERS 16-EPIOESTRIOL, 17-EPIOESTRIOL AND 16,17-EPIOESTRIOL].
Topics: 17-Ketosteroids; Animals; Ergotamine; Estradiol; Estriol; Estrone; Female; Gonadotropins; Gonadotrop | 1964 |
"PROPHYLACTIC" OVARIECTOMY AND OVARIAN IRRADIATION IN BREAST CANCER.
Topics: Breast Neoplasms; Castration; Estrone; Female; Humans; Mastectomy; Menopause; Neoplasms; Ovariectomy | 1964 |
ENDOCRINE TREATMENT OF BREAST CANCER.
Topics: Anabolic Agents; Androgens; Breast Neoplasms; Castration; Estrone; Female; Humans; Menopause; Nandro | 1964 |
HORMONE EXCRETION PATTERNS IN BREAST AND PROSTATE CANCER ARE ABNORMAL.
Topics: 17-Ketosteroids; Adrenal Cortex Hormones; Aged; Androsterone; Breast Neoplasms; Creatine; Creatinine | 1964 |
[ROLE OF HORMONAL FACTORS IN THE PATHOGENESIS OF HYPERCHOLESTEREMIA AND ATHEROSCLEROSIS. EFFECT OF ESTROGENS ON LIPID METABOLISM AND ON THE DEVELOPMENT OF ATHEROSCLEROSIS].
Topics: Arteriosclerosis; Atherosclerosis; Biomedical Research; Chorionic Gonadotropin; Estradiol; Estriol; | 1964 |
VAGINAL ELECTRO POTENTIALS--A NEW TECHNIQUE FOR ASSESSING THE ESTROGENIC STATUS OF PATIENTS.
Topics: Diagnosis; Electrophysiology; Estradiol Congeners; Estrogens; Estrone; Female; Gynecology; Humans; M | 1964 |
OOPHORECTOMY AND CORTISONE TREATMENT AS A METHOD OF ELIMINATING OESTROGEN PRODUCTION IN PATIENTS WITH BREAST CANCER.
Topics: 17-Hydroxycorticosteroids; Breast Neoplasms; Castration; Cortisone; Estradiol; Estriol; Estrogens; E | 1964 |
ENDOCRINE RELATIONSHIPS OF LEUKOCYTE ALKALINE PHOSPHATASE.
Topics: Alkaline Phosphatase; Androgens; Breast Neoplasms; Castration; Child; Enzyme Inhibitors; Estradiol; | 1965 |
THE EXCRETION OF OESTROGENS AND PREGNANEDIOL IN PATIENTS WITH MAMMARY CARCINOMA.
Topics: Breast Neoplasms; Drug Therapy; Estradiol; Estriol; Estrogens; Estrone; Female; Fluids and Secretion | 1964 |
II. URINARY EXCRETION OF ESTRONE, ESTRADIOL, AND ESTRIOL BY PATIENTS WITH BREAST CANCER AND BENIGN BREAST DISEASE.
Topics: Breast Diseases; Breast Neoplasms; Contraceptive Agents, Female; Estradiol; Estriol; Estrogens; Estr | 1965 |
Estrone sulfate soluble in the treatment of estrogen deficiency.
Topics: Climacteric; Estrogens; Estrone; Female; Humans; Menopause | 1952 |
Body size and ethnicity are associated with menstrual cycle alterations in women in the early menopausal transition: The Study of Women's Health across the Nation (SWAN) Daily Hormone Study.
Topics: Adult; Age Distribution; Asian People; Black People; Body Constitution; Cohort Studies; Corpus Luteu | 2004 |
[Simplification of cytological diagnosis of uterine cancer during the menopause by Papanicolaou's and Traut's method of preliminary folliculin treatment].
Topics: Climacteric; Estrogens; Estrone; Female; Humans; Menopause; Neoplasms; Uterine Neoplasms; Uterus | 1950 |
Mammographic densities and circulating hormones: a cross-sectional study in premenopausal women.
Topics: Adult; Body Weight; Breast Neoplasms; Cross-Sectional Studies; Estradiol; Estrone; Female; Hormone R | 2006 |
Naturally occurring menopause in cynomolgus monkeys: changes in hormone, lipid, and carbohydrate measures with hormonal status.
Topics: Androstenedione; Animals; Blood Glucose; C-Peptide; Carbohydrates; Dehydroepiandrosterone Sulfate; E | 2005 |
Cigarette smoking, estrogen levels, and hot flashes in midlife women.
Topics: Baltimore; Body Mass Index; Case-Control Studies; Chi-Square Distribution; Educational Status; Estra | 2006 |
Bio-identical steroid hormone replacement: selected observations from 23 years of clinical and laboratory practice.
Topics: Cobalt; Estradiol; Estrogen Replacement Therapy; Estrogens; Estrone; Female; Humans; Menopause; Mens | 2005 |
Relation of cardiovascular risk factors in women approaching menopause to menstrual cycle characteristics and reproductive hormones in the follicular and luteal phases.
Topics: Adult; Blood Glucose; Blood Pressure; Body Composition; Body Mass Index; Cardiovascular Diseases; Co | 2006 |
Relations between body composition, functional and hormonal parameters and quality of life in healthy postmenopausal women.
Topics: Absorptiometry, Photon; Adipose Tissue; Aged; Androstenedione; Body Composition; Cross-Sectional Stu | 2006 |
Is bio-identical hormone replacement therapy safer than traditional hormone replacement therapy?: a critical appraisal of cardiovascular risks in menopausal women.
Topics: Cardiovascular Diseases; Estriol; Estrogen Replacement Therapy; Estrone; Female; Hormone Replacement | 2006 |
Characterizing daily urinary hormone profiles for women at midlife using functional data analysis.
Topics: Adult; Estrone; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menopause; Menstr | 2007 |
Synthesis of highly tritium labeled steroids for evaluation of aromatase and steroidsulfatase activities in endometrial tumors.
Topics: Aromatase; Cell Differentiation; Endometrial Neoplasms; Estrone; Female; Humans; Isotope Labeling; M | 2006 |
Hot flash severity in hormone therapy users/nonusers across the menopausal transition.
Topics: Adult; Estrogen Replacement Therapy; Estrone; Female; Follicle Stimulating Hormone, Human; Hot Flash | 2007 |
The effects of various estrogenic preparations; changes in the vaginal mucosa and general status of climacteric women following the injection of aqueous suspensions of estrone and estradiol.
Topics: Climacteric; Estradiol; Estrogens; Estrone; Female; Humans; Menopause; Mucous Membrane; Suspensions; | 1949 |
Factors related to declining luteal function in women during the menopausal transition.
Topics: Adult; Asian People; Body Mass Index; Estrone; Female; Follicle Stimulating Hormone; Humans; Luteal | 2008 |
HDL-cholesterol and sex-hormone status.
Topics: Age Factors; Aged; Cholesterol; Estradiol; Estrone; Female; Humans; Lipoproteins, HDL; Menopause; Mi | 1980 |
Pituitary-ovarian hormones after low-dose endometrial afterloading irradiation.
Topics: Adolescent; Adult; Age Factors; Amenorrhea; Endometrium; Estradiol; Estrone; Female; Follicle Stimul | 1981 |
Effect of oestrogen and progesterone on fasting serum cholesterol and triglyceride levels in post-menopausal women.
Topics: Adult; Aged; Cholesterol; Clonidine; Dydrogesterone; Estradiol; Estradiol Congeners; Estrogens, Conj | 1982 |
Endocrine and clinical effects of estradiol and testosterone pellets used in long-term replacement therapy.
Topics: Adult; Drug Implants; Drug Therapy, Combination; Estradiol; Estrogens; Estrone; Female; Follicle Sti | 1982 |
Effect of oestrogen replacement therapy on blood coagulation factors in postmenopausal women.
Topics: Blood Coagulation; Blood Coagulation Factors; Blood Coagulation Tests; Contraceptives, Oral, Combine | 1983 |
Effects of tamoxifen on the serum levels of oestrogens and adrenocortical steroids in postmenopausal breast cancer patients.
Topics: Adrenal Cortex Hormones; Breast Neoplasms; Dehydroepiandrosterone; Estradiol; Estrogens; Estrone; Fe | 1982 |
Serum levels of cortisol, dehydroepiandrosterone, dehydroepiandrosterone sulphate, estrone and prolactin after surgical trauma in postmenopausal women.
Topics: Adrenal Cortex Hormones; Aged; Cholecystectomy; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfa | 1982 |
Endocrine effects of low dose aminoglutethimide alone in advanced postmenopausal breast cancer.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Aged; Aminoglutethimide; Androstenedione; Breast Neoplasms; Cos | 1983 |
Behavior of some steroids in endometrial adenomatous and atypical hyperplasia.
Topics: Adult; Androgens; Androstenedione; Dehydroepiandrosterone; Endometrial Hyperplasia; Estradiol; Estro | 1983 |
Peripheral hormone levels and the endometrial condition in postmenopausal women.
Topics: Body Weight; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Endometrium; Estradiol; Estroge | 1983 |
Adrenal androgen concentrations in breast tumours and in normal breast tissue. The relationship to oestradiol metabolism.
Topics: 17-Hydroxysteroid Dehydrogenases; Adenocarcinoma; Adult; Aged; Androstenediol; Androstenediols; Brea | 1984 |
The effect of various regimens of hormone therapy on serum cholesterol and triglyceride concentrations in postmenopausal women.
Topics: Cholesterol; Drug Combinations; Estradiol; Estrogens; Estrogens, Conjugated (USP); Estrone; Female; | 1980 |
Radioimmunoassay of plasma equilin and estrone in postmenopausal women after the administration of premarin.
Topics: 17-Ketosteroids; Equilin; Estrogens; Estrogens, Conjugated (USP); Estrone; Female; Humans; Kinetics; | 1981 |
The role of estradiol dehydrogenase in mediating progestin effects on endometrium from postmenopausal women receiving estrogens and progestins.
Topics: 17-Hydroxysteroid Dehydrogenases; DNA; Endometrium; Estradiol; Estradiol Dehydrogenases; Estrogens, | 1981 |
Oestrone sulphate in plasma from postmenopausal women and the effects of oestrogen and androgen therapy.
Topics: Adrenal Cortex Hormones; Adult; Aged; Castration; Dehydroepiandrosterone; Estradiol; Estrogens; Estr | 1980 |
A group-comparative study of effects of Ovestin cream versus Premarin cream in post-menopausal women with vaginal atrophy.
Topics: Aged; Atrophy; Estradiol; Estrogens, Conjugated (USP); Estrone; Female; Follicle Stimulating Hormone | 1980 |
Adrenal steroids, bone mineral content and endometrial pathology in postmenopausal women.
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Bone and Bones; Dehydroepiandrosterone; Dehydr | 1981 |
Systemic absorption of conjugated estrogenic cream by the irradiated vagina.
Topics: Administration, Topical; Estradiol; Estrogens, Conjugated (USP); Estrone; Female; Follicle Stimulati | 1981 |
Effects of various oestrogens on circulating androgens and cortisol during replacement therapy in post-menopausal women.
Topics: Aged; Androgens; Androstenedione; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dose-Respo | 1981 |
Conservative treatment of urinary incontinence in women with special reference to the use of oestrogens.
Topics: Age Factors; Emepronium; Estradiol; Estrogens; Estrogens, Conjugated (USP); Estrone; Female; Humans; | 1981 |
Estrogenic potency of oral replacement therapy estimated by the induction of pregnancy zone protein.
Topics: Climacteric; Estradiol; Estriol; Estrogens; Estrogens, Conjugated (USP); Estrone; Ethinyl Estradiol; | 1982 |
Adrenocortical steroids, bone mineral content and endometrial condition in post-menopausal women.
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Bone and Bones; Dehydroepiandrosterone; Estron | 1982 |
Comparison of pharmacodynamic properties of various estrogen formulations.
Topics: Angiotensinogen; Diethylstilbestrol; Estradiol; Estrogens; Estrogens, Conjugated (USP); Estrone; Eth | 1982 |
Differential clinical response to oestrogens after menopause.
Topics: Estrogens; Estrogens, Conjugated (USP); Estrone; Female; Humans; Menopause | 1982 |
Plasma estrone-sulfate: assessment of reduced estrogen production during treatment of metastatic breast carcinoma.
Topics: Adrenalectomy; Adult; Aged; Aminoglutethimide; Breast Neoplasms; Estrogens, Conjugated (USP); Estron | 1982 |
Effects of various replacement oestrogens on hepatic transcortin synthesis in climacteric women.
Topics: Climacteric; Estradiol; Estriol; Estrogens, Conjugated (USP); Estrone; Ethinyl Estradiol; Female; Hu | 1983 |
Biological effects of various doses of vaginally administered conjugated equine estrogens in postmenopausal women.
Topics: Administration, Oral; Calcium; Cholesterol; Creatinine; Dose-Response Relationship, Drug; Estradiol; | 1983 |
Biological effects of various doses of vaginally administered conjugated equine estrogens in postmenopausal women.
Topics: Administration, Oral; Calcium; Cholesterol; Creatinine; Dose-Response Relationship, Drug; Estradiol; | 1983 |
Biological effects of various doses of vaginally administered conjugated equine estrogens in postmenopausal women.
Topics: Administration, Oral; Calcium; Cholesterol; Creatinine; Dose-Response Relationship, Drug; Estradiol; | 1983 |
Biological effects of various doses of vaginally administered conjugated equine estrogens in postmenopausal women.
Topics: Administration, Oral; Calcium; Cholesterol; Creatinine; Dose-Response Relationship, Drug; Estradiol; | 1983 |
Behaviour of some steroids in postmenopausal women with coelomic ovarian tumors.
Topics: Adenocarcinoma, Mucinous; Androstenedione; Carcinoma; Dehydroepiandrosterone; Dehydroepiandrosterone | 1983 |
The relationship between 17 beta-hydroxysteroid dehydrogenase activity and oestrogen concentrations in human breast tumours and in normal breast tissue.
Topics: 17-Hydroxysteroid Dehydrogenases; Adenocarcinoma; Adenofibroma; Adult; Aged; Breast; Breast Neoplasm | 1983 |
Depo-medroxyprogesterone acetate compared with conjugated estrogens for the treatment of postmenopausal women.
Topics: Adult; Calcium; Creatinine; Delayed-Action Preparations; Estradiol; Estrogens, Conjugated (USP); Est | 1984 |
Estrone sulfate, estrone and estradiol concentrations in normal and cirrhotic postmenopausal women.
Topics: Estradiol; Estrogens, Conjugated (USP); Estrone; Female; Humans; Liver Cirrhosis; Menopause; Radioim | 1983 |
Estrogen replacement therapy by transdermal estradiol administration.
Topics: Calcium; Climacteric; Creatinine; Double-Blind Method; Estradiol; Estrone; Female; Follicle Stimulat | 1983 |
Profiles and endocrine correlations in endometrial carcinoma.
Topics: Age Factors; Aged; Androstenedione; Diabetes Complications; Estradiol; Estrone; Female; Follicle Sti | 1983 |
Influence of severe obesity on peripheral hormone concentrations in pre- and postmenopausal women.
Topics: Adult; Androstenedione; Climacteric; Estrone; Female; Follicle Stimulating Hormone; Gonadal Steroid | 1983 |
[Clinical effects of metharmon F for postmenopausal women with climacteric symptoms: its relationship with serum level of hormones].
Topics: Androstenediol; Androstenediols; Androstenedione; Climacteric; Drug Combinations; Estrogens; Estrone | 1983 |
Gonadotropins, estrogens, and adrenal steroids during the menopausal hot flash.
Topics: Androstenedione; Body Temperature; Dehydroepiandrosterone; Estradiol; Estrone; Female; Follicle Stim | 1980 |
Treatment with oral estrone sulphate in the female climacteric. II. Hormonal aspects.
Topics: Adult; Climacteric; Dehydroepiandrosterone; Estrogens; Estrone; Female; Follicle Stimulating Hormone | 1981 |
Oestrogens, the menopause and the adrenopause.
Topics: Adrenal Glands; Adult; Age Factors; Androgens; Androstenedione; Castration; Dehydroepiandrosterone; | 1981 |
How effective is surgical adrenalectomy in lowering steroid hormone concentrations?
Topics: Adrenalectomy; Aged; Aldosterone; Androgens; Androstenedione; Breast Neoplasms; Dehydroepiandrostero | 1982 |
Ovarian and peripheral plasma levels of progestogens, androgens and oestrogens in post-menopausal women.
Topics: 17-alpha-Hydroxyprogesterone; Androgens; Androstenedione; Estradiol; Estrogens; Estrone; Female; Hum | 1984 |
The endogenous concentration of estradiol and estrone in normal human postmenopausal endometrium.
Topics: Aged; DNA; Endometrium; Estradiol; Estrone; Female; Humans; Menopause; Middle Aged; Reference Values | 1984 |
Androgen and estrogen dynamics in women with vertebral crush fractures.
Topics: Androgens; Androstenedione; Dihydrotestosterone; Estradiol; Estrogens; Estrone; Female; Fractures, B | 1984 |
Serum levels of sex hormones in vulvar lichen sclerosus, and the effect of topical testosterone.
Topics: Administration, Topical; Adult; Aged; Androgens; Androstenedione; Dihydrotestosterone; Estradiol; Es | 1984 |
Estrone and dehydroepiandrosterone sulfatase activities and plasma estrone sulfate levels in human breast carcinoma.
Topics: Breast Neoplasms; Estradiol; Estrone; Female; Humans; Menopause; Middle Aged; Progesterone; Receptor | 1984 |
Metabolism of estrone sulfate in human endometrium.
Topics: Aged; Endometrium; Estradiol; Estrone; Female; Humans; Hydrolysis; Menopause; Middle Aged; Progester | 1983 |
Physical characteristics and sex hormone levels in patients with osteoporotic hip fractures or endometrial cancer.
Topics: Aged; Androstenedione; Body Weight; Estradiol; Estrone; Female; Gonadal Steroid Hormones; Hip Fractu | 1983 |
Plasma levels of estrone, estrone sulfate, and estradiol and the percentage of unbound estradiol in postmenopausal women with and without breast disease.
Topics: Aged; Body Weight; Breast Diseases; Estradiol; Estrone; Female; Humans; Menopause; Middle Aged; Sex | 1983 |
Effects of a continuous estrogen-progestogen therapy for climacteric symptoms on circulating sex steroids and gonadotrophins.
Topics: Adult; Androstenedione; Climacteric; Estradiol; Estriol; Estrone; Female; Gonadotropins; Humans; Men | 1983 |
Estrone sulphate plasma levels in postmenopausal women with and without endometrial cancer.
Topics: Aged; Body Weight; Estrone; Female; Humans; Menopause; Middle Aged; Radioimmunoassay; Time Factors; | 1984 |
Variation in the fractional conversion of plasma estrone to estriol among women and men.
Topics: Adult; Aging; Biotransformation; Estriol; Estrone; Female; Humans; Male; Menopause; Middle Aged; Par | 1984 |
Estriol production and metabolism in normal women.
Topics: Adult; Estradiol; Estriol; Estrone; Female; Follicular Phase; Half-Life; Humans; Luteal Phase; Menop | 1984 |
Hormonal profile of endometrial cancer.
Topics: Adult; Aged; Castration; Estradiol; Estrone; Female; Humans; Hysterectomy; Infertility, Female; Meno | 1984 |
Plasma androstenedione and oestrone levels in the climacteric syndrome.
Topics: Aged; Androstenedione; Estrone; Female; Humans; Menopause; Middle Aged; Plasma; Radioimmunoassay | 1984 |
Metabolic clearance rate of oestrone sulphate in post-menopausal women.
Topics: Estradiol; Estrone; Female; Humans; Menopause; Metabolic Clearance Rate; Middle Aged | 1984 |
Central and peripheral metabolites of norepinephrine and dopamine in postmenopausal women.
Topics: Adult; Age Factors; Aged; Central Nervous System; Dopamine; Estradiol; Estrogens; Estrone; Female; H | 1984 |
[Studies on the early diagnosis of endometrial carcinoma. Analysis of risk factors and cytological approach].
Topics: Adult; Aged; Cytodiagnosis; Endometrial Hyperplasia; Estrone; Female; Humans; Menopause; Middle Aged | 1984 |
The significance of oestriol in the management of the post-menopause.
Topics: Aged; Cervix Mucus; Endometrium; Estradiol; Estriol; Estrone; Female; Follicle Stimulating Hormone; | 1980 |
Pharmacokinetic studies on low dose estradiol 17 beta administered orally to postmenopausal women.
Topics: Administration, Oral; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Humans; Kinetics; Lu | 1980 |
Plasma hormones in pre- and postmenopausal breast cancer.
Topics: Adult; Age Factors; Aged; Breast Neoplasms; Cortisone; Estradiol; Estrone; Female; Follicle Stimulat | 1980 |
Absorption of percutaneous oestradiol in postmenopausal women.
Topics: Estradiol; Estrone; Female; Follicle Stimulating Hormone; Gels; Humans; Luteinizing Hormone; Menopau | 1980 |
[Estrone, estradiol and estriol content after intravaginal application of estriol in postmenopause].
Topics: Aged; Estradiol; Estriol; Estrone; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone | 1980 |
Hormonal profiles in postmenopausal women after therapy with subcutaneous implants.
Topics: Adult; Castration; Drug Combinations; Drug Implants; Estradiol; Estrone; Female; Follicle Stimulatin | 1981 |
Effect of medroxyprogesterone acetate on serum levels of LH, FSH, cortisol, and estrone in patients with endometrial carcinoma.
Topics: Adenocarcinoma; Aged; Castration; Estrone; Female; Follicle Stimulating Hormone; Humans; Hydrocortis | 1981 |
Oestrogens, gonadotropins and prolactin after intra-vaginal administration of oestriol in post-menopausal women.
Topics: Absorption; Aged; Estradiol; Estriol; Estrogens; Estrone; Female; Follicle Stimulating Hormone; Gona | 1981 |
The absorption and metabolism of oral oestradiol, oestrone and oestriol.
Topics: Adult; Estradiol; Estriol; Estrogens; Estrone; Female; Follicle Stimulating Hormone; Glucuronates; H | 1981 |
Pharmacokinetics and pharmacodynamic effects of vaginal oestradiol administration from silastic rings in post-menopausal women.
Topics: Estradiol; Estrone; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menopause; Ra | 1981 |
Gonadotropins and prolactin during estrogen replacement therapy.
Topics: Adult; Estradiol; Estriol; Estrogens; Estrone; Ethinyl Estradiol; Female; Follicle Stimulating Hormo | 1981 |
Influence of conjugated oestrogens on circulating oestradiol, oestrone, LH, FSH and prolactin levels in postmenopausal women.
Topics: Aged; Dose-Response Relationship, Drug; Estradiol; Estrogens; Estrone; Female; Follicle Stimulating | 1981 |
Hormone levels in healthy post-menopausal women and in women with post-menopausal bleeding with or without endometrial carcinoma.
Topics: Adult; Aged; Androstenedione; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Hormones; Hu | 1981 |
Serum concentrations of FSH, oestradiol, oestrone and androstenedione in normal and obese women.
Topics: Adult; Aged; Androstenedione; Body Weight; Estradiol; Estrogens; Estrone; Female; Follicle Stimulati | 1982 |
Post-menopausal concentrations of plasma oestradiol, oestrone, FSH and LH and of total urinary oestradiol and oestrone after a single sublingual dose of oestradiol-17 beta.
Topics: Absorption; Aged; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Humans; Luteinizing Horm | 1982 |
Effect of the plasma estrone/17 beta-estradiol ratio on the prolactin and TSH responses to TRH.
Topics: Estradiol; Estrone; Female; Humans; Menopause; Middle Aged; Prolactin; Thyrotropin; Thyrotropin-Rele | 1982 |
Estradiol and progesterone receptor levels in human breast cancer in relation to cytosol and plasma estrogen level.
Topics: Adenocarcinoma; Breast; Breast Neoplasms; Cytosol; Estradiol; Estrone; Female; Humans; Kinetics; Men | 1983 |
Obesity, serum cholesterol, and estrogens in premenopausal women.
Topics: Adolescent; Adult; Aging; Body Weight; Cholesterol; Estradiol; Estriol; Estrogens; Estrone; Female; | 1983 |
Estrone sulfate concentrations in plasma of normal individuals, postmenopausal women with breast cancer, and men with cirrhosis.
Topics: Adult; Aged; Breast Neoplasms; Chromatography; Estrone; Female; Humans; Liver Cirrhosis; Male; Menop | 1983 |
Percutaneous estrogen replacement therapy. Effects on circulating estrogens, gonadotropins and prolactin.
Topics: Administration, Topical; Estradiol; Estrone; Female; Gonadotropins; Hormones; Humans; Menopause; Mid | 1983 |
The pharmacology of progestogens.
Topics: Animals; Chemical Phenomena; Chemistry; Estrogen Antagonists; Estrone; Female; Humans; Lipoproteins, | 1982 |
Radiometric analysis of biological oxidations in man: sex differences in estradiol metabolism.
Topics: Aryl Hydrocarbon Hydroxylases; Biotransformation; Cytochrome P-450 CYP2C8; Cytochrome P-450 CYP2C9; | 1980 |
Peripheral venous concentrations of oestrogens in postmenopausal women with ovarian cancer.
Topics: Aged; Estradiol; Estriol; Estrogens; Estrone; Female; Humans; Menopause; Middle Aged; Ovarian Neopla | 1982 |
Origin of serum estradiol in postmenopausal women.
Topics: Androstenedione; Body Weight; Estradiol; Estrone; Female; Humans; Menopause; Metabolic Clearance Rat | 1982 |
Steroid hormone profiles in women treated with aminoglutethimide for metastatic carcinoma of the breast.
Topics: Adrenal Glands; Aminoglutethimide; Aromatase Inhibitors; Breast Neoplasms; Castration; Estradiol; Es | 1982 |
In vivo effects of delta 1-testololactone on peripheral aromatization.
Topics: Aged; Androstenedione; Aromatase; Breast Neoplasms; Dexamethasone; Dose-Response Relationship, Drug; | 1982 |
Plasma androstenedione and oestrone levels before and after the menopause. I. Glandular hyperplasia and adenocarcinoma of the endometrium.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aging; Androstenedione; Endometrial Hyperplasia; Estrone; F | 1982 |
Plasma androstenedione and oestrone levels before and after the menopause. II. Non-endocrine ovarian tumours and cysts.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Androstenedione; Carcinoma; Cystadenocarcinoma; Cystadenoma | 1982 |
A comparative longitudinal study on sex hormone binding globulin capacity during estrogen replacement therapy.
Topics: Estradiol; Estriol; Estrogens; Estrone; Ethinyl Estradiol; Female; Humans; Longitudinal Studies; Men | 1982 |
Weight reduction and oestrogen excretion in obese post-menopausal women.
Topics: Body Weight; Diet, Reducing; Estradiol; Estriol; Estrone; Female; Humans; Menopause; Middle Aged; Ob | 1982 |
Cigarette smoking and urinary estrogens.
Topics: Breast Neoplasms; Estradiol; Estriol; Estrogens; Estrone; Female; Humans; Menopause; Menstruation; M | 1982 |
[Serum sex steroid hormones in women with aging, and in the patients of climacteric syndrome and squamous cell carcinoma of the uterus].
Topics: Adult; Aged; Aging; Carcinoma, Squamous Cell; Climacteric; Estradiol; Estriol; Estrone; Female; Gona | 1982 |
Correlation of kinetics and absorption of 47Ca with estrogen and hormonal ovarian function in postmenopause.
Topics: Bone and Bones; Calcium; Estradiol; Estriol; Estrogens; Estrone; Female; Humans; Intestinal Absorpti | 1982 |
Analysis of estrone sulphate levels in post-menopausal women with and without endometrial cancer.
Topics: Adenocarcinoma; Endometrium; Estrone; Female; Humans; Menopause; Uterine Neoplasms | 1982 |
Estrone sulphate and estrone splanchnic extraction in postmenopausal women.
Topics: Estrone; Female; Humans; Menopause; Middle Aged; Radioimmunoassay; Splanchnic Circulation | 1982 |
The plasma concentration of oestrone sulphate in postmenopausal women: lack of diurnal variation, effect of ovariectomy, age and weight.
Topics: Aged; Aging; Castration; Circadian Rhythm; Estrone; Female; Humans; Male; Menopause; Middle Aged; Ob | 1981 |
Total and free estrogens and androgens in postmenopausal women with hip fractures.
Topics: Aged; Androgens; Androstenedione; Estradiol; Estrogens; Estrone; Female; Hip Fractures; Humans; Meno | 1982 |
Treatment with oral estrone sulphate in the female climacteric. I. Influence on lipids.
Topics: Adult; Cholesterol; Climacteric; Estrone; Fatty Acids; Female; Humans; Lipids; Lipoproteins; Menopau | 1981 |
Metabolic clearance rates of androgens and oestrogens in ageing women.
Topics: Adult; Aged; Aging; Androstenedione; Estradiol; Estrone; Female; Humans; Menopause; Metabolic Cleara | 1980 |
An oestrone-releasing vaginal ring in the treatment of climacteric women.
Topics: Aged; Climacteric; Delayed-Action Preparations; Estradiol; Estrone; Female; Gonadotropins; Humans; M | 1980 |
The vaginal absorption of oestrogens in post-menopausal women.
Topics: Aged; Estradiol; Estriol; Estrone; Female; Humans; Menopause; Middle Aged; Time Factors; Vagina | 1980 |
Plasma oestrone, oestradiol and androstenedione levels in post-menopausal women: relation to body weight and height.
Topics: Androstenedione; Body Height; Body Weight; Estradiol; Estrone; Female; Humans; Menopause | 1981 |
Obesity, hormones, and cancer.
Topics: Androgens; Androstenedione; Body Weight; Estrogens; Estrone; Female; Humans; Male; Menopause; Neopla | 1981 |
Oestradiol: the predominant intranuclear oestrogen in the endometrium of oestrogen-treated postmenopausal women.
Topics: Cell Nucleus; Endometrium; Estradiol; Estradiol Dehydrogenases; Estrogens; Estrone; Female; Humans; | 1981 |
Obese young men have elevated plasma estrogen levels but obese premenopausal women do not.
Topics: Adult; Age Factors; Estradiol; Estrone; Female; Humans; Male; Menopause; Menstruation; Middle Aged; | 1981 |
Changes in plasma concentrations of oestrogens and progesterone in women during anaesthesia and gynaecological operations.
Topics: Adult; Aged; Anesthesia, General; Estradiol; Estrone; Female; Genital Diseases, Female; Humans; Kine | 1981 |
Effects of estrogens and progestins on the biochemistry and morphology of the postmenopausal endometrium.
Topics: DNA; Dose-Response Relationship, Drug; Endometrium; Estradiol; Estradiol Congeners; Estradiol Dehydr | 1981 |
Oral versus vaginal absorption in oestradiol in postmenopausal women. Effects of different particles sizes.
Topics: Absorption; Administration, Oral; Adult; Biological Availability; Estradiol; Estrone; Female; Humans | 1981 |
Production rates of androgens and oestrogens in post-menopausal women.
Topics: Age Factors; Aged; Androgens; Androstenedione; Body Weight; Estradiol; Estrogens; Estrone; Female; H | 1981 |
Studies of oestrogen metabolism in postmenopausal women with cancer.
Topics: Adipose Tissue; Aged; Androstenedione; Body Weight; Breast Neoplasms; Endometrial Hyperplasia; Estra | 1981 |
Extraglandular estrogen production in postmenopausal women with and without endometrial cancer: comparison between "in vitro" and "in vivo" results.
Topics: Adipose Tissue; Androstenedione; Estrogens; Estrone; Female; Humans; In Vitro Techniques; Menopause; | 1981 |
Relationship of fasting urinary calcium to circulating estrogen and body weight in postmenopausal women.
Topics: Adult; Aged; Androstenedione; Body Weight; Calcium; Estradiol; Estrone; Ethinyl Estradiol; Fasting; | 1980 |
Concentration of cytosolic estrogen receptors in patients with postmenopausal osteoporosis.
Topics: Aged; Androstenedione; Cervix Uteri; Cytosol; Estradiol; Estrone; Female; Gonadal Steroid Hormones; | 1980 |
Ultrastructural features of endometrial atypical adenomatous hyperplasia and adenocarcinomas and the plasma level of estrogens.
Topics: Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Endometrial Hyperplasia; Estradiol; Estriol; Estroge | 1980 |
Plasma estrone sulfate levels in postmenopausal women.
Topics: Aged; Estrone; Female; Humans; Menopause; Middle Aged; Radioimmunoassay | 1980 |
[Various aspects of estrogenic activity during the menopause. II. Relation between excreted estrogens, Meisels cytohormonal estrogenic effects and specific types of cells in cytohormonal patterns].
Topics: Estradiol; Estriol; Estrogens; Estrone; Female; Humans; Menopause; Middle Aged; Vagina; Vaginal Smea | 1980 |
[Various aspects of estrogenic activity during menopause. III. Relation between estrogen excretion and the number of years after menopause].
Topics: Aged; Estradiol; Estriol; Estrogens; Estrone; Female; Humans; Menopause; Middle Aged; Time Factors | 1980 |
A comparison of serum oestrogen levels after percutaneous and oral administration of oestradiol-17 beta.
Topics: Administration, Oral; Adult; Estradiol; Estrogens; Estrone; Female; Humans; Injections, Intradermal; | 1981 |
[Assessment of serum estrogen levels by RIA with HPLC during hormone replacement therapy].
Topics: Adult; Chromatography, High Pressure Liquid; Estradiol; Estrogen Replacement Therapy; Estrogens, Con | 1995 |
Role of growth factors in the human endometrium during aging.
Topics: Adult; Aged; Aging; Androstenedione; Endometrium; Epidermal Growth Factor; ErbB Receptors; Estradiol | 1993 |
A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density.
Topics: Androstenedione; Body Mass Index; Bone Density; Climacteric; Estradiol; Estrone; Female; Follicle St | 1995 |
Use of menopausal estrogens and medroxyprogesterone in the United States, 1982-1992.
Topics: Administration, Cutaneous; Administration, Intravaginal; Administration, Oral; Adult; Aged; Aged, 80 | 1995 |
The menopausal transition: a dynamic approach to the pathogenesis of neurovegetative complaints.
Topics: Adult; Aged; Aging; Arthralgia; Climacteric; Depression; Estrone; Female; Humans; Italy; Menopause; | 1994 |
Steroid gradients across the cancerous breast: an index of altered steroid metabolism in breast cancer?
Topics: Adult; Aged; Androstenedione; Breast Neoplasms; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfa | 1994 |
Metabolism of estrone sulfate by normal breast tissue: influence of menopausal status and oral contraceptives.
Topics: Adolescent; Adult; Aged; Breast; Breast Neoplasms; Contraceptives, Oral; Endometrial Neoplasms; Estr | 1994 |
Estrogen and interrupted progestin: a new concept for menopausal hormone replacement therapy.
Topics: Adult; Blood Pressure; Body Weight; Climacteric; Drug Therapy, Combination; Endometrium; Estradiol C | 1993 |
Relationship between aromatase activity and steroid receptor levels in ovarian tumors from postmenopausal women.
Topics: Adult; Aged; Aged, 80 and over; Androgens; Androstenedione; Aromatase; Cystadenocarcinoma; Estradiol | 1993 |
A sensitive assay for measurement of plasma estrone sulphate in patients on treatment with aromatase inhibitors.
Topics: Aminoglutethimide; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibi | 1995 |
Reproducibility studies and interlaboratory concordance for assays of serum hormone levels: estrone, estradiol, estrone sulfate, and progesterone.
Topics: Analysis of Variance; Blood Chemical Analysis; Estradiol; Estrogens, Conjugated (USP); Estrone; Feas | 1996 |
Androgens and the menopause; a study of 40-60-year-old women.
Topics: Adrenal Glands; Adult; Age Factors; Androgens; Androstenedione; Body Mass Index; Dehydroepiandroster | 1996 |
Changes in serum estrogen levels in women during tamoxifen therapy.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Dehydroepiandrosterone; Estradiol; Estrogens; Estr | 1997 |
Characterization of the onset of menopause in the rhesus macaque.
Topics: Aging; Animals; Estrone; Female; Follicular Phase; Luteal Phase; Macaca mulatta; Menopause; Menstrua | 1997 |
Angiotensin converting enzyme inhibition modulates cardiac fibroblast growth.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cell Division; Cells, Cultured; C | 1998 |
Evidence for interference in estradiol-17beta inactivation to estrone by oxidized low-density lipoprotein and selected lipid peroxidation products.
Topics: 17-Hydroxysteroid Dehydrogenases; Base Sequence; Breast Neoplasms; Cell Line; DNA Primers; Estradiol | 1999 |
A study on serum carotenoid levels in breast cancer patients of Indian women in Chennai (Madras), India.
Topics: Adult; Aged; Aged, 80 and over; Anticarcinogenic Agents; Antioxidants; beta Carotene; Breast Neoplas | 1999 |
Hysterectomy, oophorectomy, and endogenous sex hormone levels in older women: the Rancho Bernardo Study.
Topics: Aged; Aged, 80 and over; Aging; Androstenedione; Estrone; Female; Gonadal Steroid Hormones; Humans; | 2000 |
A tetranucleotide repeat polymorphism in CYP19 and breast cancer risk.
Topics: Alleles; Aromatase; Breast Neoplasms; Case-Control Studies; Estradiol; Estrone; Female; Genotype; Hu | 2000 |
Estrogen and progesterone metabolites and follicle-stimulating hormone in the aged macaque female.
Topics: Aging; Animals; Anovulation; Dehydroepiandrosterone Sulfate; Estrogens; Estrone; Female; Follicle St | 2001 |
Association of CYP1B1 polymorphisms and breast cancer risk.
Topics: Adult; Aryl Hydrocarbon Hydroxylases; Biomarkers, Tumor; Breast Neoplasms; Case-Control Studies; Cyt | 2002 |
Comparison of the in vitro conversion of estradiol-17 beta to estrone of normal and neoplastic human breast tissue.
Topics: Breast; Breast Neoplasms; Endoplasmic Reticulum; Estradiol; Estradiol Dehydrogenases; Estrone; Femal | 1977 |
Hormone replacement therapy and endometrial carcinoma.
Topics: Climacteric; Drug Evaluation; Estradiol; Estradiol Congeners; Estrone; Female; Humans; Menopause; Mi | 1977 |
Ovarian function in patients receiving adjuvant chemotherapy for breast cancer.
Topics: Adult; Aged; Androstenedione; Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Dehydroepia | 1977 |
Oestrogen in breast fluid.
Topics: Adult; Body Fluids; Breast; Dehydroepiandrosterone; Estradiol; Estrone; Female; Humans; Menopause; M | 1977 |
Relation between plasma oestrone and oestradiol and climacteric symptoms.
Topics: Adult; Atrophy; Castration; Climacteric; Dyspareunia; Estradiol; Estrone; Female; Humans; Menopause; | 1978 |
Smoking, obesity, and the menopause.
Topics: Adult; Age Factors; Aged; Estrone; Female; Humans; Menopause; Middle Aged; Obesity; Smoking | 1978 |
Adipose tissue and aetiology of breast cancer.
Topics: Adipose Tissue; Aged; Body Weight; Breast Neoplasms; Estrone; Female; Humans; Menopause; Middle Aged | 1978 |
Pineal gland, F.S.H., and breast-cancer aetiology.
Topics: Aged; Breast Neoplasms; Estrone; Female; Follicle Stimulating Hormone; Humans; Melatonin; Menopause; | 1978 |
Mechanism of action of aminoglutethimide in breast cancer.
Topics: Adult; Aged; Aminoglutethimide; Androstenedione; Breast Neoplasms; Estradiol; Estrogen Antagonists; | 1979 |
Plasma hormone levels in different ethnic populations of women.
Topics: Adrenal Glands; Adult; Africa; Androstenedione; Animals; Asian People; Black People; Breast Neoplasm | 1976 |
Ovarian and adrenal contributions to peripheral steroid levels in postmenopausal women.
Topics: Adrenal Cortex Hormones; Aged; Androgens; Androstenediols; Androstenedione; Dehydroepiandrosterone; | 1976 |
Steroid hormone metabolism in skin and isolated sebaceous glands: preliminary observations on the effects of age.
Topics: Adolescent; Adult; Age Factors; Aged; Aging; Dehydroepiandrosterone; Estradiol; Estrone; Female; Gon | 1979 |
Serum levels of total dehydroepiandrosterone and total estrone in postmenopausal women with special regard to carcinoma of the uterine corpus.
Topics: Aged; Dehydroepiandrosterone; Estrone; Female; Humans; Menopause; Middle Aged; Uterine Neoplasms | 1979 |
Metabolic effects of corticosteroid therapy in post-menopausal women.
Topics: Androstenedione; Bone and Bones; Calcium; Creatinine; Dehydroepiandrosterone; Estradiol; Estrone; Fe | 1979 |
Effect of exogenous estrogen on serum pregnenolone, cortisol, and androgens in postmenopausal women.
Topics: Adrenal Cortex; Adrenocorticotropic Hormone; Androgens; Androstenedione; Dehydroepiandrosterone; Dih | 1975 |
Progesterone-binding proteins: in vitro binding and biological activity of different steroidal ligands.
Topics: Aged; Animals; Benzoates; Binding Sites; Binding, Competitive; Blood Proteins; Centrifugation, Densi | 1975 |
Androgens in postmenopausal breast cancer: excretion, production and interaction with estrogens.
Topics: 17-Ketosteroids; Aged; Androgens; Androstenedione; Binding, Competitive; Breast Neoplasms; Dehydroep | 1975 |
The hormonal activity of the postmenopausal ovary.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Aged; Androstenedione; Castration; Chorionic Gonadotrop | 1976 |
Existence of receptors bound to endogenous estradiol in breast cancers of premenopausal and postmenopausal women.
Topics: Adenocarcinoma; Breast; Breast Neoplasms; Carcinoma, Squamous Cell; Cell Nucleus; Cytosol; Estradiol | 1976 |
Proceedings: Androgens in human postmenopausal breast cancer.
Topics: Androgens; Breast Neoplasms; Dehydroepiandrosterone; Estradiol; Estrone; Female; Humans; Menopause; | 1975 |
Management of the menopause.
Topics: Atrophy; Climacteric; Estradiol; Estrogens; Estrogens, Conjugated (USP); Estrone; Ethinyl Estradiol; | 1976 |
Effect of treatment with estrogen conjugates on endogenous plasma steroids.
Topics: Androstenedione; Dehydroepiandrosterone; Estradiol; Estriol; Estrogens, Conjugated (USP); Estrone; F | 1977 |
Oestrogens and endometrial cancer: a point of view.
Topics: Adenocarcinoma; Adult; Age Factors; Aged; Breast Neoplasms; Climacteric; Contraceptives, Oral, Seque | 1977 |
Estrogens for the menopause. Maximizing benefits, minimizing risks.
Topics: Affective Symptoms; Arteriosclerosis; Breast Neoplasms; Climacteric; Cystitis; Estradiol; Estrogens; | 1977 |
Adrenal contribution to circulating estrogens in woman.
Topics: Adrenal Glands; Adrenalectomy; Adrenocorticotropic Hormone; Adult; Aged; Breast Neoplasms; Estradiol | 1978 |
Plasma levels of oestrone, oestradiol and gonadotrophins in postmenopausal women after oral and vaginal administration of conjugated equine oestrogens (Premarin).
Topics: Administration, Oral; Estradiol; Estrogens, Conjugated (USP); Estrone; Female; Follicle Stimulating | 1978 |
[Estrogen substitution and endometrial carcinoma].
Topics: Aged; Endometriosis; Estradiol; Estrogens; Estrogens, Conjugated (USP); Estrone; Female; Humans; Men | 1979 |
Plasma hormone levels and oestrogen production in a postmenopausal woman with endometrial carcinoma and an ovarian thecoma.
Topics: Adenocarcinoma; Androstenedione; Castration; Estradiol; Estrone; Female; Hormones; Humans; Hysterect | 1979 |
Plasma concentrations of unconjugated and conjugated estrogens and gonadotrophins following application of various estrogen preparations after oophorectomy and in the menopause.
Topics: Castration; Dose-Response Relationship, Drug; Estradiol; Estriol; Estrogens; Estrogens, Conjugated ( | 1979 |
Estrone sulfate and dehydroepiandrosterone sulfate concentrations in normal subjects and men with cirrhosis.
Topics: Adult; Aged; Dehydroepiandrosterone; Estrogens, Conjugated (USP); Estrone; Female; Humans; Liver Cir | 1979 |
Aminoglutethimide inhibits extraglandular estrogen production in postmenopausal women with breast carcinoma.
Topics: Adult; Aminoglutethimide; Androstenedione; Breast Neoplasms; Estradiol; Estrogens; Estrone; Female; | 1978 |
Pharmacokinetic and pharmacodynamic studies on oestradiol valerianate administered orally to postmenopausal women.
Topics: Administration, Oral; Adult; Aged; Estradiol; Estrone; Female; Humans; Intestinal Absorption; Menopa | 1977 |
Urinary excretion of estrone, estradiol, and estriol in postmenopausal women with primary breast cancer.
Topics: Aged; Breast Neoplasms; Estradiol; Estriol; Estrone; Female; Humans; Menopause; Middle Aged; Risk | 1979 |
Prevalence, pathogenesis and treatment of post-menopausal osteoporosis.
Topics: Aged; Androstenedione; Calcium; Ergocalciferols; Estradiol; Estrone; Ethinyl Estradiol; Female; Huma | 1979 |
Endocrine diagnosis in the climacteric female.
Topics: Adult; Androstenedione; Chorionic Gonadotropin; Climacteric; Estradiol; Estrone; Female; Follicle St | 1978 |
Inhibition of peripheral aromatization in postmenopausal women with breast cancer.
Topics: Androstenedione; Breast Neoplasms; Estrone; Female; Humans; Menopause; Radioimmunoassay; Testolacton | 1978 |
Deuterium-labeled steroids for study in humans. II. Preliminary studies on estrogen production rates in pre- and post-menopausal women.
Topics: Adult; Age Factors; Chromatography, Gas; Deuterium; Estradiol; Estriol; Estrogens; Estrone; Female; | 1979 |
Low urinary estrogen glucuronides in women at risk for familial breast cancer.
Topics: Adult; Age Factors; Breast Neoplasms; Estradiol; Estriol; Estrogens; Estrone; Female; Humans; Menopa | 1979 |
[Metabolism of estrone sulfate in the postmenopausal and the pregnant myometrium].
Topics: Estrone; Female; Humans; Menopause; Myometrium; Pregnancy; Uterus | 1979 |
Inhibition of peripheral aromatization of androstenedione to estrone in postmenopausal women with breast cancer using delta 1-testololactone.
Topics: Aged; Androstenedione; Breast Neoplasms; Estradiol; Estrone; Female; Humans; Mastectomy; Menopause; | 1979 |
Factors affecting sex hormone levels in postmenopausal women.
Topics: Addison Disease; Adipose Tissue; Aged; Androgens; Androstenedione; Dihydrotestosterone; Estradiol; E | 1979 |
The conversion of androstenedione to oestrone and production of oestrone in women with endometrial cancer.
Topics: Adenocarcinoma; Adult; Androstenedione; Castration; Estrone; Female; Humans; Hysterectomy; Menopause | 1979 |
Effect of a sequential oestrogen-progestin therapy on the plasma level of oestrogens and lipids in post-menopausal women.
Topics: Aged; Castration; Cholesterol; Drug Therapy, Combination; Estradiol; Estrogens; Estrone; Ethinyl Est | 1979 |
Androgen--oestrogen transformation in female patients with metastatic breast cancer.
Topics: Bone Neoplasms; Breast Neoplasms; Estradiol; Estrone; Female; Humans; Menopause; Testosterone | 1979 |
Uterine metabolism of gonadal steroids during the menstrual cycle.
Topics: Adult; Carbon Radioisotopes; Estradiol; Estrone; Female; Genital Diseases, Female; Humans; Menopause | 1979 |
Hormone replacement therapy in the menopause: a suitable animal model.
Topics: Animals; Cytosol; Endometrium; Estrone; Ethinyl Estradiol; Female; Femur; Genitalia, Female; Luteini | 1979 |
Relation between the karyopyknotic index and plasma oestrogen concentrations after the menopause.
Topics: Aged; Cell Nucleus; Dyspareunia; Estradiol; Estrogens; Estrone; Female; Humans; Menopause; Middle Ag | 1979 |
Androgen-estrogen production rates in postmenopausal women with breast cancer.
Topics: Aged; Androstenedione; Breast Neoplasms; Estradiol; Estrone; Female; Humans; Menopause; Metabolic Cl | 1978 |
Serum concentrations of estrone, androstenedione, testosterone and sex-hormone-binding globulin in postmenopausal women with breast cancer and in age-matched controls.
Topics: Age Factors; Aged; Androstenedione; Body Weight; Breast Neoplasms; Estrone; Female; Humans; Menopaus | 1979 |
Estrogen use and cancer risk.
Topics: Administration, Oral; Breast Neoplasms; Diethylstilbestrol; Dose-Response Relationship, Drug; Estrad | 1977 |
Effect of piperazine oestrone sulphate on serum lipids and lipoproteins in menopausal women.
Topics: Cholesterol; Climacteric; Estrone; Fatty Acids; Fatty Acids, Nonesterified; Female; Humans; Lipids; | 1977 |
Plasma androstenedione and oestrone levels in normal and osteoporotic postmenopausal women.
Topics: Adult; Aged; Androstenedione; Castration; Estrone; Female; Humans; Menopause; Middle Aged; Osteoporo | 1977 |
The influence of nandrolone decanoate (Deca-durabolin) on the peripheral conversion of androstenedione to oestrone.
Topics: Androstenedione; Estrone; Female; Humans; Menopause; Metabolic Clearance Rate; Middle Aged; Nandrolo | 1977 |
Effect of diabetic status on fractionated estrogen levels in postmenopausal women.
Topics: Adenocarcinoma; Diabetes Complications; Diabetes Mellitus; Estradiol; Estrone; Female; Humans; Menop | 1978 |
The relation between plasma androstenedione, plasma oestrone and androstenedione to oestrone conversion rates in post-menopausal women with and without fractures.
Topics: Adrenal Glands; Age Factors; Aged; Androstenedione; Castration; Estrone; Female; Fractures, Bone; Hu | 1978 |
Effect of obesity on conversion of plasma androstenedione to estrone in postmenopausal women with and without endometrial cancer.
Topics: Adenocarcinoma; Aged; Aging; Androstenedione; Estrogens; Estrone; Female; Humans; Menopause; Middle | 1978 |
Estriol in the management of the menopause.
Topics: Endometrium; Estriol; Estrone; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Me | 1978 |
Serum FSH, LH and oestrone levels in postmenopausal patients on oestrogen therapy.
Topics: Estradiol; Estrone; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hor | 1978 |
Peripheral production of oestrogens in postmenopausal women [proceedings].
Topics: Androgens; Androstenedione; Dexamethasone; Estrone; Female; Humans; Menopause; Middle Aged; Testoste | 1978 |
Estrogen synthesis and estradiol binding by human mammary tumors.
Topics: 17-Hydroxysteroid Dehydrogenases; Adult; Age Factors; Aged; Androstenedione; Breast Neoplasms; Estra | 1978 |
Sex hormone concentrations in post-menopausal women.
Topics: Age Factors; Aged; Androstenedione; Estradiol; Estrone; Female; Humans; Menopause; Middle Aged; Obes | 1978 |
[Clinical evaluation of estro-feminal preparation].
Topics: Administration, Oral; Estrogens; Estrone; Female; Humans; Menopause; Middle Aged | 1978 |
Preoperative localization of virilizing tumors by selective venous sampling.
Topics: Adrenal Glands; Adrenal Rest Tumor; Androgens; Androstenedione; Chorionic Gonadotropin; Estrone; Fem | 1978 |
Estradiol and progesterone receptor levels in human breast adenocarcinoma in relation to plasma estrogen and progesterone levels.
Topics: Adenocarcinoma; Breast Neoplasms; Estradiol; Estrogens; Estrone; Female; Humans; Menopause; Menstrua | 1978 |
Relationship between urine and plasma estrogen ratios.
Topics: Breast Neoplasms; Estradiol; Estriol; Estrogens; Estrone; Female; Follicular Phase; Humans; Luteal P | 1978 |
Hormonal status in normal, osteoporotic and corticosteroid-treated postmenopausal women.
Topics: Adrenal Cortex Hormones; Androstenedione; Creatinine; Estrone; Female; Humans; Hydroxyproline; Menop | 1978 |
Kinetics of testosterone metabolism in normal postmenopausal women and women with breast cancer.
Topics: Aged; Breast Neoplasms; Estradiol; Estrone; Female; Humans; Kinetics; Menopause; Metabolic Clearance | 1978 |
The relation between plasma androstenedione and oestrone levels in untreated and corticosteroid-treated post-menopausal women.
Topics: Adrenal Cortex Hormones; Adult; Aged; Androstenedione; Castration; Estrone; Female; Humans; Menopaus | 1978 |
Plasma hormone profiles after the menopause and bilateral oöphorectomy.
Topics: Aged; Androstenedione; Castration; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Humans; | 1978 |
Estriol production rates and breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Estradiol; Estriol; Estrone; Female; Humans; Menopause; Middle Aged | 1978 |
The effects of oestrogens and progestogens on the postmenopausal endometrium.
Topics: Endometrial Hyperplasia; Endometrium; Estrogens; Estrone; Female; Humans; Menopause; Menstruation; M | 1978 |
Plasma levels of oestrone and oestradiol-17beta in postmenopausal women.
Topics: Adult; Age Factors; Aged; Body Weight; Endometrial Hyperplasia; Estradiol; Estrogens; Estrone; Femal | 1979 |
The hypothalamic anterior pituitary system in the clinacteric age period.
Topics: Castration; Climacteric; Estrone; Female; Follicle Stimulating Hormone; Follicular Phase; Gonadotrop | 1975 |
Influence of thyrotropin-releasing hormone on the postmenopausal female.
Topics: Administration, Oral; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Humans; Luteinizing | 1975 |
The management of the menopause.
Topics: Adult; Climacteric; Estrogens; Estrone; Female; Humans; Menopause; Neoplasms; Pregnancy; Progesteron | 1977 |
Changes in reproductive hormone secretion during the climacteric and postmenopausal periods.
Topics: Aging; Androgens; Climacteric; Estrogens; Estrone; Female; Follicle Stimulating Hormone; Gonadal Ste | 1977 |
Plasma hormones in human gonadotropin induced ovulation.
Topics: Adult; Androstenedione; Anovulation; Chorionic Gonadotropin; Estradiol; Estrone; Female; Follicle St | 1977 |
Postmenopausal bleeding.
Topics: Adenocarcinoma; Adrenal Glands; Androstenedione; Contraceptives, Oral; Dilatation and Curettage; End | 1977 |
Steroidogenesis in the postmenopausal ovary.
Topics: Adenocarcinoma; Androgens; Androstenedione; Estradiol; Estrogens; Estrone; Female; Gonadal Steroid H | 1977 |
Basic levels of the immuno suppressive serum protein PZ in women-influence of age, parity, gonadotrophins and estrogens.
Topics: Adolescent; Adult; Age Factors; Aged; Estradiol; Estrogens; Estrone; Female; Follicle Stimulating Ho | 1977 |
The origin of androgen and estrogen in a virilized postmenopausal woman with bilateral benign cystic teratomas.
Topics: Aged; Androgens; Androstenedione; Dermoid Cyst; Estradiol; Estrogens; Estrone; Female; Humans; Menop | 1977 |
Relationship between steroid excretion patterns and breast cancer incidence in Israeli women of various origins.
Topics: 17-Ketosteroids; Adrenal Cortex Hormones; Aged; Androgens; Breast Neoplasms; Environment; Estriol; E | 1977 |
Adrenal suppression with aminoglutethimide. II. Differential effects of aminoglutethimide on plasma androstenedione and estrogen levels.
Topics: Adrenal Glands; Aminoglutethimide; Androstenedione; Breast Neoplasms; Castration; Estradiol; Estroge | 1977 |
Vaginal absorption of estrone and 17beta-estradiol.
Topics: Aged; Biopharmaceutics; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Humans; Luteinizin | 1977 |
Clinical and endocrine studies in menopausal women after estradiol pellet implantation.
Topics: Adult; Depression, Chemical; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Humans; Lutei | 1977 |
Androstenedione metabolism in patients with endometrial cancer.
Topics: Androstenedione; Estradiol; Estrone; Female; Humans; Menopause; Metabolic Clearance Rate; Testostero | 1977 |
Tamoxifen (antiestrogen) therapy in advanced breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Estradiol; Estrone; Female; Humans; Menopause; Middle Aged; Neoplasm | 1977 |
Origin of estrogen in a postmenopausal woman with a nonendocrine tumor of the ovary and endometrial hyperplasia.
Topics: Androgens; Androstenedione; Castration; Cystadenoma; Endometrial Hyperplasia; Estrogens; Estrone; Fe | 1976 |
Serum 17 beta-estradiol and estrone levels in postmenopausal women with and without endometrial cancer.
Topics: Adenocarcinoma; Aged; Androgens; Body Weight; Castration; Estradiol; Estrone; Female; Humans; Menopa | 1976 |
Intestinal metabolism of estrogens.
Topics: Ampicillin; Estrogens; Estrone; Feces; Female; Humans; Intestinal Mucosa; Menopause; Pregnancy | 1976 |
Breast cancer in Britain and Japan: plasma oestradiol-17beta, oestrone and progesterone,and their urinary metabolites in normal British and Japanese women.
Topics: Adolescent; Adult; Age Factors; Asian People; Breast Neoplasms; Estradiol; Estriol; Estrogens; Estro | 1976 |
Hormonal profiles after the menopause.
Topics: Age Factors; Aged; Androstenedione; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Hormon | 1976 |
[Experimentation on the combination of estrone monosodium sulfate and estradiol monosodium sulfate in the treatment of menopause].
Topics: Drug Therapy, Combination; Estradiol; Estrone; Female; Humans; Menopause | 1976 |
Correlation between urinary testosterone or estrogen excretion levels and interstitial cell-stimulating hormone concentrations in normal postmenopausal women.
Topics: Endometrium; Estradiol; Estrogens; Estrone; Female; Humans; Luteinizing Hormone; Menopause; Testoste | 1975 |
Duration of effect of treatment of menopausal symptoms by oestrongen fraction.
Topics: Estradiol; Estrone; Female; Follow-Up Studies; Humans; Menopause; Middle Aged; Piperazines | 1975 |
Circulating estradiol, estrone and gonadotropin levels following the administration of orally active 17beta-estradiol in postmenopausal women.
Topics: Administration, Oral; Adult; Aged; Depression, Chemical; Estradiol; Estrone; Female; Follicle Stimul | 1975 |
The effects of danazol on gonadotropins and steroid blood levels in normal and anovulatory women.
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adult; Alkynes; Endometriosis; Estradiol; Estrogen Antag | 1975 |
Production of estrone and fractional conversion of circulating androstenedione to estrone in women with endometrial carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Androstenedione; Body Height; Body Weight; Endometrium; Estriol; Estrog | 1975 |
Protection of estrogenic hormones by ascorbic acid during chromatography.
Topics: Aged; Ascorbic Acid; Breast Neoplasms; Chromatography, Gas; Chromatography, Thin Layer; Estradiol; E | 1975 |
[Estradiol-17beta, estrone, LH and FSH in serum after administration of estradiol-17beta, estradiolbenzoate, estradiol-valeriate and estradiol-undecylate in the female (author's transl)].
Topics: Adult; Benzoates; Castration; Dose-Response Relationship, Drug; Esters; Estradiol; Estrone; Female; | 1975 |
Urinary excretion of steroids and response to oophorectomy in premenopausal women with advanced breast cancer.
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenal Cortex Hormones; Adult; Breast Neoplasms; Castra | 1975 |
Post-menopausal estrogen production.
Topics: Androstenedione; Estrogens; Estrone; Female; Humans; Menopause; Pregnancy; Steroid Hydroxylases; Ute | 1975 |
Association of estrone with the development of endometrial carcinoma.
Topics: Androstenedione; Animals; Estradiol; Estrone; Female; Humans; Menopause; Time Factors; Uterine Neopl | 1976 |
Increasing incidence of endometrial cancer in the United States.
Topics: Adenocarcinoma; Adult; Age Factors; Aged; Androstenedione; Contraceptives, Oral; Estrogens; Estrone; | 1976 |
[Effect of oestro-feminal on lipid metabolism in postmenopausal women].
Topics: Adult; Arteriosclerosis; Estrogens, Conjugated (USP); Estrone; Female; Humans; Lipids; Menopause; Mi | 1992 |
On the significance of in situ production of oestrogens in human breast cancer tissue.
Topics: Adipose Tissue; Aromatase; Breast Neoplasms; Estradiol; Estrogens; Estrogens, Conjugated (USP); Estr | 1992 |
25 mg oestradiol implants--the dosage of first choice for subcutaneous oestrogen replacement therapy?
Topics: Drug Implants; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Estrone; Female | 1992 |
The origin of oestrone sulphate in normal and malignant breast tissues in postmenopausal women.
Topics: Aged; Breast; Breast Neoplasms; Danazol; Estrone; Female; Humans; Menopause; Middle Aged; Sulfatases | 1992 |
Beneficial effects on serum lipoproteins by 17 beta-oestradiol-dydrogesterone therapy in postmenopausal women; a prospective study.
Topics: Apolipoproteins A; Apolipoproteins B; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Drug Th | 1992 |
Endogenous estrogen levels in postmenopausal women with severe urogenital atrophy.
Topics: Atrophy; Circadian Rhythm; Estradiol; Estrone; Female; Humans; Menopause; Middle Aged; Urethra; Vagi | 1992 |
Endocrine evaluation of patients with benign lumps of the breast.
Topics: Adult; Aged; Aged, 80 and over; Androgens; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; E | 1992 |
Estrogens in plasma and fatty tissue from breast cancer patients and women undergoing surgery for non-oncological reasons.
Topics: Abdomen; Adipose Tissue; Breast Neoplasms; Estradiol; Estrone; Female; Humans; Menopause | 1992 |
Influence of estrogen replacement therapy on endogenous calcitonin production rates.
Topics: Aged; Aged, 80 and over; Calcitonin; Estradiol; Estrogen Replacement Therapy; Estrone; Female; Human | 1992 |
Specificity of low dose fadrozole hydrochloride (CGS 16949A) as an aromatase inhibitor.
Topics: 17-alpha-Hydroxyprogesterone; Adrenocorticotropic Hormone; Aldosterone; Androstenedione; Aromatase I | 1991 |
High-fiber diet reduces serum estrogen concentrations in premenopausal women.
Topics: Adult; Dietary Fats; Dietary Fiber; Edible Grain; Estrogens; Estrone; Female; Humans; Menopause; Mid | 1991 |
Low-dose aminoglutethimide in postmenopausal breast cancer: effects on adrenal and thyroid hormone secretion.
Topics: 17-alpha-Hydroxyprogesterone; Adrenocorticotropic Hormone; Aminoglutethimide; Androstenedione; Breas | 1991 |
Alpha 2-HS glycoprotein phenotypes and quantitative hormone and bone measures in postmenopausal women.
Topics: Aged; Alleles; alpha-Macroglobulins; Bone Density; Cohort Studies; Estradiol; Estrogens; Estrone; Fe | 1990 |
Endogenous factors affecting bone mineral content in post-menopausal women.
Topics: Adult; Aged; Aging; Body Composition; Bone Density; Creatinine; Estrone; Female; Humans; Menopause; | 1991 |
Sex hormones in postmenopausal women with primary biliary cirrhosis.
Topics: Aged; Androstenedione; Dehydroepiandrosterone; Dihydrotestosterone; Estradiol; Estrone; Female; Gona | 1991 |
Menopausal age and sex hormones in postmenopausal women with alcoholic and non-alcoholic liver disease.
Topics: Aged; Androstenedione; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; | 1991 |
Endocrine status in patients with mammary gland diseases: correlation between steroid hormones and sex steroid binding globulin.
Topics: Adult; Aged; Aged, 80 and over; Androstenedione; Breast Neoplasms; Dehydroepiandrosterone; Dehydroep | 1991 |
Tamoxifen and partial oestrogen agonism in postmenopausal women.
Topics: Aged; Breast Neoplasms; Estradiol; Estrogens; Estrone; Female; Follicle Stimulating Hormone; Humans; | 1991 |
Reliability and interrelations among serum sex hormones in postmenopausal women.
Topics: Androstenedione; Cholesterol, HDL; Estradiol; Estrone; Female; Humans; Menopause; Middle Aged; Regre | 1991 |
Endometrial cancer, obesity, and body fat distribution.
Topics: Adipose Tissue; Adult; Aged; Androstenedione; Body Mass Index; Case-Control Studies; Estradiol; Estr | 1991 |
Effects of estropipate treatment on plasma lipids and lipoprotein lipid composition in postmenopausal women.
Topics: Cholesterol; Cholesterol Esters; Estrone; Female; Humans; Lipids; Lipoproteins; Lipoproteins, HDL; L | 1991 |
[Influences of menopause and oophorectomy on bone metabolism and spinal bone mineral content].
Topics: Alkaline Phosphatase; Androstenedione; Bone and Bones; Bone Density; Calcium; Estrone; Female; Human | 1991 |
[Plasma estrogen level in patients with cervical cancer].
Topics: Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Estradiol; Estriol; Estrogens; Estrone; Female; Huma | 1990 |
The relationship of total and free estrogens and sex hormone-binding globulin with lipoproteins in women.
Topics: Amenorrhea; Apolipoprotein A-I; Apolipoproteins A; Apolipoproteins B; Body Mass Index; Cholesterol; | 1990 |
Smoking induces increased androgen levels in early post-menopausal women.
Topics: Androstenedione; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormo | 1990 |
Influence of menopause on serum lipids and lipoproteins.
Topics: Adult; Aged; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Humans; Lipids; Lipoproteins; | 1990 |
Serum oestrogen levels in postmenopausal women: comparison of American whites and Japanese in Japan.
Topics: Aged; Asian People; Estradiol; Estrogens; Estrone; Female; Humans; Japan; Menopause; Middle Aged; Se | 1990 |
Androgen and estrogen dynamics: stability over a two year interval in peri-menopausal women.
Topics: Androgens; Androstenedione; Aromatase; Estradiol; Estrogens; Estrone; Female; Humans; Menopause; Met | 1990 |
Differential effects of oral estrone versus 17 beta-estradiol on lipoproteins in postmenopausal women.
Topics: Administration, Oral; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Dose-Response Relationship, D | 1990 |
[Fixation of fluorescent estrone derivative on human breast cancer cells. Correlation with age, menopause status and histopathology].
Topics: Adult; Age Factors; Aged; Binding Sites; Breast Neoplasms; Carcinoma; Estrone; Female; Fluorescence; | 1990 |
Steroids in normal and neoplastic breast tissues.
Topics: Androgens; Breast; Breast Neoplasms; Estradiol; Estrone; Female; Humans; Menopause; Steroids | 1990 |
Gonadotrophin response to releasing hormone in post-menopausal patients with ovarian tumours.
Topics: Aged; Androstenedione; Estrone; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; M | 1989 |
Ovarian-pituitary hormone interactions during the perimenopause.
Topics: Adult; Estrone; Female; Follicle Stimulating Hormone; Gonadotropins, Pituitary; Humans; Longitudinal | 1989 |
Zoladex: endocrine and therapeutic effects in post-menopausal breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Buserelin; Estradiol; Estrone; Female; Goserelin; | 1989 |
Zoladex: therapeutic effects in postmenopausal breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Buserelin; Estradiol; Estrone; Female; Goserelin; | 1989 |
Tamoxifen prolongs luteal phase in premenopausal women but has no effect on the size of uterine fibroids.
Topics: Estrone; Female; Humans; Leiomyoma; Luteal Phase; Menopause; Pregnanediol; Progesterone; Sex Hormone | 1989 |
Urinary oestrogen excretion after the menopause in relation to age and body mass.
Topics: Age Factors; Aged; Aged, 80 and over; Body Height; Body Mass Index; Body Weight; Creatinine; Estradi | 1989 |
Lack of diurnal variation in plasma levels of androstenedione, testosterone, estrone and estradiol in postmenopausal women.
Topics: Androstenedione; Breast Neoplasms; Circadian Rhythm; Estradiol; Estrone; Female; Humans; Menopause; | 1989 |
Endogenous oestrogens and androgens in normal and malignant endometrial and mammary tissues.
Topics: Androgens; Breast; Breast Neoplasms; Endometrium; Estradiol; Estrogens; Estrone; Female; Humans; Men | 1989 |
[Estrogen production in epithelial tumors of the ovary--localization of estrogen-synthesizing cells].
Topics: Autoradiography; Cholesterol; Cystadenocarcinoma; Estradiol; Estrogens; Estrone; Female; Histocytoch | 1989 |
The epidemiology of serum sex hormones in postmenopausal women.
Topics: Aged; Alcohol Drinking; Androstenedione; Estradiol; Estrone; Exercise; Female; Gonadal Steroid Hormo | 1989 |
Influence of the maturity of the vaginal epithelium upon the absorption of vaginally administered estradiol-17 beta and progesterone in postmenopausal women.
Topics: Absorption; Aged; Drug Combinations; Epithelial Cells; Epithelium; Estradiol; Estrone; Female; Human | 1989 |
Multiple forms of 17 beta-hydroxysteroid oxidoreductase in human breast tissue.
Topics: 17-Hydroxysteroid Dehydrogenases; Adipose Tissue; Breast; Cell Fractionation; Chromatography, Gel; E | 1989 |
[Ovarian production of estrogen in postmenopausal women with endometrial carcinoma].
Topics: Adenocarcinoma; Aged; Estradiol; Estrogens; Estrone; Female; Humans; Menopause; Middle Aged; Ovary; | 1989 |
[Local production of estrogen via aromatase and estrone sulfatase in breast cancer tissue].
Topics: Adipose Tissue; Adult; Aged; Aged, 80 and over; Aromatase; Breast; Breast Neoplasms; Estrone; Female | 1989 |
Relationship between whole plasma calcitonin levels, calcitonin secretory capacity, and plasma levels of estrone in healthy women and postmenopausal osteoporotics.
Topics: Adult; Aged; Calcitonin; Estrone; Female; Humans; Menopause; Metabolic Clearance Rate; Middle Aged; | 1989 |
A comparison of the endocrine effects of low dose aminoglutethimide with and without hydrocortisone in postmenopausal breast cancer patients.
Topics: Adult; Aged; Aminoglutethimide; Androstenedione; Breast Neoplasms; Dehydroepiandrosterone; Dehydroep | 1985 |
Uptake and concentration of steroid hormones in mammary tissues.
Topics: Adult; Androgens; Androstenediol; Biopsy; Breast; Breast Diseases; Breast Neoplasms; Cell Nucleus; C | 1986 |
Treatment of advanced postmenopausal breast cancer with an aromatase inhibitor, 4-hydroxyandrostenedione: phase II report.
Topics: Adult; Aged; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Dehydroepiandrosterone; Drug E | 1986 |
Endocrine effects of low dose aminoglutethimide with hydrocortisone--an optimal hormone suppressive regimen.
Topics: Aminoglutethimide; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms | 1986 |
Serum steroid hormone profiles in postmenopausal smokers and nonsmokers.
Topics: 17-alpha-Hydroxyprogesterone; Androstenedione; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfat | 1987 |
The effects of low and high dose medroxyprogesterone acetate on sex steroids and sex hormone binding globulin in postmenopausal breast cancer patients.
Topics: Androstenedione; Antineoplastic Agents; Breast Neoplasms; Dehydroepiandrosterone; Dehydroepiandroste | 1987 |
Bone mineral density in Addison's disease: evidence for an effect of adrenal androgens on bone mass.
Topics: Addison Disease; Adult; Aged; Androgens; Androstenedione; Bone and Bones; Dehydroepiandrosterone; Es | 1987 |
A prospective long-term study in women from pre-menopause to post-menopause: changing profiles of gonadotrophins, oestrogens and androgens.
Topics: Androstenedione; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estradiol; Estrone; Female; | 1986 |
Cigarette smoking and levels of adrenal androgens in postmenopausal women.
Topics: Adrenal Glands; Aged; Androgens; Androstenedione; Dehydroepiandrosterone; Dehydroepiandrosterone Sul | 1988 |
[Changes in plasma binding protein of sex steroids and transcortin during the treatment of menopause with oral estrogens].
Topics: Administration, Oral; Estradiol; Estrogens; Estrone; Female; Gonadotropins; Humans; Menopause; Middl | 1988 |
Two partial remissions induced by an LHRH analogue in two postmenopausal women with metastatic breast cancer.
Topics: Aged; Aged, 80 and over; Breast Neoplasms; Estradiol; Estriol; Estrone; Female; Follicle Stimulating | 1988 |
High dose ketoconazole: endocrine and therapeutic effects in postmenopausal breast cancer.
Topics: 17-alpha-Hydroxyprogesterone; Aged; Aged, 80 and over; Androstenedione; Breast Neoplasms; Dehydroepi | 1988 |
Effect of long-term therapy with estrogen and progesterone on the endometrium of post-menopausal women.
Topics: Aged; Atrophy; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Drug Therapy, Combi | 1985 |
Effect of natural estrogen on the serum level of follicle-stimulating hormone (FSH), estradiol and estrone in post-menopausal women and its effect on endometrium.
Topics: Aged; Endometrium; Estradiol; Estrogens, Conjugated (USP); Estrone; Female; Follicle Stimulating Hor | 1985 |
Endocrine effects of low dose aminoglutethimide as an aromatase inhibitor in the treatment of breast cancer.
Topics: Adrenocorticotropic Hormone; Aged; Aminoglutethimide; Androstenedione; Aromatase Inhibitors; Breast | 1985 |
Pharmacokinetics and biotransformation of estradiol valerate in ovariectomized women.
Topics: Administration, Oral; Adult; Biotransformation; Castration; Estradiol; Estriol; Estrogens, Conjugate | 1985 |
Pharmacokinetics and pharmacodynamics of transdermal dosage forms of 17 beta-estradiol: comparison with conventional oral estrogens used for hormone replacement.
Topics: Administration, Oral; Administration, Topical; Climacteric; Dosage Forms; Estradiol; Estrogens; Estr | 1985 |
Sex steroids modulate prolactin response to naloxone in postmenopausal women.
Topics: Endorphins; Estradiol; Estrogens, Conjugated (USP); Estrone; Female; Follicle Stimulating Hormone; H | 1985 |
Biologic effects of transdermal estradiol.
Topics: Administration, Oral; Administration, Topical; Blood Coagulation Factors; Calcium; Carrier Proteins; | 1986 |
Prevention of endometrial abnormalities.
Topics: Endometrial Hyperplasia; Estradiol; Estriol; Estrogens; Estrogens, Conjugated (USP); Estrone; Female | 1986 |
Solid-phase enzymoimmunoassay of estrone in serum.
Topics: Antibody Specificity; Chromatography, Ion Exchange; Clomiphene; Estrone; Female; Humans; Immune Sera | 1988 |
Biological effects of estradiol-17 beta in postmenopausal women: oral versus percutaneous administration.
Topics: Administration, Oral; Administration, Topical; Adult; Aged; Angiotensinogen; Antithrombins; Estradio | 1986 |
Oestrogen production and metabolism in peri-menopausal women.
Topics: Breast Neoplasms; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Humans; Luteinizing Horm | 1986 |
The effect of physiological changes in ovarian steroids on the prolactin response to gonadotrophin releasing factor.
Topics: Adolescent; Adult; Aged; Estradiol; Estrogens; Estrone; Female; Follicle Stimulating Hormone; Humans | 1986 |
The role of serum concentrations of sex steroids and bone turnover in the development and occurrence of postmenopausal osteoporosis.
Topics: Aged; Androstenedione; Bone and Bones; Bone Resorption; Estradiol; Estrogens; Estrone; Female; Human | 1986 |
Gonadal steroids, gonadotropins and endometrial histology in postmenopausal women with malignant ovarian tumors.
Topics: Adult; Endometrium; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Gonadal Steroid Hormon | 1986 |
Steroid and gonadotropin levels in women during the peri-menopausal years.
Topics: Androgens; Estradiol; Estrogens; Estrone; Female; Follicle Stimulating Hormone; Humans; Luteinizing | 1986 |
Monitoring the menstrual cycle of humans and lowland gorillas based on urinary profiles of bioactive follicle-stimulating hormone and steroid metabolites.
Topics: Amenorrhea; Animals; Contraceptives, Oral; Estrone; Female; Follicle Stimulating Hormone; Gorilla go | 1987 |
Endometrium and plasma hormone profile in the peri-menopause and post-menopause.
Topics: Atrophy; Endometrium; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Humans; Luteinizing | 1986 |
[Sex hormones and the hypophyseo-gonadal axis in females with liver cirrhosis in postmenopause].
Topics: Androstenedione; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Gonadal Steroid Hormones; | 1987 |
Vaginal physiology in postmenopausal women: pH value, transvaginal electropotential difference, and estimated blood flow.
Topics: Blood Flow Velocity; Electrophysiology; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Hu | 1987 |
Effect of oestrogen and progestagen on gonadotrophins and sex hormones in oophorectomized women.
Topics: Adult; Drug Combinations; Estradiol; Estrogens; Estrone; Female; Follicle Stimulating Hormone; Gonad | 1988 |
Progestins increase endogenous opioid peptide activity in postmenopausal women.
Topics: Aged; Endorphins; Estradiol; Estrone; Female; Humans; Luteinizing Hormone; Medroxyprogesterone; Medr | 1985 |
Serum levels of dehydroepiandrosterone sulphate and total estrone in postmenopausal women with special regard to 'non-endocrine' ovarian carcinoma.
Topics: Age Factors; Aged; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estrone; Female; Humans; | 1985 |
Conversion of estrone to estradiol and estradiol to estrone in postmenopausal women.
Topics: Aged; Body Weight; Breast Diseases; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estradio | 1985 |
Evaluation of urinary oestrogen assays after the menopause and their potential for screening.
Topics: Estradiol; Estrogens; Estrone; Female; Humans; Menopause; Microchemistry; Middle Aged; Radioimmunoas | 1988 |
[Effects of age and obesity on the conversion of androstenedione to estrone in postmenopausal women].
Topics: Aging; Androstenedione; Estrone; Female; Humans; Menopause; Obesity | 1988 |
Metabolism of estrone sulfate in postmenopausal vaginal mucosa.
Topics: Estrone; Female; Humans; Menopause; Middle Aged; Mucous Membrane; Vagina | 1988 |
[Serum estrone sulfate levels in patients with breast cancer].
Topics: Adult; Aged; Breast Neoplasms; Combined Modality Therapy; Estrone; Female; Humans; Kinetics; Menopau | 1988 |
Influence of endocrine status on biochemical and immunocytochemical estrogen and progesterone receptor assays in breast cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Estradiol; Estrone; Female; Humans; Immunohistoche | 1988 |
[Changes in plasma sex hormone in postmenopausal type II diabetics and therapeutic effect of diagnosis and treatment with traditional Chinese medicine].
Topics: Aged; Diabetes Mellitus, Type 2; Drugs, Chinese Herbal; Estradiol; Estrone; Female; Gonadal Steroid | 1988 |
Biological and endocrine aspects of transdermal 17 beta-oestradiol administration in post-menopausal women.
Topics: Administration, Cutaneous; Blood Proteins; Estradiol; Estrone; Female; Humans; Menopause; Middle Age | 1988 |
Endogenous estrogen levels and calcium intakes in postmenopausal women. Relationships with cortical bone measures.
Topics: Age Factors; Androstenedione; Animals; Bone and Bones; Calcium, Dietary; Estrogens; Estrone; Exercis | 1988 |
Response to human chorionic gonadotropin in patients with ovarian tumors.
Topics: Aged; Androstenedione; Chorionic Gonadotropin; Estradiol; Estrone; Female; Humans; Menopause; Middle | 1988 |
[Concentration of steroid hormones in the ovarian vein and peripheral blood and the influence of ovariectomy on postmenopausal women].
Topics: Estradiol; Estrone; Female; Humans; Menopause; Middle Aged; Ovariectomy; Ovary; Postoperative Period | 1988 |
[Plasma concentration of estrogens and androgens in postmenopausal women with or without endometrial cancer].
Topics: Aged; Androgens; Androstenedione; Body Weight; Estradiol; Estrogens; Estrone; Female; Humans; Insuli | 1988 |
Re: "Sex hormone levels in serum in relation to the development of breast cancer".
Topics: Breast Neoplasms; Estradiol; Estrone; Female; Gonadal Steroid Hormones; Humans; Menopause | 1988 |
Postmenopausal urinary incontinence: comparison between non-estrogen-supplemented and estrogen-supplemented women.
Topics: Administration, Oral; Age Factors; Aged; Analysis of Variance; Estradiol; Estrogens; Estrone; Female | 1988 |
Androgen and estrogen dynamics in pre- and postmenopausal women: a comparison between smokers and nonsmokers.
Topics: Androgens; Androstenedione; Estradiol; Estrogens; Estrone; Female; Humans; Menopause; Middle Aged; O | 1988 |
Serum lipids in Finnish and Japanese postmenopausal women.
Topics: Apolipoproteins; Cholesterol; Estrone; Fatty Acids; Female; Finland; Humans; Japan; Lipids; Menopaus | 1987 |
Comparative metabolism of oestrone sulphate after oral and intravenous administration in post-menopausal women.
Topics: Administration, Oral; Estradiol; Estrone; Female; Humans; Injections, Intravenous; Liver; Menopause; | 1987 |
Estrogens and breast cancer.
Topics: Adult; Aged; Blood Specimen Collection; Breast Neoplasms; Epidemiologic Methods; Estradiol; Estrogen | 1986 |
Benign and malignant breast disease: initial study results of serum and breast fluid analyses of endogenous estrogens.
Topics: Adult; Aged; Analysis of Variance; Body Fluids; Breast; Breast Diseases; Breast Neoplasms; Estradiol | 1987 |
Sex steroids and bone mass. A study of changes about the time of menopause.
Topics: Adult; Bone and Bones; Calcium-Binding Proteins; Diet; Estradiol; Estrone; Female; Gonadal Steroid H | 1987 |
Aromatisation of androstenedione by human breast cancer tissue: correlation with hormone receptor activity and possible biologic significance.
Topics: Androstenedione; Aromatase; Breast Neoplasms; Estrone; Female; Humans; In Vitro Techniques; Menopaus | 1987 |
Serum estrogen levels after topic application of estradiol-17 beta on two different cutaneous areas.
Topics: Abdomen; Administration, Cutaneous; Aged; Estradiol; Estrone; Female; Humans; Menopause; Middle Aged | 1987 |
Demystifying menopause.
Topics: Adult; Climacteric; Diet; Estradiol; Estrone; Female; Humans; Menopause; Middle Aged; Physical Exert | 1987 |
Rates of bone loss in the appendicular and axial skeletons of women. Evidence of substantial vertebral bone loss before menopause.
Topics: Adult; Aged; Bone and Bones; Densitometry; Estradiol; Estrone; Female; Humans; Lumbar Vertebrae; Men | 1986 |
Metabolism of [3H]oestradiol in vivo by normal breast and tumour tissue in postmenopausal women.
Topics: Aged; Androgens; Breast; Breast Neoplasms; Estradiol; Estrone; Female; Humans; Menopause; Middle Age | 1986 |
Ovarian and peripheral androgen and oestrogen levels in post-menopausal women: correlations with ovarian histology.
Topics: Adenocarcinoma; Aged; Androstenedione; Estradiol; Estrone; Female; Gonadal Steroid Hormones; Humans; | 1986 |
Aromatase activity and concentrations of cortisol, progesterone and testosterone in breast and abdominal adipose tissue.
Topics: Abdomen; Adipose Tissue; Androstenedione; Aromatase; Breast; Estradiol; Estrone; Female; Humans; Hyd | 1986 |
The endogenous concentration of estradiol and estrone in pathological human postmenopausal endometrium.
Topics: Adenocarcinoma; Aged; Endometrium; Estradiol; Estrone; Female; Humans; Menopause; Middle Aged; Uteri | 1986 |
Secretion of androgens and estrogens by normal and neoplastic ovaries in postmenopausal women.
Topics: Aged; Androstenedione; Cystadenocarcinoma; Cystadenoma; Estradiol; Estrone; Female; Humans; Menopaus | 1986 |
A comparison of the in vivo uptake and metabolism of 3H-oestrone and 3H-oestradiol by normal breast and breast tumour tissues in post-menopausal women.
Topics: Aged; Breast; Breast Neoplasms; Estradiol; Estradiol Dehydrogenases; Estrone; Female; Humans; Menopa | 1986 |
Aromatization by skeletal muscle.
Topics: Aged; Androstenedione; Aromatase; Carbon Radioisotopes; Estrone; Female; Humans; In Vitro Techniques | 1986 |
Endocrine impact of pure estradiol replacement in postmenopausal women: alterations in anterior pituitary hormone release and circulating sex steroid hormone concentrations.
Topics: Estradiol; Estrone; Female; Gonadal Steroid Hormones; Humans; Menopause; Middle Aged; Pituitary Horm | 1986 |
Aminoglutethimide as an inducer of microsomal enzymes. Part 2: Endocrine aspects.
Topics: Aminoglutethimide; Breast Neoplasms; Drug Administration Schedule; Estradiol; Estrogens; Estrone; Fe | 1986 |
Preliminary report on postmenopausal endometrial hyperplasia treatment with Danazol: histological and endocrinological aspects.
Topics: Danazol; Endometrial Hyperplasia; Estrone; Female; Humans; Menopause; Middle Aged; Pregnadienes | 1986 |
Dermal prostacyclin, thromboxane A2 and prostaglandin F2 alpha in climacteric women: effect of oestrogen replacement therapy.
Topics: 6-Ketoprostaglandin F1 alpha; Dinoprost; Drug Therapy, Combination; Estradiol; Estrone; Female; Huma | 1986 |
The relationship of endogenous estrogen to bone density and bone area in normal postmenopausal women.
Topics: Aged; Anthropometry; Bone and Bones; Estradiol; Estrone; Female; Humans; Menopause; Middle Aged; Phy | 1986 |
Diagnostic significance of steroid hormones in patients with ovarian cancer.
Topics: Adult; Androstenedione; Estradiol; Estrone; Female; Humans; Menopause; Middle Aged; Ovarian Cysts; O | 1986 |
The use of nonradiolabelled steroid infusions to investigate the origin of oestrone sulphate in postmenopausal women.
Topics: Androstenediols; Androstenedione; Estrone; Female; Humans; Infusions, Parenteral; Menopause; Metabol | 1986 |
Early postmenopausal bone loss is not associated with a decrease in circulating levels of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, or vitamin D-binding protein.
Topics: Bone Diseases, Metabolic; Calcifediol; Calcitriol; Estradiol; Estrone; Female; Humans; Longitudinal | 1987 |
Estrogen production and metabolism in normal postmenopausal women and postmenopausal women with breast or endometrial cancer.
Topics: Aged; Body Weight; Breast Neoplasms; Endometrial Hyperplasia; Estradiol; Estrone; Female; Humans; Me | 1986 |
[Serum hormone level and Kupperman menopausal complaints in sexually mature women with disturbance of ovulation].
Topics: Adult; Amenorrhea; Climacteric; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Gonadotrop | 1985 |
The effect of estrogen treatment on plasma concentrations of steroid hormones, gonadotropins, prolactin and sex hormone-binding globulin in post-menopausal women.
Topics: Adult; Aged; Estradiol; Estrogens; Estrone; Female; Follicle Stimulating Hormone; Gonadal Steroid Ho | 1985 |
The effect of low-dose piperazine oestrone sulphate and low-dose levonorgestrel on blood lipid levels in post-menopausal women.
Topics: Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Estrone; Female; Hu | 1985 |
Early menopausal changes in bone mass and sex steroids.
Topics: Adult; Androstenedione; Bone and Bones; Calcium; Calcium-Binding Proteins; Estradiol; Estrone; Fasti | 1985 |
Decrease of circulating level of SHBG in postmenopausal obese women as a risk factor in breast cancer: reversible effect of weight loss.
Topics: Aged; Androstenedione; Body Weight; Breast Neoplasms; Estradiol; Estrone; Female; Humans; Hydrocorti | 1986 |
Ovarian steroid secretion in postmenopausal women with and without endometrial cancer.
Topics: Aged; Androstenedione; Estradiol; Estrone; Female; Gonadal Steroid Hormones; Humans; Menopause; Midd | 1986 |
The effects of age and body composition on circulating serum oestrogens and androstenedione after the menopause.
Topics: Age Factors; Aged; Androstenedione; Body Composition; Body Height; Body Weight; Estradiol; Estrogens | 1985 |
Endogenous concentration and subcellular distribution of estrogens in normal and malignant human breast tissue.
Topics: Adolescent; Adult; Aged; Breast; Breast Neoplasms; Cell Nucleus; Cytosol; Estradiol; Estrogens; Estr | 1985 |
Bone mass and sex steroid concentrations in postmenopausal Caucasian diabetics.
Topics: Aged; Bone and Bones; Diabetes Mellitus; Diabetes Mellitus, Type 2; Estrone; Female; Gonadal Steroid | 1985 |
Oestrone sulphate, adipose tissue, and breast cancer.
Topics: Adipose Tissue; Animals; Breast; Breast Neoplasms; Cattle; Estrone; Female; Fibrocystic Breast Disea | 1985 |
Hormone metabolism: body weight and extraglandular estrogen production.
Topics: Adrenalectomy; Androstenedione; Anorexia Nervosa; Aromatase; Body Weight; Estrogens; Estrone; Female | 1985 |
Plasma oestrogens and oestrogen receptors in breast cancer patients.
Topics: Breast Neoplasms; Estradiol; Estrogens; Estrone; Female; Humans; Menopause; Receptors, Estrogen | 1985 |
Hormonal changes in postmenopausal women with breast cancer treated with trilostane and dexamethasone.
Topics: Adrenal Cortex Hormones; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Breast Neo | 1985 |
Endocrine profiles and breast cancer.
Topics: 11-Hydroxycorticosteroids; Adult; Aged; Breast Neoplasms; Dehydroepiandrosterone; Estradiol; Estriol | 1973 |
[Excretion of estrogens and testosterone following administration of dehydroepiandrosterone sulfate].
Topics: Administration, Oral; Adult; Dehydroepiandrosterone; Estradiol; Estriol; Estrogens; Estrone; Female; | 1970 |
Post-menopausal hyperoestrogenism caused by carcinoma of the adrenal cortex.
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenal Gland Neoplasms; Aged; Carcinoma; Dehydroepiandr | 1970 |
Studies on the urinary excretion, biological effects and origin of oestrogens in post-menopausal women.
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenal Glands; Adrenocorticotropic Hormone; Age Factors | 1968 |
Evaluation of equilin 3-monosulfate and other estrogens. Comparison by study of urinary gonadotropins in women.
Topics: 17-Ketosteroids; Administration, Oral; Adult; Aged; Amenorrhea; Animals; Biological Assay; Castratio | 1971 |
Piperazine estrone sulfate and conjugated estrogens equine in the treatment of the menopausal syndrome.
Topics: Adult; Aged; Anxiety; Blushing; Depression; Estrogens, Conjugated (USP); Estrone; Female; Genital Di | 1971 |
A technique for the assay of 17-hydroxyprogesterone (17-hydroxy-4-pregnene-3,20-dione) in serum using celite column chromatography and competitive protein binding.
Topics: 17-Ketosteroids; Acetates; Acylation; Alcohols; Androstanes; Anhydrides; Chemical Phenomena; Chemist | 1971 |
Carcinoma of the breast during estrogen replacement therapy.
Topics: Adult; Aged; Breast Diseases; Breast Neoplasms; Carcinoma; Carcinoma, Intraductal, Noninfiltrating; | 1972 |
Oestrogen metabolism in cultured human breast tumours.
Topics: Adenocarcinoma, Scirrhous; Adenofibroma; Breast Neoplasms; Carcinoma; Carcinoma, Intraductal, Noninf | 1972 |
Adrenal and testicular contribution to plasma oestrogens.
Topics: 17-Ketosteroids; Adrenal Glands; Adrenocorticotropic Hormone; Adult; Aged; Androstanes; Breast Neopl | 1972 |
[Separation of the sulfate and glucuronate fractions of urinary steriods: a new analytical method (author's transl)].
Topics: Adult; Androsterone; Chromatography, Thin Layer; Estradiol; Estrogens, Conjugated (USP); Estrone; Ev | 1974 |
Mass fragmentographic determination of eleven estrogens in the body fluids of pregnant and nonpregnant subjects.
Topics: 17-Ketosteroids; Aluminum; Bile; Chromatography; Chromatography, Gas; Estradiol; Estriol; Estrogens; | 1974 |
[Excretion of classic estrogens and total phenol steroids in patients with cancer of the uterine cervix].
Topics: Adult; Cell Nucleus; Chromatography, Thin Layer; Cobalt Radioisotopes; Estradiol; Estriol; Estrogens | 1974 |
Endocrine function of the postmenopausal ovary: concentration of androgens and estrogens in ovarian and peripheral vein blood.
Topics: Adult; Aged; Androstenedione; Arm; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Humans; | 1974 |
Comparison of quick methods of the estimation of estradiol in plasma by radioimmunoassay.
Topics: Adult; Cross Reactions; Estradiol; Estrone; Evaluation Studies as Topic; Female; Fertility; Humans; | 1974 |
The relationship between the extraglandular production of estrone and the occurrence of endometrial neoplasia.
Topics: Adenocarcinoma; Adult; Age Factors; Aged; Androstenedione; Endometrium; Estrone; Female; Humans; Men | 1974 |
[The effect of synthetic estrogens (mestranol, estrone cyanate and quinestrol) on carbohydrate and lipid metabolism during menopause].
Topics: Cyanates; Estradiol Congeners; Estrone; Fatty Acids, Nonesterified; Female; Glucose; Glucose Toleran | 1974 |
Estimation of "total-oestrogens". Evaluation of a fluorimetric method.
Topics: Adult; Aged; Animals; Biological Assay; Chromatography; Estradiol; Estriol; Estrogens; Estrone; Eval | 1974 |
Therapy of the menopause with esterified estrogens standardized with sodium estrone sulphate.
Topics: Aged; Esters; Estrogens; Estrone; Female; Humans; Menopause; Middle Aged; Sulfates; Time Factors | 1972 |
[Influence of the oral adminsitration of estrogens on serum gonadotropins and prolactin after the menopause].
Topics: Estradiol; Estrone; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menopause; Mi | 1972 |
Source of estrogen production in postmenopausal women.
Topics: Aging; Androstanes; Carbon Isotopes; Chromatography, Thin Layer; Estradiol; Estriol; Estrone; Female | 1973 |
Source of estrogen production in postmenopausal women.
Topics: Aging; Androstanes; Carbon Isotopes; Chromatography, Thin Layer; Estradiol; Estriol; Estrone; Female | 1973 |
Source of estrogen production in postmenopausal women.
Topics: Aging; Androstanes; Carbon Isotopes; Chromatography, Thin Layer; Estradiol; Estriol; Estrone; Female | 1973 |
Source of estrogen production in postmenopausal women.
Topics: Aging; Androstanes; Carbon Isotopes; Chromatography, Thin Layer; Estradiol; Estriol; Estrone; Female | 1973 |
Estrogen metabolism in patients at high risk for endometrial carcinoma. II. The role of androstenedione as an estrogen precursor in postmenopausal women with endometrial carcinoma.
Topics: 17-Ketosteroids; Aged; Androgens; Androstenedione; Carbon Isotopes; Endometrium; Estriol; Estrogens; | 1973 |
Plasma estrogens in postmenopausal women.
Topics: Adult; Age Factors; Aged; Body Weight; Castration; Diabetes Mellitus; Endometrial Hyperplasia; Endom | 1973 |
Radioimmunoassay of serum estrogen.
Topics: Animals; Binding Sites, Antibody; Charcoal; Chromatography, Gel; Dextrans; Estradiol; Estrogens; Est | 1973 |
Urinary oestrogens in normal Egyptian subjects and in patients with bilharzial hepatosplenomegaly.
Topics: Adult; Biopsy; Egypt; Estradiol; Estriol; Estrogens; Estrone; Female; Hepatomegaly; Humans; Liver; L | 1973 |
[Proceedings: Etiology of corpus carcinoma].
Topics: Adipose Tissue; Androstenedione; Diabetes Complications; Estradiol; Estrone; Female; Humans; Hyperte | 1973 |
Androgens in breast cancer. II. Endometrial adenocarcinoma and breast cancer in married postmenopausal women.
Topics: Adenocarcinoma; Age Factors; Breast Neoplasms; Estradiol; Estrogens; Estrone; Female; Humans; Hyperp | 1974 |
An improved assay for plasma oestradiol using competitive protein binding.
Topics: Adult; Animals; Binding Sites; Chromatography, Affinity; Climacteric; Estradiol; Estrone; Evaluation | 1974 |
Postmenopausal bleeding.
Topics: Adenocarcinoma; Adrenal Glands; Estradiol; Estrogens; Estrone; Ethinyl Estradiol; Female; Humans; Me | 1974 |
[Study of the plasma and urinary steroids in the course of treatment of anovulation by human urinary gonadotropins. Presence of estradiol in increased quantities in peripheral vein in the blood in period of follicular maturation].
Topics: Amenorrhea; Chromatography, Ion Exchange; Desoxycorticosterone; Estradiol; Estrogens; Estrone; Femal | 1968 |
Urinary estrogen production rates in normal and endocrine-ablated subjects.
Topics: 17-Ketosteroids; Adrenal Glands; Adrenalectomy; Adult; Age Factors; Androstanes; Carbon Isotopes; Ca | 1972 |
Genetic predisposition to carcinoma of the breast: multiple human genotypes for estrogen 16 alpha hydroxylase activity in Caucasians.
Topics: Breast Diseases; Breast Neoplasms; Estradiol; Estriol; Estrone; Female; Genital Neoplasms, Female; G | 1972 |
Gas-liquid chromatographic quantitation of urinary estrogens in nonpregnant women, postmenopausal women, and men.
Topics: Chromatography, Gas; Chromatography, Ion Exchange; Chromatography, Thin Layer; Estradiol; Estriol; E | 1971 |
[Estrogen excretion in the female castrate].
Topics: Age Factors; Castration; Estradiol; Estriol; Estrogens; Estrone; Female; Humans; Menopause; Ovary | 1971 |
Evaluation of gas-liquid chromatographic techniques for the estimation of oestrogens.
Topics: Amniotic Fluid; Blood; Castration; Chemistry, Clinical; Chromatography, Gas; Colorimetry; Estradiol; | 1971 |
Metabolic clearance and blood production rates of estrogens in postmenopausal women.
Topics: Age Factors; Carbon Isotopes; Estradiol; Estrone; Female; Menopause; Metabolic Clearance Rate; Triti | 1971 |
Estrogen metabolism in patients at high risk for endometrial carcinoma. I. Urinary metabolites of H3-estradiol in normal postmenopausal women and those with endometrial carcinoma.
Topics: Chromatography; Endometrium; Estradiol; Estriol; Estrone; Female; Humans; Menopause; Middle Aged; Tr | 1969 |
Studies on the influence of age on oestrogens in post-menopausal women with atrophic endometrium and normal liver function.
Topics: Age Factors; Aged; Aging; Atrophy; Castration; Endometrium; Estradiol; Estriol; Estrogens; Estrone; | 1969 |
Estimation of estrone and estradiol in low level urines using electron-capture gas-liquid chromatography.
Topics: 17-Ketosteroids; Adult; Androstanes; Carbon Isotopes; Child, Preschool; Chromatography, Gas; Chromat | 1970 |
The effect of natural sex steroids on the excretion of follicle-stimulating and luteinizing hormone in postmenopausal women.
Topics: Animals; Biological Assay; Estradiol; Estriol; Estrone; Female; Follicle Stimulating Hormone; Gonada | 1970 |
[Urinary excretion of estrogens in women with bleeding during climacteric and in menopause].
Topics: Aged; Climacteric; Estradiol; Estriol; Estrogens; Estrone; Female; Humans; Menarche; Menopause; Mens | 1970 |
Relationship between hormonal cytology and steroid excretion in post-menopausal women.
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Aged; Androsterone; Breast Neoplasms; Estriol; Estrogens | 1970 |
[Aacifemine compared with Equigyne in the therapy of menopause disorders].
Topics: Estradiol; Estriol; Estrone; Female; Genital Diseases, Female; Humans; Menopause; Middle Aged | 1969 |
Urinary excretion of oestrogens and the oestrogenic effect in vaginal smears in post-menopausal women with uterine bleeding.
Topics: Curettage; Endometrium; Estradiol; Estriol; Estrone; Female; Humans; Menopause; Metrorrhagia; Middle | 1970 |
Studies on the human metabolism of 6:7 3 H oestradiol.
Topics: Adult; Aged; Breast Neoplasms; Colonic Neoplasms; Estradiol; Estriol; Estrone; Female; Humans; Male; | 1970 |
Recent studies on the estimation of human pituitary gonadotrophins in urine in clinical conditions.
Topics: Adult; Aged; Animals; Ascorbic Acid; Climacteric; Clomiphene; Contraceptives, Oral; Estradiol; Estri | 1970 |
The ovarian response in women to large single injections of human menopausal gonadotrophin and human chorionic gonadotrophin.
Topics: Adult; Biopsy; Chorionic Gonadotropin; Corpus Luteum; Estradiol; Estriol; Estrone; Female; Gonadotro | 1970 |
Oestrogenic function in postmenopausal women.
Topics: Age Factors; Aged; Estradiol; Estriol; Estrogens; Estrone; Female; Fluorometry; Humans; Menopause; M | 1971 |
Endocrinological studies in women approaching the menopause.
Topics: Adult; Age Factors; Estradiol; Estriol; Estrogens; Estrone; Feedback; Female; Follicle Stimulating H | 1971 |
A gaschromatographic method for the measurement of small amounts of estrogens in urine.
Topics: Aged; Alkylation; Carbon Isotopes; Chromatography, Gas; Chromatography, Thin Layer; Estradiol; Estri | 1968 |
Hypothalamopituitary hyperactivity and endometrial carcinoma. Qualitative and quantitative disturbances in hormone production.
Topics: Cholesterol; Chromatography, Thin Layer; Endometrium; Estradiol; Estriol; Estrogens; Estrone; Fatty | 1968 |
[The urinary excretion of estrogens in patients with far advanced breast cancer during treatment with prednisolone].
Topics: Adrenal Glands; Breast Neoplasms; Castration; Chromatography; Estradiol; Estriol; Estrogens; Estrone | 1968 |
Estrogen metabolism in postmenopausal women with primary and recurrent breast cancer.
Topics: Aging; Breast Neoplasms; Estradiol; Estriol; Estrogens; Estrone; Female; Humans; Menopause; Middle A | 1968 |
Concentration of unconjugated estrone and estradiol in peripheral plasma in nonpregnant women throughout the menstrual cycle, castrate and postmenopausal women and in men.
Topics: Adult; Aged; Analysis of Variance; Castration; Circadian Rhythm; Estradiol; Estrogens; Estrone; Fema | 1969 |
The climacteric and some of its problems.
Topics: Adolescent; Adrenal Glands; Adult; Arteriosclerosis; Climacteric; Coronary Disease; Diethylstilbestr | 1969 |
Endocrine function in postmenopausal women.
Topics: Estradiol; Estriol; Estrogens; Estrone; Female; Humans; Luteinizing Hormone; Menopause; Middle Aged | 1969 |
A study of estrogen metabolic clearance rates and transfer factors.
Topics: Adult; Estradiol; Estrogens; Estrone; Female; Glucocorticoids; Humans; Kinetics; Male; Menopause; Me | 1969 |
[On the endocrine substrate of diffuse female (androgenetic) alopecia].
Topics: Adult; Aged; Alopecia; Androgens; Estradiol; Estriol; Estrone; Female; Gonadotropins; Humans; Lynest | 1966 |
[Correlation between total gonadotropin excretion and estrogen levels in the urine in the climacteric].
Topics: Estradiol; Estriol; Estrogens; Estrone; Female; Gonadotropins; Humans; Menopause; Middle Aged | 1966 |